2008-2009 Basic and Clinical Science Course: Section 5: Neuro-Ophthalmology (Basic and Clinical Science Course 2008-2009)

NeuroOphthalmology Section5 2008-2009 (Last major revision 2005-2006)

~]

(j

'][~ \.V

AMERICAN ACADEMY OF OPHTHALMOLOGY TheEyeM.D.Association

L I Ff I ON EDUCATION

It.. IIi! l) I) Ij ( ~ o P H r HAL M I

r'

The Basic and Clinical Education

bers in planning of clinical alized, Active members

Science

Course

for the Ophthalmologist their continuing

education

products

self-directed

is one component

(LEO) framework, medical

education.

that members

learning

credits

to earn the LEO Award. Contact

further

information

LEO includes

an array

may select to form individu-

plans for updating

or fellows who use LEO components

of the Lifelong

which assists mem-

their clinical

may accumulate

the Academy's

Clinical

knowledge.

sufficient

Education

CME

Division

for

on LEO.

The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American maximum

Academy

of 40 AMA

commensurate

provides

this material

the only or best method

cian's own judgment is beyond inserts

for educational

purposes

or other independent

sources,

and considered

is made for illustrative

purposes

only and is not intended

may include

that reflect indications

for use only in restricted

it is the responsibility device

he or she wishes

consent

in compliance

and all liability

of the physician with

applicable

and other products to constitute

on applications

not included research

to determine

to use, and to use them

an endorsement FDA labeling,

The FDA has stated

the FDA status

with appropriate,

of each drug informed

specifically

that may arise from the use of any recommendations

information

herein.

or that or

patient

disclaims

of any kind, from negligence

Copyright @ 2008 American Academy of Ophthalmology All rights reserved Printed in Singapore

condition

in this course

for any and all claims contained

be

package

that are not considered

in approved

settings.

law. The Academy

for injury or other damages

all indicashould

in light of the patient's

of such. Some material standard,

instruments.

information

Including

in the manufacturers'

drugs,

that are approved

only. It is not intended

and recommendations

included

to certain

community

Reference

for a

agents for each drug or treatment

All information information

activity

only claim credit

in every case, nor to replace a physi-

advice for case management.

the scope of this material.

and history.

should

in the activity.

side effects, and alternative

prior to use, with current

this educational

Physicians

or procedure

or give specific

tions, contraindications. verified.

designates

1 Credits.

with the extent of their participation

The Academy to represent

of Ophthalmology PRA Category

any

or otherwise, or other

Basic and Clinical Science Course Gregory L. Skuta, MD, Oklahoma City, Oklahoma, Senior Secretary for Clinical

Education

Louis B. Cantor, MD, Indianapolis, Indiana, Secretary for Ophthalmic Knowledge

Jayne S. Weiss, MD, Detroit, Michigan, BCSC Course Chair

Section 5 Faculty Responsible for This Edition Lanning B. Kline, MD, Chair, Birmingham, Alabama Anthony C. Arnold, MD, Los Angeles, California Eric Eggenberger, DO, East Lansing, Michigan Rod Foroozan, MD, Houston, Texas Karl C. Golnik, MD, Cincinnati, Ohio Joseph F. Rizzo III, MD, Boston, Massachusetts Harold E. Shaw, MD, Greenville, South Carolina Practicing Ophthalmologists Advisory Committee for Education Dr. Eggenberger states that he has an affiliation with Biogen and Teva. The other authors state that they have no significant financial interest or other relationship with the manufacturer of any commercial product discussed in the chapters that they contributed to this course or with the manufacturer of any competing commercial product. Recent Past Faculty Deborah 1. Friedman, MD Steven A. Newman, MD Patrick S. O'Connor, MD In addition, the Academy gratefully acknowledges the contributions of numerous past faculty and advisory committee members who have played an important role in the development of previous editions of the Basic and Clinical Science Course.

American Academy of Ophthalmology Staff Richard A. Zorab, Vice President, Ophthalmic Knowledge Hal Straus, Director, Publications Department Carol L. Dondrea, Publications Manager Christine Arturo, Acquisitions Manager Nicole DuCharme, Production Manager Stephanie Tanaka, Medical Editor Steven Huebner, Administrative Coordinator

'][~ ~

AMERICAN ACADEMY OF OPHTHALMOLOGY The Eyt M.D. Auoc;"t;on

655 Beach Street Box 7424 San Francisco, CA 94120-7424

Contents General Introduction

.xi

Objectives . . . Introduction. .

.1

1 Neuro-Ophthalmic Anatomy

.3

.5

Bony Anatomy . Skull Base . . The Orbit . . Vascular Anatomy Arterial System . Venous System . Afferent Visual Pathways Retina. . . . Optic Nerve . Optic Chiasm. Optic Tract. . Cortex. . . . Efferent Visual System (Ocular Motor Pathways) Extraocular Muscles. . . . . . Cranial Nerves . . . . . . . . Facial Motor and Sensory Anatomy. Trigeminal Nerve (CN V) Facial Nerve (CN VII). . Eyelids. . . . . . . . . Ocular Autonomic Pathways . Sympathetic Pathways. . Parasympathetic Pathways

. 5 .5 .9 10 II 20 23 23 25 27 27 28 32 41 42 49 50 54 56 56 56 57

2 Neuroimaging in Neuro-Ophthalmology

61

History . . . . . . . . . . . . . Computerized Tomography . . . . Magnetic Resonance Imaging (MRI) Vascular Imaging. . . . . . . . . Conven tional! Cath eter /Con tras tAn giograp hy Radiation Therapy . . . . . . . . . Fundamental Concepts in Localization Critical Questions in Imaging When to Order . What to Order How to Order. Negative Studies Glossary. . . . .

61 61 62 66 66 69 70 71 71 75 78 78 78 v

vi

.

Contents

3

The Patient With Decreased Vision: Evaluation.

83

History . . . . . . . . . . . . . . . . Unilateral Versus Bilateral Involvement Time Course of Visual Loss. Associated Symptoms . . . . Examination. . . . . . . . . . Best-Corrected Visual Acuity. Pupillary Testing . . Fundus Examination Visual Fields . . . Adjunctive Testing .

4

The Patient With Decreased Vision: Classification and Management. Ocular Media Abnormality. Maculopathy. . . . . . . Cone Dystrophy . . . Age- related Macular Degeneration Cystoid Macular Edema . . . . . Central Serous Chorioretinopathy . Macular Hole. . . . Epiretinal Membrane . . . . . Other Retinopathy . . . . . . . . Central Retinal Artery Occlusion Central Retinal Vein Occlusion . Multiple Evanescent White Dot Syndrome Acute Zonal Occult Outer Retinopathy.

Paraneoplastic Syndromes Retinitis Pigmentosa. Amblyopia. . . . . . . Optic Neuropathy. . . . Visual Field Patterns. Anterior Optic Neuropathies With Optic Disc Edema Anterior Optic Neuropathies Without Optic Disc Edema. Posterior Optic Neuropathies. Optic Atrophy . . . Chiasmal Lesions. . . . . . . . Visual Field Patterns. . . . . Parasellar Lesions Affecting the Chiasm Retrochiasmal Lesions. . . . Visual Field Loss Patterns Optic Tract. . . Temporal Lobe Parietal Lobe . Occipital Lobe

5

83 83 83 83 84 84 84 87 89 96

103 . . . .

103 104 104 104

. 104 . 105 . 105

. 105 . 105 . 105 . 106 . 107 . 107 . 108 . 110 . III . III . III . III . 129 . 141 . 157 . 158 . 158 . 160 . 164 . 164 . 164 . 166 . 166 . 167

The Patient With Transient Visual Loss

171

Examination. . . . . . . . . . Transient Monocular Visual Loss. . . . . . . . .

. 173 . 173

Contents. Ocular. . Orbital. . Systemic . Vasospasm/H yperviscosity/ Hypercoagulability Transient Binocular Visual Loss. Migraine. . . . . . Occipital Mass Lesion Occipital Ischemia. Occipital Seizures. .

6

.

and Disorders of Higher Cortical Function .

173 175 175 184 185 185 185 185 186

187 . 187 . 187 . 189 . 189 . 189 . 189 . 190 . 190 . 191 . 192 . 194 . 195

The Patient With Supranuclear Disorders . . . . . . . . . . . . Fundamental Principles of Ocular Motor Control. . . Anatomy and Clinical Testing of the Functional Classes of Eye Movements . . . Ocular Stability. . . . Vestibulo-Ocular Reflex Optokinetic Nystagmus Saccadic System. Pursuit System . . . . Convergence. . . . . Clinical Disorders of the Ocular Motor Systems. Ocular Stability Dysfunction . . . . Vestibulo-Ocular Dysfunction . . . Optokinetic Nystagmus Dysfunction. Saccadic Dysfunction Pursuit Dysfunction. . . . Vergence Disorders . . . . Tonic Deviation of the Eyes.

197 . 197

The Patient With Diplopia.

213 . 213 . 213

of Ocular Motility

8

. . . . . . . . .

The Patient With Hallucinations, Illusions, The Patient With Illusions . Ocular Origin . . Optic Nerve Origin . . Cortical Origin. . . . The Patient With Hallucinations Ocular Origin . . Optic Nerve Origin . . . . Cortical Origin. . . . . . The Patient With Disorders of Higher Cortical Function. The Patient With Problems of Object Recognition. . The Patient With Disordered Visual-Spatial Relationships The Patient With Problems With Awareness of Vision or Visual Deficit . . . . . . . . . . . . . . .

7

vii

History . . . . . . . Physical Examination. . . . . . .

. 199 . 199 .200 .201 .202 .203 .203 .204 .204 . 205 . 205 .206 . 210 .210 . 211

viii

.

9

Contents

Monocular Diplopia. Comitant Deviations Divergence Insufficiency. Skew Deviation. . . . . Incomitant Deviations. . Differentiating Neural and Restrictive Etiologiesof Ocular Palsy Restrictive Syndromes. . . . . . . Thyroid-Associated Orbitopathy . . Posttraumatic Restriction . . . . . Post-Cataract Extraction Restriction. Orbital Myositis. . . . Neoplastic Involvement . . . Brown Syndrome. . . . . . Congenital Fibrosis Syndrome Paretic Syndromes . . . . . . . Central Lesions of the Ocular Motor Cranial Nerves. Supranuclear Involvement Internuclear Involvement. Nuclear Involvement . . Fascicular Involvement. . Peripheral Lesionsof the Ocular Motor Cranial Nerves Subarachnoid Involvement. . . . . . . . . . . Cavernous Sinus and Superior Orbital Fissure Involvement .

. 235

The Patient With Nystagmus or Spontaneous Movement Disorders. . .

239

. 216 . 216 . 216 . 217 . 217 . 217 . 217

. 217 . 218 . 219 . 219 . 219 . 219 . 220 . 221 . 221

. 222 . 224 . 226 . 227 . 227 . 227

Eye

Introduction. . . . . . . . . . . Early-Onset (Childhood) Nystagmus Congenital Nystagmus. . . . . Latent Nystagmus. . . . . . . Monocular Nystagmus of Childhood. Spasmus Nutans . . Gaze-Evoked Nystagmus. Rebound Nystagmus. Vestibular Nystagmus. . Peripheral Vestibular Nystagmus

Central Forms of Vestibular Nystagmus Acquired Pendular Nystagmus Oculopalatal Myoclonus . See-SawNystagmus. . Dissociated Nystagmus . . . Saccadic Intrusions. . . . . Saccadic Intrusions With Normal Intersaccadic Intervals. Saccadic Intrusions Without Normal Intersaccadic Interval. Voluntary Nystagmus . . . . . . . Additional EyeMovement Abnormalities Convergence-Retraction Nystagmus.

. 239 . 241 . 241 . 242 . 243 . 243 . 244 . 244 . 245

. 245

. 247 . 250 . 251 . 251 . 251 . 252 . 252 . 253 . 253 . 254 . 254

.

Contents Superior Oblique Myokymia . . Oculomasticatory Myorhythmia. Treatment of Nystagmus. . . . . . Eye Movements in Comatose Patients . Ocular Bobbing . . . . . . . . . .

10

11

ix

.254 . 255 . 255 . 256 . 256

The Patient With Pupillary Abnormalities.

257

History . . . . . . . Pupillary Examination. Baseline Pupil Size Pupil Irregularity. . . Anisocoria. . . . . . Physiologic Anisocoria. Anisocoria Equal in Dim and Bright Light Anisocoria Greater in Dim Light . . . . Anisocoria Greater in Bright Light. . . . Disorders of Pupillary Reactivity: Light-Near Dissociation. Afferent Visual Pathway . . . . . . . . Midbrain. . . . . . . . . . . . . . . Aberrant Regeneration of the Third Nerve Rare Pupillary Disorders. . . . . . . . Paradoxical Pupillary Reactions. . . Benign Episodic Pupillary Mydriasis.

. 257 . 258 . 259 . 259 . 260 . 260 . 260 . 260 . 265 . 269 . 269 . 270 . 270 . 270 . 270 . 270

The Patient With Eyelid or Facial Abnormalities

273

Examination Techniques. Ptosis. . . . . . . . Congenital Ptosis. Acquired Ptosis. . Pseudoptosis. . . Apraxia of Lid Opening Eyelid Retraction. . . . . Abnormalities of Facial Movement Seventh Nerve Disorders. . . . . Disorders of Underactivity of the Seventh Nerve. Disorders of Overactivity of the Seventh Nerve .

. . . . . . .

12 The Patient With Head, Ocular, or Facial Pain Evaluation of Headache . . . . . . . . . Migraine and Tension-Type Headache. . . . . Cluster Headache. . . . . . . . . . . . . . Icepick Pains and Idiopathic Stabbing Headache. Inherited Encephalopathies Resembling Migraine . Ocular and Orbital Causes of Pain Photophobia . . . . Facial Pain. . . . . . . . . . Trigeminal Neuralgia . . . Glossopharyngeal Neuralgia Temporomandibular Disease .

273 276 276 277 278 278 279 . 280 . 281 . 281 . 286

291 . . . . .

291 292 297 297 297 . 298 . 299 . 299 . 299 . 300 . 300

x

.

Contents Carotid Dissection . . . . . Herpes Zoster Ophthalmicus . Neoplastic Processes. . . Mental Nerve Neuropathy . .

13

The Patient With Functional Visual Disorders Examination Techniques. . . . . . Afferent Visual Pathway . . . . Ocular Motility and Alignment . Pupils and Accommodation . . Disturbances of Eyelid Position and Function. Management of the Functional Patient. . . . .

14

Selected Systemic Conditions With Neuro-Ophthalmic Signs Immunologic Disorders . Multiple Sclerosis. . . . . . . Myasthenia Gravis . . . . . . Thyroid-Associated Orbitopathy (Thyroid Eye Disease, Graves Ophthalmopathy). . . . Sarcoidosis. . . . . . . . . . . . . . . Intraocular Manifestations. . . . . . Neuro-Ophthalmologic Manifestations. Diagnosis . . . Treatment . . . Inherited Disorders. Myopathies. . . Neurocutaneous Syndromes (Phakomatoses) . Neuro-Ophthalmic Disorders Associated With Pregnancy Cerebrovascular Disorders. Transient Visual Loss . . . . . Carotid System. . . . . . . . Vertebrobasilar System Disease . Cerebral Aneurysms. . . . . Arterial Dissection . . . . . . Arteriovenous Malformations. . Cerebral Venous and Dural Sinus Thrombosis Neuro-Ophthalmic Manifestations of Infectious Diseases Acquired Immunodeficiency Syndrome Lyme Disease. . . . Fungal Infections . . Cat-Scratch Disease.

BasicTexts. . . . . Related Academy Materials. Credit Reporting Form. Study Questions. Answers . Index. . . . .

.300 .300 . 301 . 301 303 .305 .305 . 311 . 313 . 314 . 315

317 . 317 . 317 . 325 .329 .332 . 333 .333 . 333 .333 . 334 .334 .335 .343 .345 .345 .346 .347 .350 .354 . 355 . 357 .358 .359 .362 .364 .368 .369 . 371 . 373 .377 .384 .389

General Introduction

The Basic and Clinical Science Course (BCSC) is designed to meet the needs of residents and practitioners for a comprehensive yet concise curriculum of the field of ophthalmology. The BCSC has developed from its original brief outline format, which relied heavily on outside readings, to a more convenient and educationally useful self-contained text. The Academy updates and revises the course annually, with the goals of integrating the basic science and clinical practice of ophthalmology and of keeping ophthalmologists current with new developments in the various subspecialties. The BCSC incorporates the effort and expertise of more than 80 ophthalmologists, organized into 13 Section faculties, working with Academy editorial staff. In addition, the course continues to benefit from many lasting contributions made by the faculties of previous editions. Members of the Academy's Practicing Ophthalmologists Advisory Committee for Education serve on each faculty and, as a group, review every volume before and after major revisions. Organization of the Course The Basic and Clinical Science Course comprises 13 volumes, incorporating fundamental ophthalmic knowledge, subspecialty areas, and special topics: 1 2 3 4 5 6 7 8 9 10 11 12 13

Update on General Medicine Fundamentals and Principles of Ophthalmology Clinical Optics Ophthalmic Pathology and Intraocular Tumors Neuro-Ophthalmology Pediatric Ophthalmology and Strabismus Orbit, Eyelids, and Lacrimal System External Disease and Cornea Intraocular Inflammation and Uveitis Glaucoma Lens and Cataract Retina and Vitreous Refractive Surgery

In addition, a comprehensive throughout the entire series.

Master Index allows the reader to easily locate subjects

References Readers who wish to explore specific topics in greater detail may consult the references cited within each chapter and listed in the Basic Texts section at the back of the book. These references are intended to be selective rather than exhaustive, chosen by the BCSC faculty as being important, current, and readily available to residents and practitioners. xi

xii

.

General Introduction

Related Academy educational materials are also listed in the appropriate sections. They include books, online and audiovisual materials, self-assessment programs, clinical modules, and interactive programs. Study Ouestions and CMECredit Each volume of the BCSC is designed as an independent study activity for ophthalmology residents and practitioners. The learning objectives for this volume are given on page 1. The text, illustrations, and references provide the information necessary to achieve the objectives; the study questions allow readers to test their understanding of the material and their mastery of the objectives. Physicians who wish to claim CME credit for this educational activity may do so by mail, by fax, or online. The necessary forms and instructions are given at the end of the book. Conclusion The Basic and Clinical Science Course has expanded greatly over the years, with the addition of much new text and numerous illustrations. Recent editions have sought to place a greater emphasis on clinical applicability while maintaining a solid foundation in basic science. As with any educational program, it reflects the experience of its authors. As its faculties change and as medicine progresses, new viewpoints are always emerging on controversial subjects and techniques. Not all alternate approaches can be included in this series; as with any educational endeavor, the learner should seek additional sources, including such carefully balanced opinions as the Academy's Preferred Practice Patterns. The BCSC faculty and staff are continuously striving to improve the educational usefulness of the course; you, the reader, can contribute to this ongoing process. If you have any suggestions or questions about the series, please do not hesitate to contact the faculty or the editors. The authors, editors, and reviewers hope that your study of the BCSC will be oflasting value and that each Section will serve as a practical resource for quality patient care.

Objectives Upon completion of BCSC Section 5, Neuro-Ophthalmology, reader should be able to

.

describe a symptom-driven

the

approach to patients with common

neuro-ophthalmic complaints in order to formulate an appropriate differential diagnosis

. select the most appropriate

. .

tests and imaging, based upon symptomatology, to diagnose and manage neuro-ophthalmic disorders in a cost-effective manner review anatomic structures relevant to the neuroophthalmologist (including the skull and orbit, brain, vascular system, and cranial nerves) in order to localize lesions assess eye movement disorders and the ocular motor system

. describe the association between pupil and eyelid position and

. .

ocular motor pathology review the pathophysiology and management of diplopia and central eye movement disorders identify the effects of systemic disorders on visual and ocular motor pathways

. explain the possible systemic significance of ophthalmic disorders

Introduction The Basic and Clinical Science Course has undergone continuous evolution since its inception. These volumes originated as a topic outline with suggested reading lists, including primary and secondary sources for each topic. In recent years, the books have grown into far more detailed reviews of each of the ophthalmic subspecialties, taking on many of the attributes of textbooks. Section 5, Neuro-Ophthalmology, has likewise evolved. With the revision published in 200 1, we introduced a relatively major change in format. To increase clinical relevance, the text was reorganized to take a symptom-driven approach, focusing on how to approach patients with neuro-ophthalmic complaints. The emphasis here is on the examinationboth basic and extended-and the appropriate use of adjunctive studies to determine the status of the visual system as a whole. With this edition, we have simplified some of the diagnostic approaches, revised much of the illustrative material, and updated references. This book is in no way a substitute for a textbook; thus, we have included a list of some of the more useful secondary sources of information as well as references with primary source material. We have endeavored to make this book more readable as well as clinically relevant and hope that it will help to instill confidence in approaching patients with common clinical neuro-ophthalmic problems.

3

CHAPTER 1

Neuro-Ophthalmic Anatomy

Medicine in general and surgical subspecialties in particular are exercises in applied anatomy. Although an adequate understanding of physiology and, increasingly, molecular genetics is important in understanding disease and potential treatments, anatomy is the foundation. Important anatomic topics for the neuro-ophthalmologist include the anatomy of the globe (both the anterior and posterior segments), the orbit and adnexal structures, and the afferent and efferent visual pathways with their intracranial projections. The anatomy of the globe and adnexal structures is covered in more detail in BCSC Section 2 (Fundamentals and Principles of Ophthalmology), Section 7 (Orbit, Eyelids, and Lacrimal System), and Section 8 (External Diseaseand Cornea). The material in this book is not intended to substitute for detailed anatomy texts; rather, it focuses on tracing the important anatomic connections that underlie visual function. Accordingly, we outline the intracranial pathways subserving the afferent and efferent visual pathways. We also briefly discuss the sensory and motor anatomy of the face and the autonomic nervous system as it applies to the eye and visual system.

Bony Anatomy The relevant bony anatomy is discussed in the following sections. Skull Base Understanding the anatomy of the visual pathways should start with the bony anatomy of the head. The skull base in particular has an intimate relationship with visually critical structures. The orbit makes up the anterior aspect of the skull base, which is connected posteriorly to the parasellar region. The roof of the orbit is formed by the frontal bone anteriorly and the sphenoid bone posteriorly (Fig 1-1). The sella turcica, located posterior and medial to the 2 orbits, is a skull-based depression within the body of the sphenoid. The body of the sphenoid bone is pierced by the optic canals, which allow the optic nerves to exit from the orbit. The superior orbital fissure, which transmits the ocular motor nerves (cranial nerves III, IV, VI), the sensory trigeminal nerve (CN VI)' the sympathetics, and the superior ophthalmic vein (Fig 1-2), represents the gap between the lesser and greater

wings of the sphenoid. The parasellar region is connected laterally to the petrous and temporal bones and inferiorly to the clivus, extending to the foramen magnum and the exit of the spinal cord. The posterior skull base is enclosed by the occipital bones. The skull base is connected to the lower facial skeleton by 3 sets of pillars formed by the maxillary and zygomatic bones anteriorly and the pterygoid process of the sphenoid 5

6

. Neuro-Ophthalmology

Figure ,-,

A. The anterior

orbital

roof is

formed by the frontal bone, which joins the zygomatic bone laterally at the frontozygomatic suture (solid arrow), The notch medially (supraorbital notch, labeled SF) transmits the terminal branches of the frontal nerve, The frontal process of the maxilla (*) extends upward to form part of the lateral wall of the nose, The zygoma articulates with the maxilla at the zygomatomaxillary suture (open arrow), The floor of the orbit is composed of the maxillary bone medially, which contains the infraorbital foramen (!labeled IA usually 7 mm from the orbital rim) and the zygomatic bone laterally, The sphenoid bone, seen in the center of the orbital opening, forms the posterior lateral wall of the orbit just temporal to the superior orbital fissure, B. In this view looking down on the right orbital roof, the skullcap and the frontal lobes have been removed, Anteriorly, the paired cribriform plates (CP) transmit the nasal olfactory fibers and are separated by the elevated crista galli (CG), The most posterior extent of the orbital roof is the anterior clinoid, which is just temporal to the optic canal (OC) (or optic foramen) and represents the lesser wing (LW) of the sphenoid, The frontosphenoidal sutures (*) separate the frontal bone from the more posterior sphenoid bone, The temporal lobe has also been removed to show the floor of the middle cranial fossa (MCF), The cavernous sinus occupies the medial aspect of the middle cranial fossa (just lateral to the sella). The divisions of CN V (trigeminal) exit the middle cranial fossa through the large oval opening (foramen ovale [FO!. containing the mandibular division); the notch just below and temporal to the anterior clinoid (foramen rotundum [FRI, containing the maxillary division); and the superior orbital fissure hidden beneath the anterior clinoid (containing the ophthalmic division). Just lateral to the FO, the small oval opening (foramen spinosum [FSA transmits the middle meningeal artery, C. Bony components of the right orbit (colored): maxilla (orange); zygoma (beige); sphenoid bone, greater wing (light blue); lesser wing (dark blue); palatine bone (light green); ethmoid bone {lamina papyraceal (purple); lacrimal bone (pink); frontal bone (green). D. The orbital walls, Top, The roof is composed mainly of the orbital plate of the frontal bone with a minor contribution of the lesser wing of the sphenoid posteriorly where it joins the optic canal (optical foramen [OFI), Approximately 5 mm posterior to the medial aspect of the rim, the trochlear fossa (TF) denotes the attachment of the cartilaginous pulley for the tendon of the superior oblique muscle, The lacrimal gland lies in the fossa (lacrimal fossa [LFI) anteriorly and temporally, Middle left, The lateral wall is formed by the orbital surface of the zygomatic (l) bone (beige to the left! anteriorly and the greater wing of the sphenoid ([SI light blue to the right! posteriorly, The superior orbital fissure (SOF) divides the light blue greater wing from the dark blue lesser wing, The inferior orbital fissure (IOF) divides the light blue sphenoid from the orange maxilla, This fissure transmits venous and nervous branches to the sphenopalatine ganglion (WT) and pterygoids below, Whit nail's tubercle is the point of attachment for several structures, At the anterior end of the inferior orbital fissure, a small groove serves as the passage for the zygomatic nerve and vessels (arrow),

(Continues)

B

c

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

7

D Figure 1-1 The small openings (ZF) in the zygomatic bone (beige) transmit the zygomaticofacial and zygomaticotemporal branches of the maxillary division of the trigeminal nerve. Near the upper end of the superior orbital fissure. the orbital branch of the middle meningeal artery may pass through the meningeal foramen (MF). Bottom, Most of the orbital floor is formed by the orbital plate of the maxilla (orange!. This contains the infraorbital groove (IG), which transmits the infraorbital nerve. Small contributions to the floor are made laterally by the maxillary process of the zygomatic bone (beige) and posteriorly by the palatine bone (light green). The hole at the bottom of the picture (anteriorly in the floor) carries the nasolacrimal duct inferiorly into the inferior meatus of the nose. A shallow rough area at the anteromedlal angle (stippled) marks the origin of the inferior oblique muscle. Middle right, Anteriorly, the medial wall is bounded by the anterior lacrimal crest (ALC) formed by the frontal process of the maxilla (orange). Just behind the orbital rim the lacrimal bone (pink) contains the posterior lacrimal crest (PLC), which is a ridge at the back edge of the lacrimal sac. Most of the medial wall is made up of the ethmoid bone (purple!. Superiorly, the anterior and posterior ethmoid foramina transmit the anterior (A E) and posterior (PE) ethmoid vessels and nerves. This border with the frontal bone (green) also marks the level of the cribriform plate and thus the anterior cranial fossa above and the ethmoids below. (Reproduced with permission from Zide BM Jelks GW Surgical Anatomy of the Orbit. New York: Raven; 1985.1

l

8

. Neuro-Ophthalmology

/)

B

J .A J1t-..

Figure1-2 A. The superior orbital fissure (50F) widens medially where it lies below the level of the optic foramen. Its total length is 22 mm. Note the foramen rotundum (FA)just inferior to the confluence between the SOF and inferior orbital fissure (lOF).B. The common tendinous ring, or annulus of Zinn, divides the SOF. The extraocular muscles arise from this common ring. The portion of the annulus that is formed by the origin of the lateral rectus muscle (blue) divides the SOF into 2 compartments. The area encircled by the annulus is termed the oculomotor foramen, which opens into the middle cranial fossa and transmits cranial nerve III (III), superior (5) and inferior (I)divisions; cranial nerve VI (VI);the nasociliary (N) branch of cranial nerve V,; ophthalmic veins; the orbital branch of the middle meningeal artery (occasionally); and sympathetic nerve fibers. Above the annulus, note cranial nerve IV (IV)and the frontal (F)and lacrimal (L)branches of cranial nerve V,. It is important to realize that the frontal and lacrimal branches of the ophthalmic division of cranial nerve V and cranial nerve IVenter the orbit

outside

the

muscle

Orbit. New York:Raven; 1985.1

cone.

(Reproduced

with permission

from Zide 8M. Jelks Gw. Surgical Anatomy of the

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

9

bone posteriorly. Superiorly, the vault of the skull is made up of the parietal bones, meeting at the sagittal suture and adjoining the frontal bone at the coronal suture, and the occipital bone at the lambdoid suture.

The Orbit The orbit is surrounded by several important structures. The paranasal sinuses surround the floor (maxillary sinus) and the medial wall (ethmoid and sphenoid sinuses) of the orbit (Fig 1-3). The frontal sinus has a variable relationship to the anterior orbital roof. The other major structures around the orbit are the anterior cranial fossa superiorly (containing the frontal lobe) and the temporal fossa laterally (containing the temporalis muscle). The roof of the ethmoid complex, delineated by the frontal ethmoidal suture (top of the lamina papyracea), marks the inferior boundary of the anterior cranial fossa. It is important to note that surgical intervention above this anatomic landmark will result in entrance into the anterior cranial fossa and is likely to cause a cerebrospinal fluid (CSF) leak. The sphenoid sinus forms the medial wall of the optic canal. Surgery within the sphenoid sinus has the potential to damage the optic nerve; alternatively, the sphenoid sinus is a surgical route facilitating decompression of the chiasm. In approximately 4% of patients, the bone may be incomplete, leaving sinus mucosa covering the optic nerve. The pterygomaxillary area underlies the apex of the orbit, containing the sphenopalatine ganglion and the internal maxillary artery. This area communicates posteriorly through the foramen rotundum and the vidian canal to the middle cranial fossa, anteriorly through the infraorbital canal to the cheek and lower eyelid, and superiorly through the inferior orbital fissure with the orbit. The orbit measures approximately 45 mm wide and 35 mm in maximal height. The total volume of the orbit is approximately 30 cc. The medial wall is approximately 40 mm from the rim to the optic canal. The medial walls are roughly parallel, whereas the lateral

Figure '-3 The roof of the orbit is removed except for the frontosphenoid suture (*). The sinuses are indicated as follows: frontal sinus (green); anterior ethmoidal air cells (light purple); posterior ethmoidal air cells (dark purple);

and

permission

sphenoid

sinus

(blue).

(Reproduced

from Zide 8M, Jelks GW Surgical Anatomy

the Orbit. New York: Raven;

1985.1

with of

10

.

Neuro-Ophthalmology

walls form an angle of almost 90°. The orbital rim is made up of the frontal bone superiorly, which connects to the zygomatic bone (at the frontozygomatic suture) laterally. The inferior orbital rim is made up of the zygomatic bone inferolaterally and the maxillary bone inferonasally (meeting at the zygomaticomaxillary suture). Medially, the orbital rim consists of the maxillary and lacrimal bones, which join the frontal bone superiorly. Three additional bones contribute to the orbit: the ethmoidal bone (lamina papyracea) medially, the palatine bone inferiorly in the posterior orbit, and the sphenoid bone laterally and superiorly in the orbital apex. Canals and fissures The orbit communicates with the surrounding areas through several bony canals and fissures. Posteriorly, the orbit is contiguous with the extradural parasellar cavernous sinus through the superior orbital fissure, which transmits the ocular motor nerves (cranial nerves III, IV, and VI), the ocular sensory nerve (VI)' the ophthalmic sympathetics, and the orbital venous drainage (superior ophthalmic vein). The medial wall of the orbit continues as the lateral wall of the sphenoid bone, marking the medial extent of the cavernous sinus. Therefore, when sharp objects enter the medial orbit, they are directed through the superior orbital fissure, where they can lacerate the carotid artery. The orbit is connected superiorly and posteriorly to the anterior cranial fossa by way of the optic canal, which transmits the optic nerve and ophthalmic artery. Inferiorly at the apex the orbit is connected to the pterygopalatine area through the inferior orbital fissure. This fissure carries the parasympathetics that innervate the lacrimal gland, as well as collateral meningeal arteries that help connect the external and internal carotid circulation. Anteriorly, the orbit connects to the inferior meatus of the nose (beneath the inferior turbinate) through the nasolacrimal duct, which carries excess tears to the nose. In addition, multiple variable bony canals carry blood vessels that travel to and from the orbit and surrounding structures. Some of the most constant of these canals include the anterior and posterior ethmoidal foramina, which carry blood vessels connecting the internal carotid circulation (ophthalmic artery) to the external carotid (terminal branches of the ethmoidal arteries) at the level of the roof of the ethmoid complex. Additional supraorbital and zygomaticotemporal foramina carry blood vessels between the orbit and corresponding vessels of the forehead and temple. Dutton /J. Atlas of Clinical and Surgical Orbital Anatomy. Philadelphia: Saunders; 1994. Rhoton AL, Natori Y. The Orbit and Sellar Region: Microsurgical Anatomy and Operative Approaches. New York: Thieme; 1996. Zide BM, Jelks Gw. Surgical Anatomy of the Orbit. New York: Raven; 1985.

Vascular Anatomy A knowledge of the arterial and venous anatomy of the head and neck is crucial to the practicing ophthalmologist.

CHAPTER

Arterial

1: Neuro-Ophthalmic

Anatomy.

11

System

Knowledge of the vascular anatomy of the head is critical to understanding the potential for ischemic damage to the visual systems. Such ischemic damage is one of the most common pathophysiologic causes of visual dysfunction (including visual loss and double vision). The common carotid arteries, arising from the innominate artery on the right and directly from the aorta on the left, supply most of the blood to the skull and its contents. The remainder comes from the 2 vertebral arteries originating from the subclavian arteries. The latter enter the skull through the foramen magnum after traversing foramina in the cervical vertebral segments. Once the vertebral arteries penetrate the dura, they join near the pontomedullary junction to form the basilar artery, which ascends along the anterior surface of the pons to terminate in the posterior cerebral arteries at the level of the midbrain. The carotid artery divides into internal and external branches at the C2 level near the angle of the jaw. The external carotid artery supplies blood to the face through its major branches of the facial artery. The scalp is supplied via branches of the occipital artery posteriorly and the superficial temporal artery anteriorly (Fig 1-4). The paranasal sinuses receive their blood supply from branches of the maxillary artery (sphenopalatine, infraorbital), which terminates in the pterygopalatine fossa. The coverings of the brain are supplied by branches of the middle meningeal artery-a major branch of the maxillary artery-which enters the middle cranial fossa through the foramen spinoswn, lateral to

A Figure'-4 A, The internal and external carotid arterial supply to the orbit and adnexal tissues emphasizes the collateral connections between these 2 circulations that take place in and around the orbit. Lateral view. (Continues)

12

. Neuro-Ophthalmology

B

Figure 1-4 B, Anterior view of the superficial arterial supply to the eyelids and anterior orbit. C, The ophthalmic artery and its branches in the muscle cone. Key: (3) middle meningeal; (7) deep temporal; (8) buccal; (10) infraorbital; (11) sphenopalatine; (12) artery of the pterygoid canal; (13) superficial temporal artery; (14) transverse facial; (15) zygomatico-orbital; (16) frontal branch; (17) internal carotid artery; (18) ophthalmic; (19) intraconal branches of ophthalmic; (20) posterior ethmoidal branch of ophthalmic; (21) supraorbital artery; (22) supratrochlear; (23) anterior ethmoidal branch of ophthalmic; (24) infratrochlear; (25) superior peripheral arcade; (26) superior marginal arcade; (27) lacrimal; (28) recurrent meningeal; (29) zygomaticotemporal; (30) zygomaticofacial; (31) lateral palpebral; (32) inferior marginal arcade; (33) angular; (34) facial; (35) central retinal; (36) lateral posterior ciliary; (37) muscular branches (SR, SO, levator); (38) medial posterior ciliary; (39) short ciliary; (40) long ciliary; (41) anterior ciliary; (42) greater circle of the iris; (43) lesser circle of the iris; (44) episcleral; (45) subconjunctival; (46) conjunctival; (47) marginal arcade; (48) vortex vein; (49) medial palpebral; (50) dorsal nasal. (Reproduced with permission from Zide 8M. Jelks GW Surgical Anatomy of the Orbit. New York: Raven; 1985.)

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

13

the foramen ovale. Branches of the middle meningeal artery supply the parasellar area, including the lateral wall of the cavernous sinus (containing cranial nerves III, IV, and VI), and terminate in the arteries of the foramen rotundum and ovale. Variable meningeal branches may enter the superior orbital fissure. Ophthalmologists are sometimes concerned about encountering branches of the external carotid artery, particularly when performing a temporal artery biopsy or during orbital (ethmoidal branches) or lacrimal surgery. Terminal branches of the facial artery supply the marginal arcades of the eyelids. With regard to the external carotid artery, it is extremely important to understand the extent of the collateral connections between the external and internal circulations. This point is particularly critical to interventional neuroradiologists, who may inadvertently embolize distal internal carotid artery branchesincluding the central retinal artery-while placing particles into the external carotid system. This event is most likely in the treatment of arteriovenous malformations, but it can also occur when tumors of the skull base are being emboli zed prior to resection. The most important collaterals between the internal and external circulations traverse the orbit. They include the anterior and posterior ethmoidal arteries in the medial orbit, the infraorbital and supraorbital arteries (including distal connections to the lacrimal artery) anteriorly, and the zygomaticotemporal branch laterally. The facial arteries join distal branches of the supra- and infratrochlear arteries around the angular artery in the area of the medial orbit. In addition, variable collateral dural branches traverse the superior and inferior orbital fissures. In rare instances, the ophthalmic artery may also arise as a branch off the meningeal system and thus the external carotid artery. The major blood supply to the head and certainly to the intracranial contents is carried by the internal carotid arteries (Fig 1-5). They enter the bone at the base of the skull laterally in the petrous portion of the temporal bone running anteromedially. Within the petrous bone, the carotid is in close proximity to the middle and inner ear, as well as the intrapetrosal portion of the facial nerve. The carotid is also paralleled superficially by the greater superficial petrosal nerve that supplies the parasympathetics to the lacrimal gland. As the carotid reaches the parasellar area, it turns superiorly just above the foramen lacerum. Sympathetic fibers that continue within the intrapetrous carotid sheath exit to run through the vidian canal to reach the pterygomaxillary area. The carotid then enters the cavernous sinus, where it first gives off the meningohypophyseal trunk and then turns anteriorly to run horizontally parallel to the body of the sphenoid. The meningohypophyseal trunk subsequently divides into the inferior hypophyseal, artery of the tentorium (the artery of Bernasconi-Cassinari), and the dorsal meningeal artery (extending to the tip of the petrous bone and clivus). These arteries supply the dura at the back of the cavernous sinus and the nerves entering the cavernous sinus (CN III, CN IV, CN V, and CN VI). They also variably supply the lateral aspect of the sella, including the pituitary capsule and a large portion of the gland itself. More anteriorly along the horizontal course of the carotid artery within the cavernous sinus, the inferolateral trunk supplies the cranial nerves before they enter the superior orbital fissure and forms anastomoses with branches of the middle meningeal artery. At the anterior aspect of the cavernous sinus, the carotid makes a loop to reverse its direction under the anterior clinoid and the optic nerve, which is exiting the optic canal. This loop of the carotid passes through 2 dural rings, both in relationship to the anterior

14

. Neuro-Ophthalmology

-.---

A

B

\

'--

Figure'-5 Branches of the internal carotid artery (lCA).A, Lateral view. 8, AP view. Proximal internal carotid artery branches: ophthalmic artery (Oph.A.) and its branches, anterior and posterior ethmoidal arteries (A.& P Eth.As.); choroidal blush (Ch.BI.);central retinal artery (CRA); falcine artery (Fal.A.). Posterior communicating artery (PComm.A.). Anterior choroidal artery (A.Chor.A.). Anterior communicating artery (A.Comm.A.). Anterior cerebral artery (A.Cer.A.) and its branches, callosomarginal artery (Cal. Marg.A.); pericallosal artery (PeriCal.A.). Middle cerebral artery (MCA) and its branches, lateral lenticulate striate (Lat.LSA); posterior temporal artery (P Temp.A.); angular artery (Ang.A.). (Reproduced with permission from Kupersmith MJ. Neurovascular Neuro-Ophthalmology. New York:Springer-Verlag;1993.)

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

15

clinoid (the terminal portion of the lesser wing of the sphenoid). As the carotid passes through the second ring, it becomes intradural. Just after the artery becomes intradural, the carotid gives off the ophthalmic artery, which enters the orbit along with the optic nerve. Within the orbit, the ophthalmic artery (see Fig 1-4) may anastomose with recurrent meningeal branches that enter through the superior orbital fissure. The ophthalmic artery gives off the central retinal artery (CRA). The CRA enters the substance of the optic nerve approximately 10-12 mm posterior to the globe. Within the eye, the CRA divides into superior and inferior arcades. Like vessels within the central nervous system, these arteries and arterioles have tight junctions that form a blood-retinal barrier, similar to the blood-brain barrier. These intraretinal arterioles run within the substance of the nerve fiber layer to supply the inner two thirds of the retina. Capillaries run in 4 planes, bracketing the inner nuclear layer (bipolar cells) and the ganglion cells. The lacrimal artery runs parallel to the lacrimal branch of VI in the superior lateral orbital roof to reach the lacrimal gland. It also gives off a branch that forms the anterior ciliary artery of the lateral rectus muscle and reaches the anterior segment at the muscle's insertion. The frontal artery runs within the superior orbit, paralleling the frontal branch of V 1 to branch and terminate as the supraorbital and supratrochlear arteries, which, along with the lacrimal artery, supply the eyelid. The next branches leaving the ophthalmic artery are the superior and inferior muscular arteries. They supply the anterior ciliary arteries of the medial and inferior rectus (inferior muscular artery) and the superior rectus and superior oblique (superior muscular branch). They enter the extraocular rectus muscles (usually 2 arterial branches within the medial, inferior, and superior rectus muscles) and supply the extraocular muscles and the anterior segment. They are responsible for the major blood flow to the ciliary body (producing aqueous). The medial and lateral long posterior ciliary arteries variably anastomose with penetrating branches of the anterior ciliary arteries (within the rectus muscles) to form the greater arterial circle near the anterior part of the ciliary body. Branches from this circle extend radially within the iris to form a second anastomotic circle (the lesser arterial circle) near the collarette of the iris. The terminal ophthalmic artery supplies additional branches that collateralize with the anterior and posterior ethmoidal arteries and form the short (up to 20 small branches supplying the optic disc and posterior choroid) and the long posterior ciliary arteries (running in the horizontal axis to help supply the anterior segment and the anterior choroid) (Fig 1-6). Together, these arteries supply blood to the choroid, the retinal pigment epithelium, and approximately one third of the outer retina, including the retinal receptors. In approximately 30% of individuals, branches of the posterior ciliary arteries directly supply a portion of the inner retina (cilioretinal arteries); this blood supply may protect the macula in the setting of a central retinal artery occlusion. Approximately 4 short posterior ciliary arteries form a variably complete anastomotic ring (known as the circle of Zinn-Haller) around the optic disc. It is also supplied from the choroid and the terminal branches of the pial network. Collateral branches from terminal branches of the infraorbital artery and the superficial temporal artery help to supply the lower and upper eyelids and may also provide

16

.

Neuro-Ophthalmology

Figure 1-6 Partialcutaway view of vasculatureof optic nerve head. Short posteriorciliaryarteries (PCA) supply centripetal capillary beds of anterior optic nerve head. Central retinal artery (CRA) contribution is restricted to nerve fiber layer capillaries and those of anterior intraorbital optic nerve. Capillary beds at all levels drain into central retinal vein (CRV). ZH = intrascleral circle of Zinn-Haller. RA = recurrent posterior ciliary artery to pial plexus. (Reprintedfrom Kline L8. ed. Optic Nerve Disorders. Ophthalmology Monograph 10. San Francisco:American Academy of Ophthalmology; 1996:13.)

collateral supply to the anterior segment. These collaterals may be interrupted if the conjunctiva and Tenon's capsule are removed from the limbus during ocular surgery. Distal to the origin of the ophthalmic artery, the intradural supraclinoid internal carotid artery gives off the anterior choroidal artery and anastomoses with the proximal posterior cerebral artery through the posterior communicating arteries. The anterior choroidal artery supplies blood to the optic tract and distally to the lateral geniculate (Fig 1-7). Injury to the anterior choroidalartery can produce the optic tract syndrome, consisting of contralateral homonymous hemianopia, contralateral band atrophy of the optic disc, and a contralateral relative afferent pupillary defect. The internal carotid artery gives off the anterior cerebral artery and terminates as branches of the middle cerebral artery. The proximal anterior cerebral arteries (A 1 segment) cross over the optic nerves and join via the anterior communicating artery. The combination of the anterior and posterior communicating arteries makes up the circle of Willis, which permits collateral flow between the carotid and vertebrobasilar systems when there is vascular compromise. Small perforating branches arising from the proximal anterior cerebral artery (as well as the anterior communicating artery) supply the intracranial optic nerves and the chiasm. More distally, the anterior cerebral artery divides into frontal. frontopolar. paracallosal, and pericallosal branches. Although the afferent visual pathways are spared with distal anterior cerebral artery (ACA) occlusion, the premotor areas responsible for initiating saccades are supplied by branches of the ACA. Thus, patients with acute occlusion of the ACA may have a transient gaze preference and difficulty initiating saccades

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

17

LGN Post.Lat.Chor.A.

S.Col!. Brach.Conj.

II

PCA

Optic Tract

\Optic Radiations

Figure 1-7 The relationship of the lateral geniculate body (nucleus) to nearby structures and its blood supply. Key: Ant.Chor.A. = anterior choroidal artery; Braeh.Conj. = brachium conjunctivum; Cereb.Ped. = cerebral peduncles; LGN = lateral geniculate nucleus; MCA = middle cerebral artery; MGN = medial geniculate nucleus; PCA = posterior cerebral artery; Peom = posterior communicating artery; Post. Lat. Chor.A. = posterior lateral choroidal artery; Pulv. = pulvinar; RN = red nucleus; 5. Coli. = superior colliculus. (Illustrationbv CraigA. Luce.!

to the contralateral side, although this is more commonly encountered following middle cerebral artery territory lesions. The middle cerebral artery divides into several branches, which supply the temporal lobe, parietal lobe, and superficial portions of the frontal lobe and occipital lobe. The branches that are important to the visual pathways include those supplying the optic radiations as they traverse the white matter deep to the parietal and temporal lobes. Terminal branches of the middle cerebral artery also variably supply the occipital tip representing the macula. This supply is chiefly responsible for macular sparing that can occur in the setting of posterior cerebral or calcarine artery occlusion. In addition to the afferent pathways, the middle cerebral artery supplies the middle temporal region (MT), which is critical in visually guided pursuit movements. Lack of blood supply can thus cause problems with ipsilateral pursuit or asymmetry in optokinetic nystagmus (OKN) as the drum is rotated toward the side of the infarct. Blood supply to the posterior aspect of the intracranial contents begins with the aortic arch. The right vertebral artery arises from the innominate artery; the left vertebral artery begins as a branch off the proximal subclavian artery. The vertebral arteries travel

18

.

Neuro-Ophthalmology

through a series of foramina in the lateral aspects of the cervical vertebral processes. After penetrating the dura at the foramen magnum, the vertebral arteries give rise to the posterior inferior cerebellar artery (PICA) before joining to form the basilarartery (Fig 1-8).The PICA arteries represent the most caudal of the major circumferential arteries that wrap around the brain stem. Proximally, the PICA and basilar arteries first give off branches that perforate the medial portion of the brain stem at the medullary level;the paramedian branches that follow supply the lateral aspects of the brain stem. Distally, the PICA supplies the inferior cerebellum, including the flocculus and nodulus, which (together as the vestibulocerebellum) are intimately involved in eye movements. Vertebral artery or PICA occlusion is associated with Wallenberg lateral medullary syndrome, which manifests as ipsilateral Horner syndrome; skew deviation; cranial nerve V, IXIX paresis; and contralateral body numbness. There is no extremity weakness with the syndrome. The second set of circumferential arteries are the anterior inferior cerebellar arteries (AICA). The AICA arise from the caudal basilar artery and supply the area of the pontomedullary junction of the brain stem, as well as the cerebellum, distally. A large proximal branch of AICA, the internal auditory artery, supplies the CN VIll complex in the subarachnoid space and follows it into the internal auditory canal. Terminally, the internal auditory artery branches into the anterior vestibular artery (supplying the anterior and horizontal semicircular canals and the utricle), the posterior vestibular artery (supplying the posterior semicircular canal and the saccule plus part of the cochlea), and the cochlear artery. Along the course of the basilar artery, small perforators arise directly to supply portions of the pons and midbrain. The branches off the basilar are divided into median or paramedian vessels and short circumferential branches. The median perforators are particularly important, as they supply the medial longitudinal fasciculus, the paramedian pontine formation, and the medially located nuclei of CN Ill, IV, and VI. Interruption of these branches (which occurs commonly with vertebrobasilar atherosclerotic disease or emboli to these endarteries) often affects these pathways, producing variable ophthalmoplegia, internuclear ophthalmoplegia, and skew deviation. Pontine branches of the basilar artery also supply the proximal portions of the cranial nerves (particularly the trigeminal) as they exit. The distal 2 sets of circumferential arteries consist of the superior cerebellar (SCA) followed by the posterior cerebral arteries (PCA), representing the terminal branches of the basilar artery at the level of the midbrain. Perforators from the proximal SCA partially supply the third nerve nucleus and its fascicles. In addition, small branches often supply the trigeminal root. The tentorium, separating the posterior cranial fossa below, opens to pass the midbrain between these 2 arteries. The third nerve exits between the SCA and the PCA, where it may be compressed. Proximally (PI segment), perforators from the posterior cerebral arteries (including the median thalamostriate branches and the lateral choroidal arteries) supply rostral portions of the midbrain involved in vertical gaze and part of the lateral geniculate. A large branch, the artery of Percheron, often supplies both sides of the midbrain from 1posterior cerebral artery. Because thalamostriate arteries originate from PI, infarcts related to the internal carotid-middle cerebral artery spare the thalamus. The PI segment ends with

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

19

A

B

Figure1-8 Vertebrobasilar arterial system and major arteries with common variations of the cortical branches of the posterior cerebral artery. A, Lateral view. B, AP view. Vertebrobasilar branches: posterior inferior cerebellar artery {PICA};anterior inferior cerebellar artery {AICA};superior cerebellar artery {S.CerebellarA}. Posterior cerebral artery (Post.CerA} and its branches; posterior temporal (Post. Temporal A); parieto-occipital artery; calcarine artery; posterior communicating persmith

MJ. Neurovascular

Neuro-Ophthalmology.

artery {PComm.A}. New York: Springer-Verlag;

(Reproduced 1993.)

with permission

from Ku-

20

.

Neuro-Ophthalmology

the posterior communicating artery (P. Com), which joins the vertebrobasilar circulation to the carotid anteriorly. The connecting artery parallels the course of CN III, which explains the high frequency of third nerve palsy with aneurysms of the P. Com. As the distal PCA courses around the brain stem, it gives off a parieto-occipital branch before terminating in the calcarine branch, which supplies the primary visual cortex (Fig 1-9). Venous System Although discussed less often, the venous system is also critical to normal function of the visual pathways. Ocular venous outflow begins in the arcade retinal veins that exit in the central retinal vein and in the choroidal veins that exit the sclera through the vortex veins. Anteriorly, the episcleral venous plexus collects both blood from the anterior uveal circulation and aqueous percolating

through

Schlemm's canal. These 3 primary

venous drainage

pathways (Fig 1-10) empty primarily into the superior ophthalmic vein, which runs posteriorly within the superior medial orbit to the orbital apex, where it crosses laterally to enter the cavernous sinus posterior to the superior orbital fissure. Microscopic collaterals variably exist between these venous beds. In rare instances, shunts connecting retinal veins to choroidal veins may be seen within the retina. More commonly (usually in association with central retinal vein occlusion or optic nerve sheath meningioma), optociliary shunt vessels may appear on the disc surface. At a more macroscopic level, the superior ophthalmic vein is variably connected anteriorly to the angular and facial veins and inferiorly to the inferior ophthalmic vein and pterygoid venous plexus. These collaterals may become important, particularly in the setting of elevated venous pressure (usually related to a carotid-cavernous fistula). Intracranially, the superficial cortical system drains mainly superiorly and medially to the superior sagittal sinus (SSS) running in the sagittal midline. In addition to the cortical drainage, the superior sagittal sinus absorbs CSF through the arachnoid villi and the pacchionian granulations. Thus, obstruction to venous outflow results in decreased CSF absorption and elevated intracranial pressure. The SSS runs posteriorly to terminate

@

8 Upper br. Lower br.

Figure'-9 The occipital cortex and its blood supply. Areas V7, V2, and V3 keyed by color. CC = corpus callosum; MCA

by Craig

A. Luee.!

= middle

cerebral

artery;

PCA

= posterior

cerebral artery.

(Illustration

CHAPTER

Figure 1-10 Venous drainage of the orbit. adjacent plexus. 8, Anterolateral view.

A, Lateral

1: Neuro-Ophthalmic

view

of venous

drainage

Anatomy.

of the orbit (Continues)

21

and

22

.

Neuro-Ophthalmology

Figure 1-10 C. Superficial venous structures of the eyelid. Key: acv = anterior collateral vein; afv = anterior facial vein; av = angular vein; crv = central retinal vein; cs = cavernous sinus; iopv = inferior ophthalmic vein; iov = infraorbital vein; ipv = inferior palpebral vein; ir = inferior root of superior ophthalmic vein; Iv = lacrimal vein; mb = muscular branch; mcv = medial collateral vein; mopv = medial ophthalmic venous vein; nb = nasal branch; pp = pterygoid plexus; psav = posterior superior alveolar vein; sopv = superior ophthalmic vein; sov = supraorbital vein; spv = superior palpebral veins; sr = superior root of superior ophthalmic vein; stv = supratrochlear vein; vv = vena vorticosa (superior lateral and medial vorticose veins; inferior lateral and medial vorticose veins). (Reproduced with permission from Rootman J, Stewart 8, Goldberg RA. Orbital Surgery:

A Conceptual

Approach. Philadelphia:

Lippincott-Raven;

1995.)

at the torcular Herophili (confluence of the venous sinuses) at the level of the tentorium separating the cerebellum from the occipital lobes. The transverse sinuses (T5) run anteriorly from the connection of the tentorium and the skull to the petrous pyramid, where they turn to run caudally as the sigmoid sinus (55) down to the jugular bulb, where the internal jugular vein exits the skull. Inferior superficial cortical venous drainage is carried directly down to the transverse and sigmoid sinus through the vein of Labbe and the basilar vein of Rosenthal. The deep drainage of the supratentorial diencephalon and mesencephalon begins as deep draining veins (often in relationship to the ventricular system). These drain together to form the

1: Neuro-Ophthalmic

CHAPTER

Anatomy.

23

vein of Galen, which runs posteriorly to drain into the straight sinus. This runs within the tentorium to drain along with the SSS into the torcular HerophilL Some anterior cerebral venous drainage may access the cavernous sinus. The 2 cavernous sinuses are joined by variable connections through the sella and posteriorly through a plexus of veins over the clivus. The cavernous sinus drains primarily caudally into the jugular bulb via the inferiorpetrosal sinus (IPS),which traverses Dorello'scanalwith CN VI under the petroclinoid ligament. Alternatively, drainage may be lateral along the petrous apex through the superior petrosal sinus (SPS) to the junction of the transverse and sigmoid sinuses. Small veins may drain through the foramen rotundum and ovale as well as through the pterygoid plexus to anastomose with the facial venous system (external jugular vein). Veins of the eyelids anastomose medially between the angular vein and branches of the superior ophthalmic vein (particularly at the superior medial orbit in the region of the trochlea). Facial veins drain inferiorly and laterally to form the external jugular vein, which eventually joins the internal jugular in the neck. Kupersmith

M). Neurovascular

Lasjaunias P, Berenstein Vascular Nolte

Anatomy

). The Human

and Brain:

New York: Springer- Verlag; 1993.

Neuro-Ophthalmology.

A, ter Brugge KG. Surgical Variations.

Neuroangiography.

New York: Springer;

An Introduction

2nd

ed. vol

1. Clillical

200 I.

to Its Functional

Anatomy.

5th ed. St Louis: Mosby;

2002. Rootman ), Stewart B, Goldberg Lippincott; 1995.

Afferent

Visual

RA. Orbital

Surgery:

A Conceptual Approach. Philadelphia:

Pathways

The afferent visual pathways, which are responsible for mapping the outside world onto our consciousness, begin with the anterior segment, which refracts light onto the retina. (The details of the anterior segment anatomy are covered in more detail in BCSC Section 2, Fundamentals and Principles of Ophthalmology, and Section 8, External Disease and Cornea.) It is important to recognize that any disturbance in afferent function may result in the same complaints of visual loss seen with pathology affecting the retina, optic nerve, and visual pathways. Retina The posterior segment transduces the focused electromagnetic image photochemically into a series of impulses. (The anatomy of the retina is covered in more detail in BCSC Section 2, Fundamentals and Principles of Ophthalmology, and Section 12, Retina and Vitreous.) Photochemical transduction takes place within the outer segments of the rods (approximately 80-120 million, distributed uniformly over the retina except at the fovea) and cones (approximately 5-6 million, with a peak distribution at the foveaapproximately 50% within 30°). The absence of retinal receptors over the optic disc creates a physiologic scotoma (the blind spot), located approximately 17° from the fovea and measuring approximately 5° x 7°. Cones are divided into 3 subgroups according to the presence of pigments with peak sensitivity to red, green, or blue wavelengths. The blue

24

.

Neuro-Ophthalmology

cones (the smallest subpopulation) are, like the rods, absent at the fovea. The fovea (approximately 1.5 mm or 1 disc diameter) is located approximately 4 mm (or 2.5 disc diameters) from and 0.8 mm lower than the optic disc. The retina measures approximately 2500 mm2 in surface area and is between 100 and 250 /lm thick. The choroid, the extremely vascular posterior extension of the uvea, lines the sclera and supports the single-cell-layer retinal pigment epithelium (RPE). The RPE is in direct contact with the retinal receptors and is responsible for metabolic support as well as regeneration of the chromophore II-trans-retinal to the cis form to restore receptor sensitivity. The impulses that make up the optical signal originate in the ganglion cells within the inner retina. Between the outer and inner retinal layers, the retinal signal starting in the receptors is processed primarily through the bipolar cells that connect the receptors to the ganglion cells. Most ganglion cells can be subdivided into small P-cells (parvocellular, accounting for 80%) and larger M-cells (magnocellular, approximately 5%-10%). Smaller sets of ganglion cells are less well characterized. One additional group of very small cells has very large receptive fields and may project preferentially to extrastriate areas. The P-cells are concerned with color perception and have small receptor fields and low contrast sensitivity. The M-cells have larger receptor fields and are more responsive to luminance contrast and motion. Horizontal, amacrine, and interplexiform cells (which communicate horizontally between neighboring cells) permit initial signal processing within the retinal layer. Physiologically, this processing includes the center surround system that underlies response preferentially to dots of light, edges of light, oriented edges, and moving oriented edges at progressively more complicated levels of interaction. In addition, the color-opponent system (red and green, blue and "yellow") permits color appreciation across the visible spectrum. The glial support cells-Muller's cells and astrocytes-also affect image processing and probably playa metabolic role as well. One of the primary anatomic features of retinal organization in the primate is the variable ratio of receptor cells to ganglion cells. The ratio is highest in the periphery (at more than 1000:1) and lowest at the fovea (where a ganglion cell may receive a signal from a single cone). This ratio underlies the increase in receptor field with increasing eccentricity and the maximal spatial resolution at the fovea. Ganglion cell density in the macula is approximately 60 times that in the periphery. This "central weighting" of neural tissue continues throughout the afferent visual system. In the cortex, the number of cells responding to foveal stimulation may be 1000 times the number associated with peripheral activity. Because of the increased density of ganglion cells centrally (69% within the central 30°), the bipolar cells are oriented radially within the macula. This radial arrangement of the axons of the bipolar cells (Henle's layer) is responsible for fluid accumulation in a starshaped pattern. Multiple neurotransmitters are present in the retina, including primarily glutamate but also gamma-aminobutyric acid (GABA), acetylcholine, and dopamine. The other critical anatomic feature of the retina is the location of the optic disc and the beginning of the optic nerve nasal to the fovea. Thus, although ganglion cell fibers coming from the nasal retina can travel uninterrupted directly to the disc, those coming from the temporal retina must avoid the macula by anatomically separating to enter the disc at either the superior or the inferior pole (Fig 1-11). This unique anatomy means

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

25

HR

A

Figure1-11 A, Pattern of nerve fiber layer ofaxons from ganglion cells to optic disc. Superior, inferior, and nasal fibers take a fairly straight course. Temporal axons originate above and below horizontal raphe (HR)and take an arching course to the disc. Axons arising from ganglion cells in nasal macula project directly to the disc as the papillomacular bundle (PM). Band C, Artist's schematic depiction of nasal and macular fibers and patterns of atrophy corresponding to damage to particular fibers. B, Band or bow-tie atrophy occurs with loss of nasal macular and peripheral fibers in the contralateral eye of a patient with a pregeniculate homonymous hemianopia or a bitemporal hemianopia. C. Pattern of nerve fiber loss and optic atrophy resulting from damage to fibers from ganglion cells temporal to the fovea in the ipsilateral eye of a patient with a pregeniculate homonymous hemianopia. (PartA reprintedfromKline LB. Optic Nerve Disorders. Ophthalmology Parts B, C courtesy of Neil Miller, MD.)

Monograph

10. San Francisco. American Academy

of Ophthalmology;

1996.

that some of the nasal fibers (nasal within the macula) enter the disc on its temporal side (papillomacular bundle). Focal loss of the nerve fiber layer may be seen as grooves or slits or as reflections paralleling the retinal arterioles where the internal limiting membrane drapes over the vessels, whereas diffuse nerve fiber layer loss is often more difficult to detect and brings the retinal vessels into sharp relief. Optic Nerve The optic nerve begins anatomically at the optic disc but physiologically and functionally within the ganglion cell layer that covers the entire retina. The first portion of the optic nerve, representing the confluence of approximately 1.0-1.2 million ganglion cell axons,

26

.

Neuro-Ophthalmology

traverses the sclera through the lamina cribrosa, which contains approximately 200-300 channels. The combination of small channels and a unique blood supply (largely from branches of the posterior ciliary arteries) probably plays a role in several optic neuropathies. The axons of the optic nerve are dependent on metabolic production within the cell bodies in the retina. Axonal transport of metabolic products occurs along the length of the optic nerve. This type of transport (and a smaller component of retrograde transport) requires high concentrations of oxygen and is sensitive to ischemic, inflammatory, and compressive processes. Interruption of axonal transport, from whatever cause, at the optic disc produces swelling, or disc edema. Just posterior to the sclera, the optic nerve acquires a dural sheath that is contiguous with the periorbita of the optic canal and an arachnoid membrane that supports and protects the axons and is contiguous with the arachnoid of the subdural intracranial space through the optic canal. This arrangement permits a free circulation of CSF around the optic nerve up to the optic disc. Just posterior to the lamina cribrosa, the optic nerve also acquires a myelin coating, which increases its diameter to approximately 3 mm (6 mm with the optic nerve sheath) from the 1.5 mm of the optic disc. The myelin investment is part of the membrane of oligodendrocytes that join the nerve posterior to the sclera. The intraorbital optic nerve extends approximately 28 mm back to the optic canal. The extra length of the intraorbital optic nerve allows unimpeded globe rotation as well as axial shifts within the orbit. The central retinal artery and vein travel within the anterior 10-12 mm of the optic nerve. The central retinal artery supplies only a minor portion of the optic nerve circulation; most of the blood supply comes from pial branches of the surrounding arachnoid, which is in turn supplied by small branches of the ophthalmic artery. Topographic (retinotopic) representation is maintained throughout the optic nerve. Peripheral retinal receptors are found more peripherally, and the papillomacular bundle travels temporally and increasingly centrally within the nerve. As the optic nerve enters the optic canal,the optic nerve sheath fuses with the periorbita. It is also surrounded by the annulus of Zinn, which serves as the origin of the 4 rectus muscles and the superior oblique. Within the canal, the optic nerve is accompanied by the ophthalmic artery inferiorly and separated from the superior orbital fissure by the optic strut (the lateral aspect of the lesser wing of the sphenoid), which terminates superiorly as the anterior clinoid. Medially, the optic nerve is separated from the sphenoid sinus by bone that may be thin or even dehiscent. The canal normally measures approximately 8-10 mm in length and 5-7 mm in width but may be elongated and narrowed by processes that cause bone thickening (fibrous dysplasia, intraosseous meningioma, and so on). The canal runs superiorly and medially. Within the canal, the optic nerve is relatively anchored and can easily be injured by shearing forces transmitted from blunt facial trauma. At its intracranial passage, the optic nerve passes under a fold of dura (the falciform ligament) that may impinge on the nerve, especially if it is elevated by lesions arising from the bone of the sphenoid (tuberculum) or the sella. Once it becomes intracranial, the optic nerve no longer has a sheath. The anterior loop of the carotid artery usually lies just below and temporal to the nerve, and the proximal anterior cerebral artery (ACA) passes over the nerve. The gyrus rectus,the most inferior portion of the frontal lobe, lies

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

27

above and parallel to the optic nerves. The 8-12 mm intracranial portion of the optic nerve terminates in the optic chiasm. Optic Chiasm The optic chiasm measures approximately 12 mm wide, 8 mm long in the anteroposterior direction, and 4 mm thick. It is inclined at almost 45° and is supplied by small branches off the proximal ACA and anterior communicating artery. The chiasm is located just anterior to the hypothalamus and the anterior third ventricle (forming part of its anterior wall and causing an invagination) and approximately 10 mm above the sella. The exact location of the chiasm with respect to the sella is variable. Most of the time it is directly superior but may be either anterior (prefixed) in approximately 17% of individuals or posterior (postfixed) in approximately 4%. Within the chiasm, the fibers coming from the nasal retina (approximately 53% of total fibers) cross to the opposite side to join the corresponding contralateral fibers. The inferior fibers (subserving the superior visual field) are first to cross. Recent evidence suggests that the anterior loop of fibers into the contralateral optic nerve (Wi/brand's knee) may be an artifact; however, the finding of a superior temporal visual field defect contralateral to a central scotoma still localizes pathology to the junction of the optic nerve and chiasm. The macular fibers tend to cross posteriorly within the chiasm; this arrangement underlies the bitemporal scotomatous field defects seen with posterior chiasmatic compression. Optic Tract The fibers exiting from the chiasm proceed circumferentially around the diencephalon lateral to the hypothalamus and in contact with the ambient cistern (Fig 1-12). Just prior to the lateral geniculate, the fibers involved in pupillary pathways exit to the pretectal nuclei; other fibers exit to the superficial layers of the superior co/liculus via the brachium of the superior colliculus. These fibers come from (or are branches of) primarily the magnocellular ganglion cells but also from the so-called gamma cells (corresponding to the W-cells in the cat). It is likely that these cells, with large receptive fields, are involved in supplying information to the pupillary pretectal nuclei (mainly the pretectal olivary nucleus). Additional fibers leave the tract to directly innervate the suprachiasmatic nucleus of the hypothalamus, which is probably responsible for light-induced diurnal rhythms. Throughout the optic tract, the fibers associated with the superior visual field remain inferior and vice versa. The incongruous nature of optic tract visual field defects is explained by the lack of immediate contact between corresponding fibers from the right and left eyes. Most of the axons that originated in the retinal ganglion cells terminate within the lateral geniculate. The lateral geniculate is located in the posterior thalamus below and lateral to the pulvinar and above the lateral recess of the ambient cistern. This peaked, mushroomshaped structure is divided into 6 levels. The 4 superior levels are the terminus of parvocellular axons, which are the ganglion cells with smaller receptive fields that are responsible for mediating maximal spatial resolution and color perception. The 2 inferior

28

.

Neuro-Ophthalmology

Figure 1-12 Anatomic dissection of the visual radiations. Key: (1) olfactory bulb; (2) olfactory tract; (3) olfactory trigone; (4) medial olfactory stria; (5) lateral olfactory stria; (6) optic nerve; (7) optic chiasm; (8) limen insulae; (9) tuber cinereum with infundibulum; (10) anterior (rostral) perforated substance; (11) claustrum; (12) putamen; (13) lateral part of globus pallidus; (14) medial part of globus pallidum; (15) basis pedunculi; (16) mamillary body; (17) optic tract; (18) posterior (interpeduncular) perforated substance; (19) cortex of insula; (20) superior cerebellar peduncle; (21) substantia nigra; (22) mesencephalic (cerebral) aqueduct; (23) medial geniculate nucleus; (24) lateral geniculate body; (25) temporal genu of optic radiation; (26) pulvinar of thalamus; (27) sagittal stratum; (28) splenium of corpus callosum; (29) upper lip of calcarine sulcus. (Reproduced with permission from Gluhbegovic N, Williams TH. The Human Brain: A Photographic Guide. Hagerstown, MD: Harper & Row; 1980.1

layers receive input from the magnocellular fibers, which are the ganglion cells with larger receptive fields that are more sensitive to detecting motion, Axons originating in the contralateral eye terminate in layers 1, 4, and 6; the ipsilateral fibers innervate 2, 3, and 5. As the fibers approach the lateral geniculate, the superior fibers move superomedially and the inferior fibers swing inferolaterally. Overall, the retinal representation rotates almost 90°, with the superior fibers moving medially and the inferior fibers laterally. The macular fibers tend to move superolaterally. Cortical and subcortical pathways may modulate activity in the lateral geniculate. Pathways have been identified from the raphe nucleus and the locus ceruleus. In addition, the cortex, superior colliculus, and pretectal nuclei project back to the lateral geniculate. Cortex Following a synapse in the lateral geniculate, the axons travel posteriorly as the optic radiations to terminate in the primary visual (calcarine) cortex in the occipital lobe (Fig 1-13).

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

29

The most inferior of the fibers first travel anteriorly, then laterally and posteriorly to loop around the temporal horn of the lateral ventricles (Meyer's loop). More superiorly, the fibers travel posteriorly through the deep white matter of the parietal lobe. The macular (central) fibers course laterally, with the peripheral fibers concentrated more at the superior and inferior aspects of the radiations. Injury to fibers within the radiations produces a homonymous hemianopia: a contralateral visual field defect that respects the vertical midline. If the corresponding fibers from the 2 eyes are together, the field defect is identical in each eye (congruous). Congruous field defects occur with lesions involving the calcarine cortex. More anterior involvement often produces incongruous field defects, suggesting that the corresponding fibers are farther apart more anteriorly in the visual pathways. The primary visual area (known variously as V 1, striate cortex, or Brodmann area 17) is arrayed along the horizontal calcarine fissure, which divides the medial surface of the occipital lobe. Fibers of the optic radiations terminate in the fourth of the 6 layers in the primary visual cortex. This layer, the lamina granularis interna, is further subdivided into 3 layers:4A, 48, and 4C (4C, also known as the line ofGennari, gives rise to the name striate cortex). Parvocellular input terminates mainly in 4Cbeta (the lower half of 4C), whereas magnocellular fibers project mainly to 4Calpha. The macular fibers terminate more posteriorly. Fibers from the most lateral (temporal crescent) visual field (originating only in the contralateral eye) terminate most anteriorly. The cortex is heavily weighted to central retinal activity, with 50%-60% of the cortex responding to activity within the central 10° and approximately 80% of the cortex devoted to macular activity (within 30°). The superior portion of the cortex continues to receive information from the inferior visual field in a retinotopic distribution. This retinotopic mapping throughout the afferent visual pathways allows lesions to be localized on the basis of visual field defects. Neurons within the striate cortex may be separated into 3 types: simple, complex, and end stopped, based on their receptive field properties. The simple cells respond optimally to specifically oriented light-dark borders. The complex cellsrespond maximally to oriented motion of the light-dark interface. The end-stopped cellsdecrease firing when the stimulus reaches the end of the cell's receptive field. Simple cells may receive input from 1 eye, whereas complex cells, end-stopped cells, and other simple cells receive binocular information (from corresponding retinal ganglion cells from both eyes). The preference for information coming from one eye or the other may be seen as ocular dominance columns, which run perpendicularly to the cortical surface within the calcarine cortex. In addition to eye-specific columns, the cortex is also marked by orientation-preference columns. The parastriate cortex (also called V2, or Brodmann area 18) is contiguous with the primary visual cortex and receives its input from VI. Area V3 lies primarily in the posterior parietal lobe and receives direct input from VI. V3 has no sharp histological delineation from V2 and sends efferent information to the basal ganglia (pulvinar) and the midbrain. Cells in this area are thought to be capable of responding to more than one stimulus dimension, suggesting that visual integration occurs in this region. V3a, identified as having a separate retinotopic representation, receives its input from V3. Cells in this area are mostly binocularly driven and are sensitive to motion and direction. V4,

30

.

Neuro-Ophthalmology

B

A Left visual

Right visual field

cortex

90

180

c

-

1 em

D

270

Figure 1.13 A, Left occipital cortex showing location of striate cortex within the calcarine fissure (running between arrows). The boundary (dashed line) between striate cortex (V1)and extrastriate cortex (V2) contains the representation of the vertical meridian. B, View of striate cortex after lips of the calcarine fissure are opened. Oashed lines indicate the coordinates of the visual field map. The representation of the horizontal meridian runs approximately along the base of the calcarine fissure. Vertical dashed lines mark the isoeccentricity contours from 2.5° to 40°. Striate cortex wraps around the occipital pole to extend about 1 cm onto the lateral convexity of the hemisphere, where the fovea is represented. C, Schematic flattened map of the left striate cortex shown in part B representing the right hemifield. The row of dots shows where striate cortex folds around the occipital tip. The black oval marks the region of striate cortex corresponding to the contralateral eye's blind spot. HM = horizontal meridian. D, Right visual hemifield, plotted with a Goldmann perimeter. Stippled area corresponds to the monocular temporal crescent, which is mapped in the most anterior -8% of striate cortex. (Reprinted with permission from Horton JC. Hoyt WF. The representation of the visual field in human striate cortex. Arch Ophthalmol. 1991;109:822. Copyright 1991, American Medical Association.)

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

31

located within the lingual and fusiform gyrus, seems to be particularly sensitive to color. Damage to this area is probably responsible for most cases of cerebral achromatopsia. Anterior and lateral to area V4, V5 (posterior and within the superior temporal sulcus and gyrus subangularis) is very sensitive to movement and direction (Fig 1-14). The underlying white matter is heavily myelinated. The V5 area, which corresponds to the MT region, receives ipsilateral input from VI but also directly from the magnocellular layers of the lateral geniculate. The neurons here encode the speed and direction of moving stimuli. This sensory area is likely the origin of pursuit movements and thus links the afferent and efferent pathways together. Compared to VI, the receptive fields are larger. One additional associative area, V6 (located medially in the parietal cortex adjacent to V3a), is thought to have representation of "extrapersonal space:' The superior col/iculus receives afferent input both directly from the anterior visual pathways and secondarily from the calcarine cortex. The superficial layers contain a retinotopic map that overlies the deeper layers that are primarily concerned with saccadic generation. Trobe JD. The Neurology of Vision. New York: Oxford University Press; 200 I.

Visual Cortex

~ Vlsuo-vlsual

Figure 1-14

Parallel

visual

"O~ ~ .,.

~ ~

Dorsal Occlpltofugal "Where" pathway

~

Ventral Occlpltofugal "What" pathway

processing

pathways

in the human. The ventral, or "what," pathway to the angular gyrus for language processing, the inferior temporal lobe for object identification and limbic structures. The dorsal, or "where," pathway begins in the striate cortex and projects to the posterior parietal and superior tempocortex; ral cortex, dealing with visuospatial analysis. FEF = frontal eye field; PMC = premotor parietal cortex. (Used with permission from Kline LB. Bajandas FJ Neuro-Ophthalmology RePPC = posterior

begins in the striate cortex (Vl) and projects

view Manual. Rev 5th ed. Thorofare.

NJ: Slack; 2004.)

32

.

Neuro-Ophthalmology

Efferent

Visual

System

(Ocular

Motor

Pathways)

The efferent visual system also spans a large segment of the central nervous system. The output of the vestibular nuclei provides both the major infranuclear input into ocular motility and the major tonic input into eye position. This system has one of the shortest arcs in the nervous system, producing a fast response with extremely short latency. The hair cells of the semicircular canals (Fig 1-15) alter their firing in response to relative movement of the endolymph. The signal is produced by a change in velocity (head acceleration) in anyone of 3 axes. The information is then conveyed to the vestibular nuclei (located laterally in the rostral medulla) via the inferior and superior vestibular nerves. An additional contribution to the vestibular nerve is from hair cells in the macula acoustica of the utricle and saccule. Calcium carbonate crystals within the otoliths respond to linear acceleration (most importantly, gravity) to orient the body. The vestibular nerve and the output of the membranous labyrinth (the cochlear nerve) make up the eighth nerve complex and exit the petrous bone through the internal auditory meatus. CN VIII traverses the subarachnoid space within the cerebellopontine angle. Within the medulla, the vestibular information synapses in the medial, lateral, and superior vestibular nuclei. Tonic information from the horizontal canal crosses directly to the contralateral gaze center within the sixth nerve nucleus in the dorsal medial aspect of the caudal pons just under the fourth ventricle. Tonic information from the anterior and posterior canals (Fig 1-16) travels rostrally through several of the important internuclear

Hair Cell

n

n

n

Neuron

Depolarization Hyperpolarization

B

Vestibular system. A, Schematic of the mammalian labyrinth. The crista of the lateral semicircular canal is shown but not labeled (with the canal projecting forward). B, Motion transduction by the vestibular hair cells. At rest there is a resting rate of action potential discharge in the primary vestibular afferents (center). Shearing forces on the hair cells cause depolarization (left) if the stereocilia are deflected toward the kinocilium (indicated by the longest cilium, with beaded end). or hyperpolarization (right)if the stereocilia are deflected away from the kinocilium. This modulates the discharge rate in the vestibular nerve neuron. (ReproFigure 1-15

duced with permission Press; 1999.1

from Leigh RJ. Zee OS. The Neurology of Eye Movements.

3rd ed. New York: Oxford University

CHAPTER 1: Neuro-Ophthalmic

ANTERIOR

ANTERIOR

Anatomy.

CANAL-EXCITATORY PROJECTIONS SR

POSTERIOR

CANAL-EXCITATORY PROJECTIONS SO

HORIZONTAL CANAL. EXCITATORY PROJECTIONS

CANAL-INHIBITORY PROJECTIONS SO

POSTERIOR

CANAL.INHIBITORY PROJECTIONS

HORIZONTAL

33

CANAL. INHIBITORY PROJECTIONS

,

M"i~ Figure 1-16 Probable direct connections of vestibulo-ocular reflex (VOR). Excitatory neurons are indicated by open circles and inhibitory neurons by filled circles. Key: III = oculomotor nucleus; nucleus; XII = hypoglossal nucleus; VI = abducens nuclear complex; IV = trochlear tract of Deiters; BC = brachium conjunctivum; AC = anterior semicircular canal; ATD = ascending nucleus of Cajal; 10 = inferior (or lateral) semicircular canal; INC = interstitial HC = horizontal LV = lateral vestibuoblique muscle; IR = inferior rectus muscle; LR = lateral rectus muscle; MV = medial fasciculus; MR = medial rectus muscle; lar nucleus; MLF = medial longitudinal nucleus; SV = superior semicircular canal; PH = prepositus vestibular nucleus; PC = posterior vestibular nucleus; SO = superior oblique muscle; SR = superior rectus muscle; V = inferior vespathway. (Reproduced with permission from Leigh RJ, lee OS. tibular nucleus; VTP = ventral tegmental The Neurology

of Eye Movements.

3rd ed New York: Oxford

University

Press;

1999.)

connections to innervate the vertical gaze center in the rostral midbrain. Medial and inferior vestibular nuclei, as well as the nucleus prepositus hypoglossi and the inferior olivary nucleus, project to the nodulus (a central nucleus of the cerebellum) and the ventral uvula. This pathway, which projects back to the vestibular nuclei, is responsible for the velocity storage mechanism (that is, maintaining the vestibular signal beyond the output of the primary vestibular neurons). Supranuclear input may be divided into visually and non-visually guided movements. Obviously, visually guided movements require afferent system information either from the primary visual system and cortex or from the accessory afferent system. The

34

.

Neuro-Ophthalmology

non-visually guided saccadic supranuclear input comes largely from the prefrontal eye fields (Brodmann area 8). Cortical cells discharge prior to contralateral saccades. Supplementary eye fields, located on the dorsomedial surface of the superior frontal gyrus, receive input from the frontal eye fields and are responsible for programming saccades (particularly as part of learned behavior). The supranuclear pathways descend to the superior colliculus, midbrain, and pontine pause cells that are located in the nucleus raphe interpositus as well as the nucleus reticularis tegmenti pontis (NRTP). The pursuit system for visual targets originates in VS-the human homologue of MT -where it receives input from the primary visual system both from the cortex and likely from magnocellular input directly from the geniculate (Fig 1-17). Retinal image slip serves as a stimulus to tonically alter ocular drift. The medial superior temporal (MST) area is also involved in generating pursuit signals in response to moving stimuli. It appears to be supplied with information about head movement as well as eye movement commands (efference copy) and thus is critical to generating pursuit movements to follow a target while the head is moving. Target recognition and selection probably receive additional input through the reciprocal connections to area 7a, lying ventral to the intraparietal sulcus. Information from the MT and MST projects via the posterior portion of the internal capsule to the dorsolateral pontine nuclei (DLPN) and lateral pontine nuclei, including the NRTP. Visually guided saccades largely originate in or receive information from the superficial superior col/iculus. The motor signal originates within the deeper layers (the stratum griseum profundum and stratum album profundum) that receiveposition information from the more superficial layers. These areas project to multiple locations throughout the brain stem, most particularly to the NRTP and the DLPN. As already suggested, distribution of both infranuclear and supranuclear information (Fig 1-18) requires internuclear communication within the brain stem. The most important of these pathways, the medial longitudinal fasciculus (MLF), runs as 2 parallel columns from the spinal cord to terminate in an area of the midbrain posterior commissure including the rostral interstitial nucleus of the MLF (riMLF). This is located dorsomedial to the red nucleus and rostral to the interstitial nucleus ofCajal (INC). The bulk of the fibers contributing to the MLF have their origin in the vestibular nuclei. The projections from the superior vestibular nucleus are ipsilateral, and those from the medial vestibular nucleus are contralateral. The MLF also receives interneurons originating from the contralateral abducens (CN VI) nucleus. Additional vertical pathways include the brachium conjunctivum and the ascending tract of Deiters. The latter pathway runs lateral to the MLF and conveys signals from the vestibular nuclei ipsilaterally to the medial rectus subnucleus in the midbrain. Horizontal gaze is coordinated through the horizontal gaze center located within the sixth nerve nucleus in the dorsal caudal pons (Fig 1-19). This center receives tonic input from the contralateral horizontal semicircular canal through the medial and lateral vestibular nuclei. Burst information

is supplied from the paramedian

pontine

reticular

formation

(PPRF)

that is directly adjacent to the sixth nerve nucleus and the MLF. The burst cells are normally inhibited by pause neurons located in the nucleus raphe interpositus. It is now thought that saccades are initiated by supranuclear inhibition of the pause cells, which allows burst cell impulses to activate the horizontal gaze center. To produce horizontal movement of both

CHAPTER

FRONTAL

1: Neuro-Ophthalmic

Anatomy.

35

EXTRASTRIArE

Retinal image motion

MT(V5) MST PI'

FEF SEF

Pontine nuclei (DLPN)

CEREBELLAR CORTEX

Dorsal vermis

Fastigial nucleus

Paraflocculus Flocculus

Medial vestibular nucleus

y-Group

Ocular rnotoneurons CN III, IV. VI

A

Smooth-pursuit eye movement

Figure'.17 A, Hypothetical anatomic scheme for smooth pursuit eye movements. Signals encoding retinal image motion pass via the lateral geniculate nucleus (LGN)to striate cortex (Vl) and extrastriate areas: MT (V5, middle temporal visual area). MST (medial superior temporal visual area). PP (posterior parietal cortex), FEF (frontal eye fields). SEF (supplementary eye fields). The nucleus of the optic tract (NOT) and accessory optic system (AOS) receive visual motion signals from the retina and also from extrastriate cortical areas. Cortical areas concerned with smooth pursuit project to the cerebellum via pontine nuclei, including the dorsolateral pontine nuclei (DLPN).The cerebellar areas concerned with smooth pursuit project to ocular motoneurons via fastigial, vestibular, and y-group nuclei; the pursuit pathway for fastigial nucleus efferents has not yet been defined. The NOT projects back to LGN.The NOT and AOS may influence smooth pursuit through their projections to the pontine nuclei and, indirectly, via the inferior olive. (Continues)

36

. Neuro-Ophthalmology nucleus Putamen Thalamus

Temporal occipital pontine pathway Frontal pontine

parietal

Red nucleus Cerebral peduncle

pathway

Superior cerebellar peduncle Motor nucleus of V Middle cerebellar peduncle DLPN

Dorsal vermis

Flocculus

and paraflocculus

Abducens nucleus Abducens nerve

B Figure 1-17 B, Hypothetical scheme for horizontal smooth pursuit. Primary visual cortex (V1) projects to the homologue of the middle temporal visual area (MT) that in humans lies at the temporal-occipita I-parietal junction. The MT projects to the homologue of the medial superior temporal visual area (MST) and also to the frontal eye field (FEF). The MST also receives inputs from its contralateral counterpart. The MST projects through the retrolenticular portion of the internal capsule and the posterior portion of the cerebral peduncle to the dorsolateral pontine nucleus (OLPN). The DLPN also receives inputs important for pursuit from the FEF; these inputs descend in the medial portion of the cerebral peduncle. The DLPN projects, mainly contra laterally, to the flocculus, paraflocculus, and ventral uvula of the cerebellum; projections also pass to the dorsal vermis. The flocculus projects to the ipsilateral vestibular nuclei (VN), which in turn project to the contralateral abducens nucleus. Note that the sections of the brain stem are in different planes from those of the cerebral hemispheres. (Reproduced with permission from

Leigh

RJ, Zee

OS. The

Neurology

of Eye Movements.

3rd ed. New

York: Oxford

University

Press:

1999.)

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

37

Figure 1-18 Sagittal section of monkey brain stem showing the location of the rostral interstitial nucleus of the medial longitudinal fasciculus (rostral iMLF) and other structures important in the control of vertical and horizontal gaze. The shaded areas indicatethe mesencephalic reticular formation (MRF), paramedian pontine reticular formation (PPRF),and medullary reticular formation (Med RF). Asterisks indicate the location of cell groups of the paramedian tracts, which project to the flocculus. Key: III = oculomotor nucleus; IV = trochlear nucleus; complex; iC = interstitial nucleus of VI = abducens nucleus; cg = central gray; h = habenular Cajal; mb = mamillary body; MT = mammillothalamic tract; N III = rootlets of the oculomotor nerve; N IV = trochlear nerve; N VI = rootlets of the abducens nerve; N VII = facial nerve; nO = nucleus of Darkschewitsch; NRTP = nucleus reticularis tegmenti pontis; PC = posterior com-

missure; ppH = nucleus prepositus hypoglossi;

sc = superior

tractus retroflexus. (Modified from Leigh RJ. Zee OS. The Neurology University Press; 1999. Modified by C. H. Wooley.)

colliculus;

of Eye Movements.

t = thalamus;

TR =

3rd ed. New York' Oxford

38

.

Neuro-Ophthalmology

Figure 1-19 Anatomic scheme for the synthesis of signals for horizontal eye movements. The abducens nucleus (CN V/) contains abducens motoneurons, which innervate the ipsilateral lateral rectus muscle (LR), and abducens internuclear neurons, which send an ascending projection in the contralateral medial longitudinal fasciculus (MLF) to contact medial rectus (MR) motoneurons in the contralateral third nerve nucleus (CN /I/). From the horizontal semicircular canal, primary afferents on the vestibular nerve project mainly to the medial vestibular nucleus (MVN), where they synapse and then send an excitatory connection to the contralateral abducens nucleus and an inhibitory projection to the ipsilateral abducens nucleus. Saccadic inputs reach the abducens nucleus from ipsilateral excitatory burst neurons (fBN) and contralateral inhibitory burst neurons (lBN). Eye position information (the output of the neural integrator) reaches the abducens from neurons within the nucleus prepositus hypoglossi (NPH) and adjacent MVN. The medial rectus motoneurons in CN III also receive a command for vergence eye movements. Putative neurotransmitters for each pathway are shown. The anatomic sections on the right correspond to the level of the arrowheads on the schematic on the left. Key: Abd. nucl. = abducens nucleus; ATD = ascending tract of Deiters; CN VI/ = facial nerve; crr = central tegmental tract; ICP = inferior cerebellar peduncle; IVN = inferior vestibular nucleus; Inf. olivary nucl. = inferior olivary nucleus; MRF = medullary reticular formation; PPRF = pontine paramedian reticular formation; SVN = superior vestibular nucleus. (Reproduced with permission from Leigh

RJ. Zee

OS. The Neurology

of Eye Movements.

3rd ed. New

York:

Oxford

University

Press;

1999.1

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

39

eyes, a signal to increase firing must be distributed to 1 lateral rectus and the contralateral medial rectus. The lateral rectus is supplied directly through the ipsilateral CN VI. The contralateral medial rectus is stimulated by interneurons that cross in the pons and ascend in the contralateral MLF. Pathology affecting 1 MLF will result in an ipsilateral adduction deficit with attempted contralateral gaze, often accompanied by abducting nystagmus of the contralateral eye (internuclear ophthalmoplegia). Vertical gaze is controlled through the midbrain. The primary gaze center is located in the riMLF (Fig 1-20). This area receives input from the medial and superior vestibular nuclei via the MLF and other internuclear connections. Other areas in the rostral midbrain, including the INC and the nucleus of Darkschewitsch, also modulate vertical motility. Burst cell input may come in part from the PPRF caudally but also locally within the riMLF. The INC receives signals from the riMLF and from the vestibular nuclei and projects to the motoneurons of the third and fourth nerve nuclei through the posterior commissure. Activity from the vertical gaze center is distributed to the oculomotor (CN III) and trochlear (CN IV) nuclei. Information involved in upgaze crosses in the posterior commissure. Damage to this pathway in the dorsal midbrain results in Parinaud dorsal midbrain syndrome, which clinically includes vertical gaze difficulty (most commonly impaired supraduction), skew deviation, light-near pupillary dissociation, lid retraction, and convergence-retraction nystagmus (CRN). CRN is usually elicited by having the patient follow a downward rotating OKN drum and represents simultaneous co-contraction of the medial and lateral rectus muscles. Light-near dissociation occurs because the pupillary fibers also cross in the posterior commissure. To maintain eccentric gaze, additional tonic input must be provided to the yoke muscles that hold the eye in position. This additional tonic input is provided by integrating the velocity signal provided by the burst neuron activity. For horizontal eye movements, integration takes place in the nucleus prepositus hypoglossi (NPH) located adjacent to the medial vestibular nucleus at the pontomedullary junction, with input from the cerebellum. Neural integration for vertical eye movements involves the INC in addition to the cerebellum. Pathology affecting this neural integrator (often metabolic, associated with alcohol consumption or anticonvulsant medication) results in failure to maintain eccentric gaze, recognized clinically as gaze-evoked nystagmus. The other major connection in the ocular motor system is to the vestibulocerebellum. The structures in this area, largely through the brachium conjunctivum, are responsible for adjusting the gain of all ocular movements. Gain may be defined as the output divided by the input. For example, keeping the eyes stable in space while the head rotates requires the eyes to move in a direction opposite that of head rotation at the same velocity and distance; this would be considered a gain of 1. The cerebellum is involved in gain adjustment to allow compensation after peripheral lesions (eg, vestibular nerve dysfunction such as vestibular neuritis). Disease processes directly affecting the cerebellum may increase or decrease the gain of eye movement systems such as the vestibular ocular reflex. The cerebellum can be divided into the archaeocerebellum (the most caudal and inferior portion, containing the paired flocculi and the midline nodulus), the paleocerebellum (consisting of the vermis, the pyramis, the uvula, and the paraflocculus), and the neocerebellum (including the remainder of the cerebellar hemispheres). The j1occulonodular lobe plus parts of the paraj10cculus make up the vestibulocerebellum. Two additional

40

.

Neuro-Ophthalmology Upward E e Movements

Downward E e Movements PC

PC riMLF

riMLF

INC

INC Midbrain

CN III

CN III

o

CNIV

CNIV

Pons

Medulla

y-group

vn

vn

Figure '-20 Anatomic schemes for the synthesis of upward and downward movements (in red). From the vertical semicircular canals, primary afferents on the vestibular nerve (vn) synapse in the vestibular nuclei (VN) and ascend into the medial longitudinal fasciculus (MLF) and brachium conjunctivum (not shown) to contact neurons in the trochlear nucleus (CN IV), oculomotor nucleus (CN III), and interstitial nucleus of Cajal (/NC). (For clarity, only excitatory vestibular projections are shown.) The rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF), which lies in the prerubral fields, contains saccadic burst neurons. It receives an inhibitory input from omnipause neurons of the nucleus raphe interpositus (rip), which lie in the pons (for clarity, this projection is shown only for upward movements). Excitatory burst neurons in the riMLF project to the motoneurons of CN III and CN IV and send an axon collateral to INC. Each riMLF neuron sends axon collaterals to yoke-pair muscles (Hering's law). Projections to the elevator subnuclei (innervating the superior rectus and inferior oblique muscles) may be bilateral because of axon collaterals crossing at the level of the CN III nucleus. Projections of inhibitory burst neurons are less well understood and are not shown here. Signals contributing to vertical smooth pursuit and eye-head tracking reach CN III from the v-group via the brachium conjunctivum and a crossing ventral tegmental tract. io = inferior oblique subnucleus; ir = inferior rectus subnucleus; so = superior oblique nucleus; sr = superior rectus subnucleus; PC = posterior commissure. (Modified from Leigh RJ. Zee OS. The Neurology of Eye Movements.

3rd ed. New York: Oxford

University

Press;

1999.1

cerebellar nuclei of ocular motor importance located in the white matter of the cerebellar hemisphere are the dentate (most lateral) and fastigial (most medial) nuclei. Efference copy information (regarding the position of the eyes) is supplied directly from the ocular motor pathways (possibly through cell groups of the paramedian tracts), whereas afferent signal error information arrives at the cerebellum via the climbing fibers from the inferior olivary nucleus. Additional cerebellar inputs to the paraflocculus and flocculus include mossy fiber input from the vestibular nuclei and the NPH. Purkinje cells within the paraflocculus discharge during smooth pursuit. An error signal (the difference between gaze velocity and retinal image velocity) results in discharge within the

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

41

sixth and seventh lobules of the dorsal vermis; thus, the dorsal vermis, which projects to the fastigial nucleus, may playa role in initiating pursuit and saccades. The output from the flocculus projects to the superior and medial vestibular nuclei. The fastigial nucleus is responsible for overcoming a natural imbalance in the input from the vertically oriented semicircular canals. Thus, loss of fastigial function may be associated with development of downbeat nystagmus, as the imbalance in the vertical information causes constant updrift. See Chapter 9, The Patient With Nystagmus or Spontaneous Eye Movement Disorders, for further discussion of nystagmus and other disordered eye movements. The final common pathways that influence the position of the eye within the orbit are the multiple soft tissue elements connected to the globe. In addition to the extraocular muscles (discussed in the following section), these tissues include the optic nerve, Tenon's capsule, blood vessels, and the conjunctiva anteriorly. (Orbital anatomy is discussed in BCSC Section 7, Orbit, Eyelids, and Lacrimal System.) Without neural activity, the visual axes are usually mildly to moderately divergent. The major tonic input to ocular motility is supplied by 3 pairs of cranial nerves-the oculomotor (CN III), trochlear (CN IV), and abducens (CN VI)-that innervate the 6 extraocular muscles (EOMs) controlling ocular movement. In addition, CN III also innervates the levator palpebrae and the pupillary sphincter muscles. Extraocular Muscles Of the 6 EOMs, 4 are rectus muscles (lateral, medial, superior, and inferior), and 2 are oblique. The recti originate along with the levator at the annulus ofZinn, a condensation of tissue around the optic nerve at the orbital apex. They run forward within sheaths that are connected by intermuscular septa to pierce the posterior Tenon's capsule and insert on the anterior sclera, at points variably posterior to the corneal limbus, increasing from the medial through the inferior and lateral to the superior (spiral of Tillaux). The recti are also maintained in position by septal attachments to the orbital periosteum that act as pulleys. The 2 oblique muscles insert on the posterior lateral aspect of the globe. The origin of the inferior oblique muscle is in the anterior inferior medial periorbita near the posterior margin of the lacrimal fossa. The effective origin of the superior oblique muscle is the trochlea, a pulleylike structure located at the notch in the superior medial orbit. The superior oblique muscle runs anteriorly in the superomedial orbit to the trochlea, where its tendon reverses its direction of action. The EOMs are of variable mass and cross section: the inferior oblique is the thinnest, and the medial rectus is the largest. Thus, with normal tonic innervation, the somewhat stronger medial rectus reduces the divergent phoria. Each of the EOMs has a series of repeating sarcomeres that make up each of the muscle fibers. The fibrils within the EOMs can be divided into at least 2 populations: fast twitch fibers and sparse slow twitch, or tonic, fibers. Tonic fibers are innervated by a series of grapelike neuromuscular junctions (en grappe); fast twitch fibers have a single neuromuscular junction for each fiber (en plaque). Ocular myofibrils and their attendant neuromuscular connections are unique. These specializations distinguish ocular muscle systems from cardiac, smooth, or skeletal muscles, and help explain why certain diseases preferentially affect or spare the EOMs.

42

.

Neuro-Ophthalmology

The lateral rectus moves the globe into abduction. Similarly, the medial rectus moves the eye into adduction. Each of the other muscles has a primary, secondary, and tertiary function that varies depending on the position of gaze (Fig 1-21). The superior rectus muscle primarily causes elevation. As the globe moves into adduction, it becomes increasingly an intorter and adductor. Similarly, in abduction, the inferior rectus is primarily a depressor but becomes more and more an extorter and adductor as the position moves medially. The superior oblique functions as an intorter and abductor but becomes increasinglya depressor as it moves into adduction. The inferior oblique (also inserting posteriorly on the sclera) acts primarily as an extorter and abductor but becomes increasingly an elevator in adduction. The superior muscles (contralaterally innervated superior oblique and superior rectus) are thus intorters, whereas the inferiors (ipsilaterally innervated) are extorters. The obliques are abductors, whereas the vertical rectus muscles are adductors. (For further discussion and illustration of the EOMs and their actions, see BeSe Section 6, Pediatric Ophthalmology and Strabismus.) Cranial Nerves Except for the inferior oblique, the innervation to each of the EOMs occurs on the inside surface, approximately one third of the distance from the apex. The inferior oblique receives its innervation at approximately its midpoint from a neurovascular bundle running parallel to the lateral aspect of the inferior rectus. The innervating branches represent the terminal axonal branches of the ocular motor nerves.

Elevation

SR" ~ Superior Rectus Sup.Br.CN III

LR

~

EXtorsion

I~orsion

ADduction

ARduction..(

~~ ~

ABduction

Lateral Rectus Abducens CN VI

.

" ,,---,~

~... \

~

IR

~

EXtorsion

~

(Illustration

Primary,

secondary,

by Craig A. Luce.)

Medial Rectus Inf.Br.CN III

~

IN torsio:}. ~

and tertiary

~MR ADduction ABduction

Inf.Br.CNIII DepreSSIOn Figure 1-21

10

Inferior Oblique Inf. Br. CN III

)

ADduction

Inferior Rectus

,

Elevation

.,.

functions

~2r Oblique :rrochlear CN IV

D epreSSlOn

of the extraocular

muscles,

right eye.

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

43

CNVI The abducens nerve (CN VI) originates in the dorsal caudal pons just beneath the fourth ventricle. Its nucleus is surrounded by the looping fibers of the facial nerve (genu) and is adjacent to the PPRF and the MLF (Fig 1-22). The nucleus contains both primary motoneurons and interneurons that cross to the contralateral MLF to reach the third nerve nucleus. Thus, pathology affecting the sixth nerve nucleus produces an ipsilateral gaze palsy. The motor axons exiting the sixth nerve nucleus (approximately 4000-6000 axons) travel ventrally and slightly laterally,medial to the superior olivary nucleus, to exit on the ventral surface of the caudal pons. As the fascicles pass through the brain stem, they lie adjacent to the spinal tract of the trigeminal nerve and traverse the corticobulbar tracts. Exiting the brain stem, the nerves run rostrally within the subarachnoid space on the surface of the clivus from the area of the cerebellopontine angle to the posterior superior portion of the posterior fossa. The nerves pierce the dura approximately 1 cm below the petrous apex and travel beneath the petroclinoid ligament (Gruber's ligament, which connects the petrous pyramid to the posterior clinoid) to enter Dorello's canal. Within the canal, CN VI travels with the inferior petrosal sinus. Once it becomes extradural, CN VI is within the cavernous sinus (the only cranial nerve within the substance of the cavernous sinus), where it runs parallel to the horizontal segment of the carotid artery. It is also joined for a short segment by branches of the sympathetic chain, which have been within the wall of the intrapetrous carotid artery. Reaching the anterior portion of the cavernous sinus, CN VI traverses the superior orbital fissure (Fig 1-23) through the annulus of Zinn laterally to enter the medial surface of the lateral rectus muscle. CNIV The trochlear nerve (CN IV) nucleus lies within the gray matter in the dorsal aspect of the caudal midbrain just below the aqueduct, directly contiguous with the more rostral third nerve nucleus. The intra-axial portion of CN IV (fascicle) is very short, running dorsally around the periaqueductal gray to cross within the anterior medullary vellum just caudal to the inferior colliculi and below the pineal gland. CN IV is the only cranial nerve exiting on the dorsal surface of the brain and brain stem and has the longest unprotected intracranial course (which is probably responsible for its frequent involvement in closed head trauma). Within the subarachnoid space, CN IV (containing approximately 2000 fibers) swings around the midbrain, paralleling the tentorium just under the tentorial edge (where it is easily damaged during neurosurgical procedures that involve the tentorium). Just below the anterior tentorial insertion, CN IV enters the posterior lateral aspect of the cavernous sinus just underneath CN III. Covered by a variable sheath, CN IV runs forward within the lateral wall of the cavernous sinus. Anteriorly, CN IV crosses over CN III to enter the superior orbital fissure outside (superior to) the annulus of Zinno CN IV crosses over the optic nerve to enter the superior oblique muscle within the superior medial orbit. CN III The nucleus of the oculomotor nerve (CN III) is located dorsally within the midbrain beneath the aqueduct connecting the third and fourth ventricles. The nuclear complex

44

.

Neuro-Ophthalmology

Cerebral

Red

Substantia

Cerebral

CNIV Trochlear nucleus Decussation of CN IV fibers

Tentorium cerebelli

~

CNVI Abducens

Genu

A

of fibers

of

CNVII

Vascular Level Long circumferential

CN VII Facial nucleus

Territories of CN III from SCA

Short circumferential from PCA (P2) Medial from basilar

B Figure 1-22 A, Intra-axial course of the ocular motor nerves at the level of the pons (below) and midbrain (above). Note relation to the surrounding cerebellum and cranial nerves V and VII. 8, Vascular territories of perforating branches off the vertebrobasilar arteries supplying portions of CN III within its intra-axial course in the midbrain. Compromise of these arteries produces classic intra-axial brain stem pathology. III/ustrationby CraigA. Luce,)

CHAPTER

1: Neuro-Ophthalmic

Anatomy.

""",,"-CN III Dural

45

entrance

into roof of cavernous sinus

,,- -

I

1
50 years), especially when associated with a history of diabetes, hypertension, or vascular disease, is most likely microvascular, and imaging acutely may not be required. With multiple cranial nerve palsies, especially when the fifth nerve is involved, a cavernous sinus location is logical. Parasellar lesions are most effectively seen on MRI used in combination with gadolinium. The most common lesions affecting the cavernous sinus include meningioma (Fig 2-9), aneurysm, neurilemoma, chordoma, chondrosarcoma, pituitary adenomas, metastatic disease, and lymphoma. Inflammatory lesions, particularly sarcoidosis and fungal infection such as Aspergillus, may also affect that area. Skew deviation is a supranuclear lesion producing vertical misalignment. That is, a vertical deviation without evidence of restrictive orbital involvement that does not fit the pattern of a fourth or third nerve palsy suggests a skew deviation. Imaging studies of the posterior fossa must be obtained. MRI is superior to CT at demonstrating posterior fossa pathology, including inflammatory, neoplastic, or ischemic processes. Certain common clinical situations are associated with negative results on imaging. For example, in a patient older than 50 years, acute visual loss associated with evidence of optic neuropathy, ipsilateral disc edema, and lack of orbital signs or pain is almost always secondary to anterior ischemic optic neuropathy (AlaN). Although giant cell arteritis may be considered in this setting, imaging is unlikely to be of bene fit or change therapy. A second common clinical condition is the acute onset of an isolated cranial nerve palsy in a patient with a vasculopathic history. When the oculomotor nerve is involved, the status of the pupil becomes critical. Although microvascular disease can cause pupil dilation, the presence of a normally reactive pupil in the setting of an acute,

Figure 2-9 A 45-year-old patient presented with progressive third- and sixth-nerve palsies. An MRI scan reveals a cavernous sinus lesion on the right side with an enhanced extension along the dural edge (arrow). This so-called dural tail is characteristic of meningioma. (Photograph courtesy of Steven A. Newman. MD.)

CHAPTER

2: Neuroimaging

in Neuro-Ophthalmology

.

75

otherwise complete, third nerve palsy essentially precludes a mass lesion, and scanning acutely in this setting may be unnecessary. Microvascular disease resulting in an acute cranial nerve palsy should be expected to clear completely. Failure to resolve over 3 months or evidence of aberrant regeneration (lid elevation on adduction or depression, miosis on adduction or elevation, or co-contraction of the superior and inferior recti) is a clear indication for scanning. Pain unaccompanied by other findings (proptosis, motility disturbance, decreased vision, or most importantly numbness) is unlikely to be due to imageable pathology, particularly if the pain is episodic and brief. When the pain is associated with findings such as ptosis and miosis (Horner syndrome), carotid artery dissection should be evaluated; MRI and MRA through the carotid artery and, rarely, contrast angiography may be needed for confirmation.

What to Order With important exceptions (Table 2-5), MRI is usually more valuable than CT in both detecting a lesion and narrowing the differential diagnosis (Fig 2-10). The specific choice of imaging modality-including the sequence, orientation, and direction-depends on a combination of the suspected location and the expected pathology. In suspected large vessel disease, MRA, CT angiography, and digital angiography may also be considered. Casper OS, Chi TL. Trokel SL. Orbital Disease: Imaging and Analysis. New York: Thieme; 1993:101-122.

When pathology is localized to the orbit, either CT or MRI should provide useful information. Orbital fat produces excellent contrast with the other orbital components on both CT and MRI, and both give excellent anatomic localization (see Fig 2-4). More important than the choice of the modality is the selection of orientation and specific sequences. Direct coronal images are useful in most orbital disorders (Fig 2-11). Although direct coronal imaging is not a problem with MRI, it requires specific positioning (neck extension) with CT that may be difficult to achieve in older patients. MRI of the orbit

Table 2.5 Clinical Indications

for Computed

Tomography

Globe and orbital trauma (include high-resolution bone algorithms) Assessment of bony abnormalities Detection of calcification in lesions Assessment of orbital and hyperacute intracranial hemorrhage Orbital lesions When MRI is contraindicated: Ferromagnetic foreign body Pacemakers Metallic cardiac valves Non-MRI compatible intracranial aneurysm clips Cochlear implants Technical considerations Claustrophobia Too large for the bore

76

.

Neuro-Ophthalmology

A Figure 2-10 A, Axial and (8) coronal Tl-weighted fat-suppressed MRI of a patient with radiation optic neuropathy. Radiation was performed for a pituitary adenoma, and the patient developed visual loss 00 > as months after the radiation. MRI demonstrates enhancing optic nerves

(arrows)

in the

prechiasmal

region.

(Photographs

courtesy

of Eric Eggenberger.

DO.)

B Figure 2-11 A 19-year-old man was referred for double vision following a motor vehicle accident. A, He had difficulty adducting the left eye, and attempted abduction caused palpebral fissure narrowing. 8, A subsequent coronal CT scan demonstrates an entrapped medial rectus muscle

causing

restriction

(arrow).

(Photographs

courtesy

of Steven A. Newman,

MD.)

should be done with fat saturation techniques designed to eliminate the high T1 signal from fat. Each modality has advantages: CT provides information about the bony walls; MRI provides increased information about the optic nerve (distinguishing meningioma from glioma and indicating the extent of the posterior tumor) and the state of the extraocular muscles, orbital apex, and optic canal in multiplanar views. MRI also avoids the artifact seen on CT related to dental fillings. When a calcified lesion is expected (eg, retinoblastoma, choroidal osteoma, optic nerve head drusen) or if there is a metallic intraorbital foreign body, CT should be employed (Table 2-6). MRI may have advantages in imaging melanomas due to their paramagnetic properties. MRI may also be preferred

CHAPTER

2: Neuroimaging

in Neuro-Ophthalmology

.

77

when attempting to distinguish inflammatory from lymphoproliferative changes. Resolution of the orbit may be further increased with special surface or orbital coils. Often, however, one loses the opportunity of comparing the 2 orbits when the sequences are coned down to 1 side. For the parasellar region, MRI has marked advantages over CT (see Table 2-3). Exceptions include trauma if small bone fragments or fractures are possible. Intracranial soft tissue is generally better assessed with MRI than with CT. One exception is acute hemorrhage (including subarachnoid hemorrhage following rupture of an aneurysm or arteriovenous malformation), which does not show up well on Tl- or T2weighted MRI (best seen on FLAIR sequences). MRI does offer the advantage of dating intraparenchymal hemorrhage (Table 2-7), and gradient echo MRI is sensitive to petechial hemorrhage from traumatic axonal shearing injury. The posterior fossa is much better visualized with MRI than with CT because of the close proximity of bone. Suspicion of intra-axial or extra-axial brain stem or cerebellar pathology calls for MRI sequences of the posterior fossa. If we look at most presumed pathology (see Table 2-4), MRI is again the choice in most clinical situations. Neoplasia, inflammation, demyelination, and ischemic changes are better visualized on MRI than on CT. Cystic lesions are also better evaluated by MRI.

Table 2-6 Clinical Limitations CT

Radiation dose Lack of direct sagittal imaging Poor resolution at the orbital apex Limited resolution in the posterior fossa Allergic reaction to iodinated contrast Claustrophobia (newer open magnets available) Unrecognized metallic foreign body Cannot be used with an implanted cardiac pacemaker Limited resolution (aneurysms 3 mm)

MRI

MRNCTA

Table 2.7 MRI/CT Appearance

Hyperacute Acute Early subacute Late subacute

Chronic

of Intraparenchymal

Hemorrhage

Biochemical

T1

T2

CT

Intracell Fe++ oxyhemoglobin Intracell Fe++ deoxyhemoglobin Intracell Fe+++ methemoglobin Extracell Fe+++ methemoglobin after cell lysis Methemoglobin (center) Hemosiderin (periphery)

Isointense Hypointense Isointense

Hyperintense

Hyperdense

Hypointense

Hyperdense

Hyperintense

Hypointense

Hyperintense

Hyperintense

Hyperdense/ isodense Hyperintense/ isodense

Hyperintense

Hyperintense

Isointense

Hypointense

Hypodense/ isodense

78

.

Neuro-Ophthalmology

CT is better for acute hemorrhage (especially subarachnoid hemorrhage), bony lesions, and for trauma. How to Order Although it is not often the role of the ophthalmologist to select the specific type of imaging, sequence, or contrast medium, the more pertinent information the radiologist is supplied, the more appropriately the imaging can be tailored to a particular patient. This information should at least include the expected location of the pathology and the suspected differential diagnosis (region and lesion of interest). Failure to supply such information often results in images that fail to show the area of interest or do so with insufficient detail. Inappropriate images (wrong location or orientation, lack of contrast administration, overly thick slices) are often worse than no images at all in that they may provide a false sense of security and may create third-party payer barriers to the required reimaging. By conveying as much specific clinical information to the radiologist as possible, the ophthalmologist will increase the usefulness of the subsequent studies.

Negative Studies The discipline of neuro-ophthalmology has been called "the reinterpretation of previously negative imaging studies:' When an imaging study fails to demonstrate expected pathology or answer the clinical question, the first step is to reexamine the studies, ideally with a neuroradiologist. Were the appropriate studies performed, including required sequences and orientations? Was the area of interest adequately imaged (Fig 2-12)? Are the study results really negative (Figs 2-13 and 2-14)? Even if the ophthalmologist cannot personally review the studies, speaking directly with the radiologist may prevent certain lesions from being overlooked and can provide the required clinical information to enhance the radiographic report's accuracy and usefulness.

Glossary BOLD

(blood oxygenation level-dependent)

demarcating

MRI technique that allows functional imaging

areas of high activity during a specific task.

eTA(computerizedtomographyangiography) CT technique used to image blood vessels. DWI(diffusion-weighted imaging) MRI technique especially useful for acute and subacute stroke. FLAIR (fluid-attenuatedinversionrecovery) MRI technique that highlights T2 hyperintense abnormalities adjacent to CSF containing spaces such as the ventricles by deemphasizing CSF signal intensity. fMRI (functionalmagneticresonanceimaging) MRI technique that allows visualization of more active brain areas during a specific task, such as reading.

CHAPTER

2: Neuroimaging

in Neuro-Ophthalmology

.

79

A

c Figure 2-12 A, This ll-year-old patient was noted to have a third nerve palsy on the right side that began at age 5 and became complete by age 7. B, Initialstudies were negative, but fine cuts through the cavernous sinus demonstrate asymmetry with a slight nodule in the superior portion of the cavernous sinus on the right. C, This area became bright with administration of gadolinium, which indicated the presence of a right third nerve neurilemoma (arrow). (Photographs courtesy of Steven A. Newman,

MD.!

Frequency-encoding analysis Gradient variation in the magnetic field results in a change in signal frequency; as the gradient is varied across the subject, the computer can localize the position of a particular signal. Gadolinium

Paramagnetic agent administered intravenously to enhance lesions.

Hounsfield unit

1/2000 of the x-ray density scale centered on water (at zero) and ranging

from air (at -1000) to bone (approaching +1000). IR (inversion recovery) Initial1S0° pulses followed by a 90° pulse and immediate acquisition of the signal; in inversion recovery sequences, the interpulse time is given by TL

80

.

Neuro-Ophthalmology

A Figure 2-13

A 41-year-old woman was referred for progressive visual loss in the right eye. She had previously been told that she had a swollen optic nerve on the right and was diagnosed as having a "mild form of MS." Visual acuity was 2/200 00 and 20/20 as, with a 1.2 log unit right afferent pupillary defect. She had reportedly had 2 previous MRI scans, which were negative. A, The right optic disc demonstrated temporal pallor with optociliary shunt vessels. The patient was referred for a third MRI scan, but this study was misdirected for workup of "microvascular brain stem disease" and revealed no abnormalities. 8, Sagittal MRI through the orbit shows abnormal optic nerve sheath appearance consistent with optic nerve sheath meningioma (arrow). (Part A courtesy of Steven A. Newman. MD: part B courtesy of Eric Eggenberger, DO.)

lamour frequency Resonant frequency of an element with a magnetic dipole (eg, 1H, 31P) when placed in a magnetic field of specific strength; radiofrequency pulses are tuned to this Lamour frequency. MRA (magnetic resonance angiography)

MRI technique for imaging blood vessels.

MRS (magnetic resonance spectroscopy) MRI technique to further characterize the tissue composition of part of the brain, which helps differentiate tumor, demyelination, and necrosis. Orbitomeatal line meatus.

Line connecting

the lateral canthus to the mid external auditory

Pixel Picture element; any of the small discrete elements that together constitute an image (as on a television screen); increasing pixels increases image resolution. Reid's line Line connecting inferior orbital rim and the upper margin of the external auditory meatus. Relaxation Process by which an element gives up (reemits) energy after having absorbed it from the radiofrequency pulses. SE (spin echo) In the most commonly employed spin-echo sequence, a 1800pulse follows a 900 pulse. For T2-weighted images, the 900 pulse is followed by two 1800pulses. The first 1800 pulse is administered at one half the TE (time to echo), and the second 1800 pulse is administered at one full TE later. The "first echo" image is referred to as proton density, and the "second echo" is T2-weighted.

CHAPTER

2: Neuroimaging

.

81

B

A Figure 2-14 A. Axial T1-weighted pre-contrast veal an enlarged enhancing intraorbital optic glioma. Note the globular appearance of the (Photographs

in Neuro-Ophthalmology

courtesy

of Eric Eggenberger,

post-contrast MRls reand (8) fat-suppressed nerve as (arrow) consistent with optic nerve mass containing cystic spaces (see Table 4-6).

DO.)

SR (saturationrecovery) With SR, the radiofrequency signal is recorded after a series of 900 pulses, with an interpulse interval less than or equal to an average tissue T 1 (0.1-1.5 see). T1 Time required for 63% of protons to return to the longitudinal plane after cessation of a 900 radiofrequency pulse. This is also referred to as the longitudinal or spin-lattice relaxation time. T2 Time required for 63% of the magnetic field in the transverse plane created by the radiofrequency pulse to dissipate. This dispersion of the magnetic vector corresponds to exchange of spin among protons and is referred to as spin-spin relaxation. This is completed much more rapidly than Tl relaxation. TE (time to echo) Tesla

Time following the pulse in which the signal is assessed.

Measure of magnetic field strength.

TI (interpulse time)

See IR (inversion recovery).

TR Time to repetition of radiofrequency pulse. Voxel Three-dimensional thickness.

cube determined by the product of the pixel size and the slice

CHAPTER

3

The Patient With Decreased Vision: Evaluation

History In addition to the age of the patient, 3 aspects of the history are critical in cases of impaired vision: the type of involvement (unilateral vs bilateral), the time course of visual loss, and associated symptoms. Unilateral Versus Bilateral Involvement This feature is crucial to localization: unilateral loss almost always indicates a lesion anterior to the chiasm, whereas bilateral loss may reflect bilateral optic nerve or retinal disease or a chiasmal or retrochiasmal process. A careful history is imperative to determine whether involvement is unilateral or bilateral. In homonymous visual field loss (involvement of the corresponding half- fields of each eye), patients often mistakenly attribute the loss to monocular involvement on the side of the affected hemifield; such patients should be asked specifically if they have checked each eye individually. Often, binocular involvement is not appreciated until the patient is examined. Time Course of Visual Loss The speed of visual loss is important in determining etiology. Sudden onset (within minutes) usually indicates an ischemic (often embolic) retinal event, such as arterial occlusion. Rapid loss occurring over hours is also most often ischemic but is more characteristic of optic nerve involvement. A course evolving over days to weeks may also reflect ischemia but more frequently denotes inflammation. Gradual progression over months is typical of toxic lesions (although they may be more acute); progression over months or years is typical of compressive causes. Patients may become acutely aware of chronic processes when the uninvolved eye is covered or when the second eye becomes affected. The time course among causes overlaps significantly, so the history may be suggestive but not definitive. Associated

Symptoms

Pain associated with visual loss may aid in localization of the process. Aching periorbital pain ipsilateral to visual loss, increased with eye movement and possibly associated with globe tenderness, is common in optic neuritis. Additional symptoms related 83

84

.

Neuro-Ophthalmology

to demyelinating disease should be sought, including diplopia, ataxia, hemiparesis, and hemisensory changes. Nonspecific pain, facial numbness, or diplopia may indicate orbital or cavernous sinus lesions. Headache may suggest an intracranial mass.

Examination Examination of the patient with decreased vision is directed toward detecting, quantifying, and localizing regions of loss, with the goal of determining etiology. The process begins with assessment of visual acuity, the most common measure of central visual function. Best-Corrected Visual Acuity Best-corrected visual acuity, which measures the maximal foveal spatial discrimination, should be obtained with refraction. Pinhole visual acuity provides a rough approximation of best -corrected visual acuity but usually underestimates it. Occasionally, however, visual acuity measured with the pinhole is worse than visual acuity measured in other ways; this finding may direct the examiner to search for corneal or lenticular irregularities. For visual acuity levels worse than 20/200, the examiner should obtain quantitative assessment by moving a standard 200 optotype E closer to the patient until its orientation is discerned. This distance is then recorded in standard Snellen notation (eg, "5/200"), providing a more accurate and reproducible measure than "finger counting @ 5 ft" for determination of change in visual status over time. Vision should be tested at distance and at near. With appropriate refractive correction for each distance, the numbers usually are equivalent. Numbers that are not equivalent may suggest specific pathology. Vision that is better at near than at distance may suggest macular disease (in which near magnification may overcome small scotomata) or nuclear sclerotic cataract; vision that is better at distance occasionally results from central posterior subcapsular or polar cataracts, depending on ambient lighting and pupillary size. The examiner should observe whether the patient requires eccentric fixation (possible macular disease), tends to read only 1 side of the eye chart (possible visual field defect), or reads single optotypes better than whole lines (possible amblyopia).

Pupillary Testing In evaluating a patient with decreased vision, pupillary examination is aimed at detecting a relative afferent pupillary defect (RAPD). This abnormality of pupillary reactivity, also known as the Marcus Gunn pupil, is the hallmark sign of impaired optic nerve conduction. The light stimulus to pupillary constriction along 1 optic nerve is transmitted to both pupils after synapse in the pretectal nuclei, producing a direct (ipsilateral) and consensual (contralateral) light (pupillary constriction) response. Impaired conduction of the light stimulus along 1 optic nerve thus produces decreased stimulus to pupillary constriction in both pupils. The RAPD derives from the disparity between the direct and consensual light responses in the affected pupil. The RAPD is elicited by means of the swinging flashlight test, which involves the observation of pupillary reactions to a light source that is alternately presented to each eye. In normal subjects, the pupil constricts as the light stimulates 1 eye, with an equal

CHAPTER

3: The Patient With Decreased

Vision: Evaluation

.

85

constriction of the contralateral pupil due to the consensual response. As the light is rapidly directed to this fellow eye, its pupil may undergo slight initial constriction because the pupillary sphincter has relaxed during the time taken to move the light from the previous side, but overall the pupils remain equal. When 1 optic nerve is damaged and a light is directed in that eye, both pupils constrict poorly. When the light is moved to the normal eye, there is a prominent initial pupillary constriction, since the normal pupil had incompletely constricted to the weakened contralateral stimulus; the pupil in the abnormal eye also constricts because of the consensual response. Upon return of the light to this abnormal eye, the pupil dilates because the poor direct light response cannot maintain the previously induced constriction. Thus, the pupil on the abnormal side appears to dilate in response to light stimulus (Fig 3-1). It should be emphasized that the initial constriction upon directing a light into the pupil from the opposite side may be normal (small amount and symmetric) or abnormal (larger amount and asymmetric). Practical

tips in testing for a relative afferent pupillary defect

1. Dim the ambient lighting; it is easier to evaluate responses in larger pupils. 2. Ensure that the patient fixates at distance so that accommodation (and the accompanying miosis) is controlled. 3. Use a bright but not superb right light source; a too-dim source may produce false-positive results, whereas a too-bright source produces false-negative results or erroneous lateralization if an adverse response is induced. The standard "muscle light" on full is a reliable light source when completely charged. 4. Move the light source rapidly between the 2 pupils but pause 1-2 seconds at each pupil to allow for equilibration; if there is a large amount of pupillary unrest (hippus), this reduces false-positive results. 5. Mentally average multiple alternating reactions; a single alternation may be misleading. 6. Compare both the initial constriction and the initial dilation of the pupils; in subtle cases, only a comparison of the 2 sides may reveal the defect. 7. In the most subtle RAPD, the affected pupil may dilate only mildly after the light is moved to it from the unaffected pupil and maintained in place (termed pupillary "escape" from its previous constriction). 8. An RAPD may be detected even if the pupillary response in 1 eye may not be evaluated because of mechanical injury (iris trauma, synechiae) or pharmacologic blockade of reactivity (mydriasis or miosis). In such cases, evaluation of the reactive pupil may demonstrate an RAPD on either side. Dilation of this pupil as the light stimulus is moved from the unreactive pupil indicates an RAPD ipsilateral to the dilation; initial constriction of this pupil indicates an RAPD in the contralateral eye. 9. Evaluate each direct pupillary reaction for sluggishness; bilateral optic neuropathy may show no relative difference between the 2 eyes when both pupillary responses are equally impaired. 10. The RAPD may be graded 1-4+ in severity or may be more precisely quantified using neutral-density filters. These commercially available filters are placed in front of the normal eye in gradually increasing steps of 0.3 log units, decreasing the intensity of light stimulating the optic nerve. When the reduced stimulus

86

.

Neuro-Ophthalmology

Figure 3-' This 19-year-old patient was noted to have decreased vision in her left eye when she was evaluated for headaches. The swinging flashlight test demonstrated a left afferent pupillary defect. Funduscopy showed left optic atrophy, and MRI revealed an optic nerve glioma.

diminishes optic nerve transmission

to the same level observed in the impaired abnormal optic nerve, no RAPD will be detected. Adding more filter density in front of the better-responding eye produces the appearance of an RAPD in the opposite eye. By placing a 0.3 or 0.6 log neutral-density filter in front of each eye in turn and assessing the pupillary response (this procedure should produce a similar RAPD on the side under cover), the examiner can detect subtle asymmetry. This may indicate the presence of a subtle «0.3 log unit) RAPD (and thus optic nerve dysfunction). 11. The magnitude of the RAPD correlates with the overall degree of damage to retinal ganglion cells, their axons, and the corresponding visual field. The magnitude will not necessarily parallel visual acuity if the papillomacular bundle is less affected. Thus, it is possible to detect a prominent RAPD in the presence of normal visual acuity. 12. The presence of an RAPD does not result in anisocoria. Although the affected pupil is poorly reactive to light, it is not dilated at baseline. The consensual response

from

the normal

input

of the fellow

eye maintains

the pupil

at equal size.

An RAPD is an extremely reliable and sensitive indicator of asymmetric optic nerve dysfunction. The absence of an RAPD should prompt reevaluation of a working diagnosis of optic neuropathy or should cause consideration of bilateral involvement. An RAPD may also result from any lesion that decreases the ganglion cell input to the optic nerve, such as severe macular disease or another retinal disorder such as detachment. The degree of the RAPD relates to the number of fibers affected; thus, a relatively small lesion of the optic nerve affects a large number of fibers and results in a large RAPD, whereas a retinal lesion must be substantially larger to produce a similar RAPD. Chiasmal lesions may produce an RAPD if fibers from the optic nerves are involved asymmetrically. Optic tract lesions may result in a mild RAPD in the contralateral eye (ie, in the eye with the temporal visual field loss) because each tract contains more crossed than uncrossed pupillary fibers, and a lesion will damage more fibers crossing from that eye. With extremely rare exceptions, an RAPD does not result from media opacities such as cataract or vitreous hemorrhage. Although an RAPD may be detected because of am-

CHAPTER

3: The Patient With Decreased

Vision: Evaluation

.

87

blyopia alone (mild compared with the loss in visual acuity), in this setting an RAPD may represent superimposed optic nerve hypoplasia, retinal ganglion cell damage, or another, treatable cause of optic neuropathy. Fundus Examination Two aspects of the fundus examination are important: the clarity of the view of the fundus structures and the appearance of the structures themselves. Both the retina (particularly the macula) and the optic nerve may show changes explaining the patient's decreased visual acuity. The direct ophthalmoscope remains a valuable tool for assessment of the fundus: it not only gives a highly magnified view of the fundus but it also allows the examiner to evaluate the visibility of the fundus, which can be impaired by media opacities. (Unlike indirect ophthalmoscopy, the optics and light source of direct ophthalmoscopy do not permit viewing through a media opacity.) The direct ophthalmoscope is first focused on the red reflex to screen for opacities or irregularities in the cornea, lens, or vitreous (such opacities appear black on the contrasting red background). As the lenses are focused on the posterior pole, the clarity of the view of the macular region suggests how much visual impairment the lesions might cause. Finally, the appearance of the optic disc and macular regions is assessed. The disc is examined for evidence of atrophy, edema, excavation, or other abnormality; the macula is examined for pigmentary disturbance, edema, scar, or other disruption of structural integrity. Used with the slit lamp, the 66, 78, or 90 D indirect lens improves viewing of the contour of both optic disc and macula by affording a stereoscopic view of the structures. Optic atrophy is the hallmark sign of damage to the retinal ganglion cells. Although atrophy is visualized at the level of the axons at the optic nerve head, it may result from damage to any portion of the cells, from cell bodies to their synapses at the lateral geniculate body. Optic atrophy does not occur immediately but takes 4-6 weeks from the time of axonal damage. Severe damage is usually easily identified by the chalky white appearance of the disc (Fig 3-2), with increased sharpness of the margins in contrast with the dull red appearance of the peripapillary retina, which is devoid of the normal softening effect of the overlying nerve fiber layer (NFL). Milder forms of atrophy, with less whitening of the normally orange-pink disc color, are more difficult to detect but may become more apparent with close attention to the following aspects:

. .

.

Comparison of the color of the 2 discs. In some cases, subtle pallor is noticeable only in relation to the normal fellow eye. (Comparison may be difficult following unilateral cataract extraction.) Evaluation

of the surface

vasculature

of the disc. Normally,

this capillary net is easily

visible with the high magnification of the direct ophthalmoscope, but the net becomes thin or is absent in early atrophy, even when pallor is still very mild. Assessment

of the peripapillary

NFL. Dropout

of these fibers, an early sign of damage

that may precede visible optic atrophy, may be seen as a loss of the normal translucent, glistening quality of the retina. Such loss produces a dull red appearance, which may be seen in broad or fine radial patches (Fig 3-3). The fine defects appear earliest in the superior and inferior arcades, where the NFL is normally thickest,

88

.

Neuro-Ophthalmology as dark bands among the normal striations. These defects have been termed rake defects for their similarity to rake marks in soil. NFL dropout is also common in the papillomacular bundle as a broader region of damage.

Optic disc edema is a manifestation of swelling of the retinal nerve fibers, both myelinated (the visible portion of the axons within the optic nerve head) and nonmyelinated (including the peripapillary NFL). The edema results from impaired axoplasmic flow from any cause, including increased intracranial pressure, local mechanical compression, ischemia, and inflammation. Optic disc and retinal vascular changes are associated with the disc edema (Fig 3-4). Regardless of cause, the major clinical features are as follows (Table 3-1):

. elevated appearance

. · ·. .

of the nerve head, with variable filling in of the physiologic cup; the retinal vessels may appear to drape over the elevated disc margin blurring of the disc margins peripapillary NFL edema (typically grayish white and opalescent, with feathered margins) obscures portions of the retinal vessels, which course within this level of the retina; the opacification of the NFL also blurs the border between the disc and the surrounding choroid hyperemia and dilation of the disc surface capillary net retinal venous dilation and tortuosity peripapillary hemorrhages and exudates

Figure 3-2 mal

optic

Fundus disc

photographs

appearance

(81.

demonstrating (Photographs

courtesy

Figure 3-3 Optic disc showing temporal atrophy with a broad region of nerve fiber layer dropout (left), contrasted with glistening intact nerve fiber layer (right), (Photograph courtesy of Anthony C. Arnold,

MD.)

diffuse

optic atrophy

of Steven A. Newman,

(AI, compared MD.)

with nor-

CHAPTER

3: The Patient With

Decreased

Vision:

Evaluation.

89

Figure 3-4 Fundus photograph of the optic disc with true papilledema. The disc margin is blurred, with grayish-white, opalescent thickening of the peripapillary nerve fiber layer (arrow). The retinal vessels are partially obscured at the disc margin and within the peripapillary retina. (Reprinted from Arnold AC. Differential diagnosis of optic disc edema

Focal Points: Clinical Modules

for Ophthalmolo-

gists. San Francisco: American Academy of Ophthalmology; 1999. module

Table 3-1 Clinical

Features

2.)

of Optic Disc Edema

Elevation of optic disc Blurring of optic disc margins Obscuration of retinal vessels at optic disc margin Hyperemia and dilation of optic disc surface capillary Retinal venous dilation Peripapillary hemorrhages and exudates Retinal or choroidal folds Macular edema

net

Additional findings may include retinal or choroidal folds, macular edema, and preretinal hemorrhage. True optic disc edema must be distinguished from other causes of elevation of the disc or blurring of its margins (pseudopapilledema). This distinction is discussed more fully in Chapter 4. Visual

Fields

Evaluation of the visual field is essential in all patients with visual loss. Visual field testing supplements visual acuity testing in establishing visual loss, aids in localization of the lesion along the afferent visual pathway, and quantifies the defect, enabling measurement of change over time. The choice of technique depends on the degree of detail required and the patient's ability to cooperate. Testing may be considered qualitative (simply looking for the pattern of any visual field abnormality) or quantitative (measuring the degree of damage). Patterns of visual field loss are discussed in detail in Chapter 4. Confrontation testing This rapid, simple technique is performed easily at the bedside or in the examination suite and should be a part of every assessment of visual loss. Confrontation testing, however, is only a screening test and must be followed with more sensitive perimetry whenever possible. The examiner is seated approximately 1 m opposite the patient, who is directed to cover 1 eye and fixate on the examiner's nose. The patient is asked whether the examiner's entire face is visible or specific portions are missing; this often identifies central or altitudinal visual field defects. The examiner then requests the patient to identify a target of 1, 2, or 5 fingers presented at the midpoint of each of the 4 quadrants (3 or 4 fingers are

90

.

Neuro-Ophthalmology

more difficult to identify). Children and nonverbal patients may be asked to mimic the examiner's finger target. The patient is then asked to add the total number of fingers presented in opposing quadrants (double simultaneous stimulation). By using an asymmetrical number of fingers in the opposite quadrants, the examiner can identify the involved visual field. Consistently missed responses in a quadrant or hemifield may indicate a subtle visual field defect or extinction. (Extinction refers to the inability to see a target in an affected hemifield only when both hemifields are stimulated simultaneously; when a target is presented in this hemifield alone, it is seen. This finding is characteristic of parietal lesions.) If the patient cannot identify fingers, the examiner presents progressively stronger stimuli (such as hand movement or light perception) in each quadrant. Accurate saccadic movement to an eccentric target is also evidence of at least relative preservation of the peripheral visual field. Subjective comparisons may be helpful in detecting subtle sensitivity defects. With an eye occluded, the patient is asked to compare the clarity of the examiner's 2 hands presented in opposing hemifields, the less clear hand indicating a relative impairment. Color comparisons have long been used to identify the subtle red desaturation seen in anterior visual pathway disease, even without demonstrable defects that occur with stronger stimuli. The examiner presents identical small red targets (such as buttons or mydriatic bottle tops) in each hemifield, asking the patient if the stimuli appear equal. Color may appear altered, washed out, or absent in a damaged hemifield; with slow movement of the target, the examiner may be able to identify a change precisely as it crosses the vertical midline. This suggests damage to the chiasmal or retrochiasmal pathway. Alternatively, comparison of the central with the peripheral visual field in an eye may identify similar impairment centrally, suggesting optic neuropathy. Amsler grid Amsler grid testing is useful as a rapid screening suprathreshold test of the central 20° of the visual field (10° from fixation). The Amsler grid plate is held at 14 inches. The patient, optically corrected for near vision, covers 1 eye and looks at a fixation point in the center of the grid. The examiner asks the patient to describe any central areas of distortion (metamorphopsia), which suggest macular rather than optic nerve disease. Peripheral "bending" of the grid may represent optical aberration from spectacles and should be disregarded. The patient is also asked to identify any scotomata, which are less specific in terms of diagnosis but suggest visual pathway damage and the need for more detailed analysis. It is important to watch the patient for scanning rather than fixating on the central point and to avoid suggesting a visual field defect during patient instruction. Amsler grid testing is rapid and simple, but sensitivity is relatively low. Perimetry should be performed whenever visual field defects are suspected, even in the face of negative results with the Amsler grid technique. Schuchard RA. Validity and interpretation of Amsler grid reports. Arch Ophthalmol. 1993; 111:776-780.

Perimetry

More detailed evaluation of the visual field isobtained by perimetry. Both static and kinetic techniques are important. In static testing, stimuli of varying intensity (a combination of

CHAPTER

3: The Patient With

Decreased

Vision:

Evaluation.

91

brightness and size) are presented at designated (static) points within the region of the visual field to be tested. The goal is to find the minimal stimulus that is consistently detected by the patient at each point (threshold sensitivity). In kinetic testing, a fixedintensity stimulus is moved from a nonseeing area to a seeing area of the visual field to determine the location at which it is the minimal stimulus that is consistently detected by the patient. Thus, the 2 techniques have the same goal (finding threshold sensitivity at

various points in the visual field) but achieve it by different methods. In kinetic testing, all points of equal threshold sensitivity for a specific stimulus are connected to form an isopter, which represents the outer limit of visibility for that stimulus. Analysis of several isopters (plotted with different stimuli) produces a "contour map" of the island of vision. In both static and kinetic techniques, the visual field is analyzed for areas of decreased sensitivity, both in location and degree. Tangent screen This technique is a rapid, effective method for evaluating the central 30° of the visual field, particularly small central scotomata. Tangent screening also is well suited to patients with limited cooperation, since there is constant interaction with the examiner. The patient sits 1 m from a black screen and fixates a central white target. The examiner uses a black wand with round white targets of varying size attached to the tip; occasionally, targets of other colors are used. Moving from the peripheral nonseeing field into the central region along each radial meridian, the examiner maps 1 or 2 isopters kinetically, usually with targets 1-5 mm in diameter, depending on visual level.The targets may be rotated to present the opposite black side, which blends into the screen background for static testing within each isopter to detect small scotomata. A major advantage of this technique is the ability to test the patient at 2 m in evaluating nonorganic visual field loss (see Chapter 13).

Goldmannbowl perimetry This form of perimetry utilizes both kinetic and static techniques, and it has the advantage of evaluating the peripheral visual field (outside the central 30°). However, because the Goldmann bowl encompasses the entire visual field, its central fixation region is smaller than that in tangent screen perimetry, making smaller defects in this region more difficult to detect and map. (Also, because the fixation light eliminates testing of the exact center of the visual field, a supplemental fixation device is necessary to test the central 5°.) In reviewing Goldmann perimetry for small central sco-

tomata, it is essential to establish

whether such central testing was performed.

Optical near correction is used for the central 30° portion of testing. Stimuli (usually white) of varying size and light intensity are presented in the same manner as in kinetic tangent screen testing, along each radial meridian from peripheral to central. Typically, 2 or 3 isopters are plotted because relative defects that might not be detected using stronger stimuli may be found by using weaker ones. Static testing, using the on-off feature of the light stimulus, is performed within each isopter to identify scotomata. The borders of these defects may then be delineated by kinetic testing and their severity measured by varying stimulus size and intensity. The technician-dependent nature of both tangent screen and Goldmann bowl perimetry is both beneficial and disadvantageous. It confers the advantage of active interaction with patients to produce optimal cooperation, and it confers 2 disadvantages: the

92

.

Neuro-Ophthalmology

requirement for an experienced perimetrist who does not tire with repetitive examinations and technician bias. Automatedstatic perimetry In the 1990s, automated static perimetry became the standard for most clinicians in the United States. Although this technique is difficult for certain patients, particularly the elderly and those with a limited attention span, it has numerous advantages over manual kinetic techniques:

· . · · ·

standardized testing conditions, which allow better serial and interinstitutional comparisons of visual fields less technician dependence improved sensitivity numerical data that are amenable to statistical analysis for comparisons and clinical studies electronic data storage

With most automated perimeters, the presentation is static: stimuli (usually the Goldmann standard size III white) are randomly presented at predetermined locations within a specified region of the visual field. Because static perimetry inherently takes longer, only a limited number of points can be practically tested. Thus, the visual field testing is typically restricted to the central 24° or 30° (Fig 3-5). The intensity of the stimuli are varied, with patient responses determining the minimum visible stimulus at each location (the so-called sensitivity threshold, as described earlier). In automated perimetry, this threshold is defined as the dimmest target identified 50% of the time at a given location. Individual sensitivity values are printed on a topographic map of the region tested. Values are displayed in decibels (the unit of a logarithmic scale of power or intensity, measuring attenuation from the maximal stimulus of the perimeter); a higher value at a certain point indicates that the patient is able to see a stimulus with higher attenuation (less intensity), reflecting greater visual sensitivity at that point. These values are not absolute numbers and not directly comparable among perimeters because there are differences in the maximal intensities, background, and other parameters (including duration of presentation). For clinical interpretation, these values are compared with age-matched normal values at each point, along with a statistical evaluation of the probability that each point value is abnormal. This information is plotted on topographic displays, along with a symbolic representation of the sensitivity values, the grayscale map (Fig 3-6). This map depicts an overall topographic impression of the visual field data by using dark symbols for low-sensitivity points and lighter symbols for high-sensitivity points. The computer interpolates between tested points to provide a user-friendly picture (Fig 3-7). Additional statistical analysis may be selected to measure point-by-point visual field sensitivity depression compared with age-matched normal subjects (the total deviation plot). Because the entire visual field sensitivity may be depressed by ocular media abnormalities (eg, corneal surface problems, cataract), the pattern-deviation plot may be useful: the sensitivity values for all points are shifted (by the seventh-highest point) and reanalyzed based on age-expected values. This compensates for the overall depression and allows recog-

CHAPTER

3: The Patient With Decreased

.

Vision: Evaluation

93

Q

-'so

t.ItI..... 4

i . 01 I

I C .,.

..

I

.III Ie b.. III. lit. ,. ,1.. .', .r...:,,:q:" -.-+- _, ~ ;..

. ~.

.i.;r~

J I

;

I I I

!'

I I ! t;

I I III

t

I

,,

i I

~...:.J j I l..' 'L I" tII"~!JI II IlL , . I, o IV j'; 'LL" L' I v - -J-rr--tj-"i'iJit. .,

II

_. . 00. c:on.ct":_ .,.0 _ cyt__ KtNt:__

I I

¥tIiIt.:

Figure 3.5 Diagrammatic representation of extent of visual field evaluated by Goldmann perimetry versus 30° central program in automated static perimetry. The largest isopter in Goldmann testing extends 90° temporally and 60° in other quadrants; typical automated static perimetry evaluates only the central 30°. (Courtesy of Anthony C. Arnold, MD.I nit ion of abnormal patterns (eg, scotomata, arcuate defects, homonymous defects) that might have been masked by the overall depression. Global indices are calculated to help determine change over time. These include a center-weighted mean of all point sensitivity depressions from normal (mean deviation) and various means of addressing localized defects (eg, pattern standard deviation, corrected pattern deviation, loss variance). These indices can be used to assess change in sensitivity over time (either overall or point by point). Patient test reliability is assessed by identifying the following:

.

False-positive

.

played (The acceptable rate is typically below 25%, but ideally these errors will be reduced by technician-patient interaction during the testing.) False-negative response rate: how often the patient fails to signal when a target

response rate: how frequently

the patient

signals

when

no light

is dis-

brighter than the previously determined threshold for that spot is displayed (The acceptable rate is typically below 25%, but the incidence will increase in regions of true visual field loss, as the patient is unable to accurately reproduce responses.) Fixation loss: how often the patient signals when a target is displayed within the · expected physiologic location of a blind spot (response not expected), indicating that the eye is not aligned with the fixation target

94

.

Neuro-Ophthalmology

Single Field Analysl. Cenlral3O-2

Eye: LeN

Threshold Test

A.aUon

r.AonItor. Bllndspol

Stimulus:

AxaUon

T a'!jet:

Bacl6 cycles/second). The size of the checkerboard pattern also is varied to grade the stimulus presented, with smaller sizes allowing detection of smaller changes in function. The transient-pattern YEP waveform typically contains an initial negative peak (Nl), followed by a positive peak (PI, also known as PIOO for its usual location at 100 ms); second negative (N2) and second positive (P2) peaks follow. The latency of onset of a peak after light stimulus and (to a lesser degree) the amplitude of the peak are the most useful features analyzed. The examiner can compare readings from each eye with standardized normal values, readings from the 2 eyes, and readings from the 2 hemispheres. Peak latencies are relatively consistent, and accurate normative data are available; amplitude data are less consistent and thus less useful. Abnormalities in the waveform result from impairment anywhere along the visual pathways, but unilateral abnormalities may reflect optic neuropathy and thus may help to reveal lesions in the absence of clearcut fundus abnormalities. Classically, demyelination of the optic nerve results in increased latency of the PI 00 waveform, without significant effect on amplitude; ischemic, compressive, and toxic damage reduce amplitude primarily, with less effect on latency. For most clinical situations, the YEP is of limited usefulness. It is subject to numerous factors that may produce abnormal waveforms in the absence of visual pathway damage, including uncorrected refractive error, media opacity, amblyopia, fatigue, and inattention (either intentional or unintentional). In most cases, the YEP is unnecessary for the diagnosis of optic neuropathy and is less accurate for its quantification than perimetry. The 2 scenarios in which VEPs remain clinically useful are I. Evaluation of the integrity of the visual pathway in infants or inarticulate adults. A preserved flash or pattern response confirms intact pathways; a consistently abnormal flash response reflects gross impairment. An abnormal pattern response is less useful: it may indicate damage or may be a false-negative result. 2. Confirming intact visual pathways in patients with markedly abnormal subjective visual responses of suspected nonorganic origin. In such cases, intact pattern re-

CHAPTER 3: The

Patient

With

Decreased

Vision:

Evaluation.

101

sponse not only confirms an intact visual pathway but also provides an estimate of true expected visual acuity when stimuli of various sizes are used. Again, an abnormal or absent pattern response does not confirm organic disease because voluntary inattention or defocusing may markedly reduce the pattern waveform. Fishman GA, Birch DG, Holder GE, et al. Electrophysiologic Testing in Disorders of the Retina, Optic Nerve, and Visual Pathway. 2nd ed. Ophthalmology Monograph 2. San Francisco: American Academy of Ophthalmology; 200 I. Morgan RK, Nugent B, Harrison 1M, et al. Voluntary alteration of pattern visual evoked responses. Ophthalmology. 1985;92:1356-1363.

Electroretinogram The electroretinogram (ERG) is a measurement of electrical activity of the retina in response to light stimulus. It is measured at the corneal surface by electrodes embedded in a corneal contact lens that is worn for testing. The full-field response is generated by stimulating the entire retina with a flash light source under varying conditions of retinal adaptation. Major components of the electrical waveform generated and measured include the a-wave, primarily derived from the photoreceptor layer; the b-wave, derived from the inner retina, probably Muller and ON-bipolar cells; and the c-wave, derived from the RPE and photoreceptors. Rod and cone photoreceptor responses can be separated by varying stimuli and the state of retinal adaptation during testing. This form of testing is useful in detecting diffuse retinal disease in the setting of generalized or peripheral visual loss. Disorders such as retinitis pigmentosa (including the forms without pigmentation), cone-rod dystrophy, toxic retinopathies, and the retinal paraneoplastic syndromes-cancer-associated retinopathy (CAR) and melanomaassociated retinopathy (MAR)-may present with variably severe visual loss and minimal visible ocular abnormality. The ERG is invariably severely depressed by the time visual loss is significant, and thus testing is extremely useful. The full-field test, however, measures only a mass response of the entire retina; minor or localized retinal disease, particularly maculopathy-even with severe visual acuity loss-may not produce an abnormal response. Fishman GA, Birch DG, Holder GE, et al. Electrophysiologic Testingill Disordersof the Retina, Optic Nerve, and Visual Pathway. 2nd ed. Ophthalmology Monograph 2. San Francisco: American Academy of Ophthalmology; 200I.

A special technique using a handheld direct ophthalmoscope-stimulator to produce localized flicker stimulation and recordings from the macular region has been termed the focal or macular ERG. This method reliably detects subtle macular dysfunction in cases of central visual loss with a normal-appearing macula on fundus and fluorescein evaluations. Fish G E, Birch DG. The focal electroretinogram Ophthalmology. 1989;96: 109-114.

in the clinical assessment of macular disease.

The ERG response generated by a pattern-reversal stimulus similar to YEP testing has been studied and is termed the pattern ERG, or PERG. It is thought that ganglion

102

.

Neuro-Ophthalmology

cell activity is reflected in the N2 component of the waveform, and thus the technique may detect subtle optic neuropathies. Reports have suggested the usefulness of PERG in distinguishing between ischemic and demyelinating optic neuropathy: the N2 component remains relatively normal in demyelination (if not atrophic) and appears abnormal in ischemia. The test has not gained wide clinical use. Kaufman DI, Lorance RW,Woods M, et al. The pattern electroretinogram: a long-term study in acute optic neuropathy. Neurology. 1988;38:1767-177 4.

A newer technique by which simultaneously recorded ERG signals from up to 250 focal retinal locations within the central 30° are mapped topographically is termed multifoeal ERG (Fig 3-10). Because it does not rely on a massed retinal response as does full-field ERG, it has demonstrated great value in detecting occult focal retinal abnormalities within the macula or more peripherally. The technique is useful in distinguishing between optic nerve and macular disease in occult central visual loss, as the signal generally remains normal in optic nerve disease. Also, it may detect regions of peripheral retinal dysfunction too small to measure by the full-field technique. A variation of measuring technique and data analysis has also enabled the generation of multifocal YEP measurements to detect and monitor focal optic nerve dysfunction. Bearse MA, Sutter EE. Imaging localized retinal dysfunction

with the muItifocal electroretino-

gram. J Optom Soc Am. 1996;13:634-640. Hood DC. Electrophysiologic imaging of retinal and optic nerve damage: the multi focal technique. Ophthalmol

Clin

North

Am.

2004; 17:69-88.

~..J'v..-J\ro~-V-..r Vy--./'vo--.Ar../'v-./Ir"lr"lr-N'""'\r "'/v>--J'V0_ ]; 1:1 D "'IS:

DATE

131

02-U-90

~::I.t'II 1:« ClJ""," ~1I:.;:~t!".c!)<j

I

,S,

a'" a nflr.llitla!

'iU.

~ I~I .Tt,.~ ,~, it ~~ II db m ~F! :z 11 )613 I :-, 4-.fi,» ,., 'I~ ,tIH

!.1 ~1i~1b !Y.' q.lfilJDllr:I anfl3E.:Q3 oCI IMO'JII 'U't.": J:I3'~

,I, . I"I I) ,~ '! II bl ,~, " "~ I

1$

,£ ..J I II ) .f ~ II.. 4 -I ., ... .~ -I -l ., -l1-1.L.J.',1S .11 ! ~.I .,I ~ ." ." ... -, .J .1.3 -,Z!.J! ~

r

~ .,

.. .,1 L (.j.::-,.;1 I I .! .~ ,~,I) ',1 .:.J.J.J !.:l.i:.;ot I., J ~

-I

.. . . "". . " . "a" . ..

.

. .

..: : :::.. "':J"~I ~ .

B

.; .:,.~

.'... ,.:.,.).1.: "

.1-)J.I lI I -I ... ~

A

I

~ 1, ,r.! ,,1 I ,.;:, It .:t

II

~:: .', n ".!U.

. . . . .. . . . ... ". . ... . ::....

:1'1',,',

:.~. . !.!\] 1.:1] I'II(.!. 1.1t] I, r. rl(.~ :J"[ '.:11

« ~ ,

Figure 4-18 A, Fundus photograph of optic disc drusen, showing blurred disc margin with scalloped edge, refractile bodies on the disc surface and at the superior pole. mild pallor, and no obscuration or retinal blood vessels. B, Visual fields confirmed the presence of an inferior> superior arcuate defect on the left produced by drusen involving the left disc. (Threshold test and photograph courtesy of Steven A. Newman, MD.)

. normal or atrophic

.

peripapillary

retinal

NFL; the retinal

are clearly visible (not obscured by NFL edema) blurring of the disc margins due to abnormalities

obscuration . anomalous

by buried drusen, pigment atrophy, retinal vascular patterns, including

vessels at the disc margin

at the level of the RPE, such as and clumping loops, increased

branchings,

and

papilledema

in 2

tortuosity Ancillary

testing

may be useful

.

in differentiating

drusen

from

papilledema:

B-scan ultrasonography may differentiate

calcified

.

ways. First, the optic nerve head with ODD is elevated and highly reflective; on decreasing the sensitivity of the display, calcified drusen maintain this high signal intensity within the nerve head (Fig 4-19), whereas with papilledema, the signal intensity decreases along with the remainder of the ocular signal. Ultrasonography may identify drusen in 48%-58% of suspected cases, although this technique's ability to detect noncalcified buried ODD is unclear. Second, with papilledema, the intraorbital portion of the optic nerve is typically widened and will decrease in width with prolonged lateral gaze (the so-called 30° test); drusen do not produce widening of the intraorbital nerve. Fluorescein angiography is also an effective method for distinction. First, certain

drusen

from

drusen, if near enough to the disc surface, demonstrate autofluorescence, in which refractile bodies are brightly visible on preinjection frames of the angiogram. Second, drusen, even in buried form, typically block fluorescence focally in early frames, with gradual dye uptake producing a nodular late staining without leakage from the disc surface capillaries (Fig 4-20). Papilledema, in contrast, results in

132

.

Neuro-Ophthalmology

Figure 4-19 B-scan ultrasonography. demonstrating focal. highly reflective (due to calcification) elevation within the optic disc (arrow). which persists when the gain is decreased. (Photograph

courtesy

of Anthony

C. Arnold.

MD.)

Figure 4.20 Late-phase fluorescein angiogram of patient with optic disc drusen shows nodular staining pattern without dye leakage. (Photograph

·

courtesy

of Anthony

C. Arnold.

MD.i

early diffuse hyperfluorescence, with late leakage overlying and adjacent to the disc (Fig 4-21). Neuroimaging may be indicated in rare cases to rule out an intracranial or optic nerve tumor and to attempt direct confirmation of calcified drusen. A CT scan remains superior to an MRI scan for detection of drusen: calcium is poorly imaged on an MRI scan, but calcium produces a bright, easily detected signal at the junction of the posterior globe and optic nerve on a CT scan (Fig 4-22).

With true chronic papilledema, refractile bodies occasionally develop on the nerve head surface, simulating ODD (see Fig 4-10). These lesions (probably residual exudate) typically form near the temporal margin of the disc rather than within its substance, are usually smaller than ODD, and disappear after a decrease in ICP. The associated signs of true disc edema may point toward true papilledema, but pallor and associated signs of optic nerve dysfunction in the chronic form may simulate ODD. Opticdisc drusen versus astrocytic hamartoma Astrocytic hamartomas of the retina, most common in tuberous sclerosisand neurofibromatosis, may take the form of so-called mulberry lesions. When located adjacent to the disc, they may closely resemble ODD, and in early reports they were termed giant drusen of the optic disc (Fig 4-23). In contrast to true ODD, disc hamartomas · originate at the disc margin, with extension to the peripapillary retina arise in the inner retinal layers and typically obscure retinal vessels

· ·. do not autofluoresce and may show tumor-like vascularity on fluorescein angimay have a fleshy, pinkish component

ography

CHAPTER

4: The Patient With Decreased

Vision: Classification

and Management.

133

Figure 4.21 In contrast to disc drusen, latephase fluorescein angiography in papilledema demonstrates diffuse hyperfluorescence and leakage of dye into surrounding retina. (Photograph

courtesy

of Anthonv

C. Arnold,

MD.J

Figure 4-22 CT scan of the orbits. Calcified optic disc drusen are visible bilaterally at the posterior globe-optic nerve junction. (Photographcourtesyof Anthonv

C. Arnold,

MD.J

B

A

Figure 4-23 Optic disc drusen must be distinguished from astrocytic hamartoma. A, Drusen demonstrate prominent refractile nodules on the disc surface, which do not obscure retinal vessels. B, Astrocytic hamartomas are nodular masses arising from peripapillary retina and obscure

the retinal

vessels.

(Reprinted from Arnold AC. Optic disc drusen. Ophthalmol Clin North Am.

1991 ;4:505-517.)

In childhood, ODD tend to be buried, with minimal atrophic changes or visual field loss. Over years, drusen become more visible on the disc surface, NFL defects and mild atrophic changes develop, and visual field defects either remain stable or very slowly worsen. Occasionally, acute episodic visual loss occurs, presumably because of optic disc ischemia. No treatment is proven to alter the clinical course, but visual impairment is usually mild, Rarely, vascular complications (eg, flame hemorrhage, nonarteritic anterior ischemic optic

134

.

Neuro-Ophthalmology

neuropathy, or peripapillary subretinal neovascularization) occur. Laser therapy has been used to arrest progression of subretinal neovascularization advancing toward the macula. Arnold AC. Optic disc drusen. Ophthalmol Beck RW, Corbett JJ. Thompson Ophthalmol.

Kurz-Levin

Clin

North

Am. 1991 ;4:505-517.

HS. et al. Decreased visual acuity from optic disc drusen. Arch

1985;103:1155-1159.

MM, Landau K. A comparison

of imaging techniques

for diagnosing

the optic nerve head. Arch Ophthalmol. 1999;117:1045-1049. Moody TA, Irvine AR, Cahn PH, et al. Sudden visual field constriction

disc drusen. J Clin Neuro-Ophthalmol.

Sarkies NjC, Sanders

associated with optic

1993; 13:8-13.

Purvin V, King R, Kawasaki A, et al. Anterior ischemic optic neuropathy

drusen. Arch Ophthalmol.

drusen of

in eyes with optic disc

2004;122:48-53.

MD. Optic disc drusen

and episodic

visual loss. Br J Ophthalmol.

1987;71 :537-539.

Tso MOM. Pathology and pathogenesis of drusen of the optic nervehead. Ophthalmology. 1981

;88: 1066-1 080.

Leber hereditary optic neuropathy Leber hereditary optic neuropathy (LHON) typically affects males age 10-30 years but may occur much later in life; women may account for 10%-20% of cases. The syndrome presents with acute, severe «20/200), painless, initially monocular visual loss associated with an RAPD and central or cecocentral visual field impairment (Fig 4-24). The classic fundus appearance includes

. hyperemia and elevation of the optic disc and thickening of the peripapillary

. ·

retina, giving rise to so-called pseudo edema of the disc ("pseudoedema" in this context refers to optic disc swelling without leakage on fluorescein angiography) peripapillary telangiectasia tortuosity of the medium-sized retinal arterioles

These findings may also be present before visual loss begins. However, the fundus may be entirely normal (over 40% in one referral series). Fluorescein angiography demonstrates no leakage or staining of the disc, in contrast to the appearance of inflammatory optic neuropathies with edema. The second eye usually becomes involved within weeks to months, and the initially involved optic disc becomes atrophic, with loss of peripapillary telangiectasia. Rarely, the interval between involvement of the 2 eyes is longer (up to 8 years). Although visual loss is usually permanent, partial recovery of vision, up to years after the initial loss, has been reported in 10%-20% of cases (see below). LHON is related to a mitochondrial DNA mutation, most frequently at the 11778 position, less commonly at the 3460 or 14484 locations. The corresponding single base-pair nucleotide substitution results in impaired mitochondrial adenosine triphosphate production, which tends to affect highly energy-dependent tissues (such as the optic nerve). Blood testing for these mutations may confirm the diagnosis, may permit genetic counseling, and may provide information about prognosis: patients with the 14484 mutation have a higher chance (up to 65%) of late spontaneous improvement in central visual function, whereas those with the 11778 mutation have a lower chance (estimated at 4%).

CHAPTER 4: The

Patient

~24.2TfR:SHCL.DTts1'

-.. ctNUlIt1x:J51I

0IL1 m.II1.D:llllJ. ..,. ~ fIIDQI

With

Decreased

Vision:

fll_TlOUE M.2'9-88 DAtE e2~.,e ~ra:tr PIX II , 1U111:.C~. .10...3. D B ..,lCIllOlt1JII....

"

.. """'... . ... 'I IUIIWII$

I: ntt[SM:IU)

TIlT

8IRT.c:JATE

J. "Nama"

-...-

86-21-81

Rlr.JICJ' ar.a .mul XJ

MIL

B I"I'A

82-1'-.

rw u:2l:'. U.. H

....-

....-

H ,

... .4 ..J oS

.. ~ , .,1

.J

,. ,,,,

+

.,

..,.

..

If'

I

IIIAW".' 11 "'c

:::: .HI'"

.of t

14" .s" ..,.,..".. " 1.1 -&.. 1

;AC/III "1U1I11(~' ~alOl.U!'(lS

-I

"'''''''-11401 "41..z4,

.,

1.1'-1.' H .

"'~"

..

.. "..... ...".

"-3 '" 2t() TlI'IF

161

HRI'If_ROBERT 10 1018043 BIRT~f[ 10-28-23 onTE ~-30-ea 11,"" 01111158 PM PUPIL OJAP'£TU ".0 MJ'1~ 20"2' ()C)I DEC RX USED 2.7'5 05

R1CHT

.

EXPECTED

NO. . DEFlLeT O£P~ IN DB . CENTW.. ~ DB REF' LEVEL

and Management.

2 TH~SHOLD TEST C£NT~ 24 STIf1lA...US 1.1, UHITC. eo:CNO 31.5 RSB BLIND SPOT CHEa: SIZE OFf Ft~T10N TAACET C£NTRQl Sf.AT[CV FlA.L T~$HOl 0

ROBERT 10 IOI~J BIRTHDRTE 10-28-23 OAT[ 0'.30-88 Tlt'£ 01 :26:20 Pt1 "l,.PIL OIFIttETE~ .. ,0 1"11 A 20/30 11:)(lISEO 1.50 DS oee DC'I It. · I

1.1

iI1.I~~io':1 ;o\.ioG~ ~: ~L3 prism diopters). Some cases of presumed congenital fourth nerve palsy are secondary to a (benign) schwan noma of the fourth nerve.

anomalous site of its insertion,

Helveston EM, Krach 0, Plager DA, et al. A new classification on congenital

variations in the tendon. Ophthalmology.

of superior oblique palsy based

1992;99: 1609-1615.

In patients older than 50 years, an isolated fourth nerve palsy is typically caused by

microvascular disease that is benign, and function

returns to normal within 3 months.

The fourth nerve is particularly vulnerable to closed-head cranial trauma. In addition, the fourth nerve can be damaged by disease within the subarachnoid space or cavernous sinus. Diagnostic evaluation for an isolated fourth nerve palsy usually yields little information because most cases are either congenital, secondary to trauma, or idiopathic. In patients in the vasculopathic age group, a full medical evaluation looking for vascular risk factors, including diabetes and hypertension is appropriate. Older patients should be followed to ensure recovery. Lack of recovery after 3 months should prompt neuroimaging (with

234

.

Neuro-Ophthalmology

A Figure 8-14 Congenital left fourth nerve palsy. A. Note the left hypertropia and right head tilt as a child. B. Forty years later, the right head tilt is still present, but the patient complains of more difficulty maintaining single, binocular vision. C. Following eye muscle surgery, the diplopia

and

head

tilt

have

resolved.

(Photographs

courtesy

of Lanning

B. Kline, MD.)

and without contrast) directed toward the base of the skull to search for a mass lesion. A diagnosis of skew deviation should be considered in cases of nonresolving vertical diplopia. In younger patients, a skew deviation is most typically caused by demyelination. In older patients, a skew deviation is usually caused by stroke, either from large-vessel (basilar or vertebral artery) disease or small-vessel disease that produces lacunae. Other possible causes of an acquired vertical strabismus include orbital restrictive syndromes (eg, thyroid-associated orbitopathy or previous trauma) and myasthenia gravis. Sixth nerve palsy An isolated sixth nerve palsy typically presents as horizontal diplopia that worsens on ipsilateral gaze, especially when viewing at distance. The abduction deficit is typically associated with an esodeviation at near that worsens at distance and always with gaze to the affected side. As described earlier, a pattern of divergence paralysis may occur in the evolving or resolving phase of a sixth nerve palsy, An ischemic mononeuropathy is the most common cause of a sixth nerve palsy. Lesions of the cerebellopontine angle (especially acoustic neuroma or meningioma) may involve the sixth and other contiguous cranial nerves and cause decreased hearing with vestibular symptoms, facial paralysis, and decreased facial and corneal sensitivity. Chronic inflammation of the petrous bone may cause a similar presentation (Gradenigo syndrome), especially in children who have experienced recurrent infections of the middle ear. In adults, nasopharyngeal carcinoma, chordoma, or chondrosarcoma may produce a similar picture by invasion within or through the skull base, In addition, the sixth nerve is vulnerable to injury from shear forces of trauma or elevated intracranial pressure. In such cases, injury occurs where the sixth nerve enters the cavernous sinus through Dorello's canal (the opening below the petroclinoid ligament), Congenital sixth nerve palsies almost never occur in isolation, Abduction paresis present early in life usually manifests as a Duane syndrome (see Fig 8-6).

CHAPTER

8: The Patient With

Diplopia

.

235

Isolated sixth nerve palsies in adults over the age of 50 years are usually ischemic and resolve within 3 months. In general, at the onset of an isolated sixth nerve palsy in a vasculopathic patient, neuroimaging is not required. As noted with other isolated ocular motor cranial nerve palsies, medical evaluation is appropriate. However, a cranial MRI is mandatory if obvious improvement has not occurred after 3 months. Other diagnostic studies that may be required include lumbar puncture, other hematologic studies, and chest x-ray to identify an underlying systemic process such as collagen vascular disease, sarcoidosis, or syphilis. Recovery does not necessarily indicate a benign cause. Occasionally, an ocular motor cranial nerve palsy will resolve spontaneously and then recur as a manifestation of an intracranial tumor. Ophthalmoplegia due to impaired abduction in patients under age 50 years requires careful scrutiny, because few such cases are due to ischemic cranial neuropathy. Younger individuals should undergo cranial MRI. If negative, consideration should be given to performing a Tensilon test and a lumbar puncture. Leukemia or brain stem glioma are important considerations in children. In adolescents and young adults, demyelination may be the cause, in which case MRI with fluid-attenuated inversion recovery (FLAIR) imaging, should be part of the evaluation. (See Chapter 2 for a discussion of neuroimaging and Chapter

14 for a discussion

of multiple

Multiple

cranial nerve palsies

The guidelines for managing that no other

neurologic

isolated abnormalities

sclerosis.)

cranial nerve palsies are based on the assumption are present. Benign, microvascular disease rarely

causes simultaneous involvement of more than one ocular motor cranial nerve. Involvement of multiple contiguous nerves strongly suggests a mass lesion in the region of the cavernous sinus (see below). Bilateral involvement of cranial nerves suggests a diffuse process such as infiltrative disease (eg, carcinomas, leukemia, or lymphoma), a midline mass lesion that extends bilaterally (eg, chordoma, chondrosarcoma, or nasopharyngeal carcinoma), an inflammatory polyneuropathy (Guillain-Barre syndrome or its variant, the Miller Fisher syndrome, or sarcoidosis), or myasthenia gravis.

A

neurologic

evaluation should be obtained if symptoms or signs indicate that more

than one cranial nerve is involved. In this case, if neuroimaging is normal, a lumbar puncture should be performed. In addition to routine testing (always including measurement of intracranial pressure), spinal fluid should be placed in a centrifuge and the pellet should undergo cytopathologic examination. Special testing for cancer-associated protein markers may be helpful in uncovering an elusive diagnosis. Idiopathic multiple cranial neuropathy syndrome should be considered only after neuroimaging, spinal fluid analysis, and other tests have excluded a neoplastic, inflammatory, or infectious cause.

Cavernous Sinus and Superior Orbital Fissure Involvement The hallmark of ophthalmoplegia secondary to a lesion of the cavernous sinus is multiple, ipsilateral ocular motor nerve dysfunction from some combination of third, fourth, and sixth cranial nerve abnormalities. Fifth nerve involvement with facial hypoesthesia also localizes the lesion to the cavernous sinus. A third-order Horner syndrome might also be present. If only locular motor nerve is involved, it is usually the sixth nerve, which

236

.

Neuro-Ophthalmology

is the only ocular motor nerve not protected within the dural wall of the cavernous sinus. Aggressive lesions of the cavernous sinus, especially infectious or inflammatory processes, may compromise venous outflow and produce engorgement of ocular surface vessels, orbital venous congestion, increased intraocular pressure, and increased ocular pulse pressure. It is often impossible to clinically distinguish cavernous sinus lesions from those involving the superior orbital fissure (the ocular motor nerves pass through this fissure from the cavernous sinus to the orbit). In recognition of this difficulty, the more general designation of spheno-cavernous syndrome may be used. The offending lesion may extend toward the optic foramen or into the orbital apex, in which case optic nerve function can be compromised. The designation orbital apex syndrome is then applied. Tolosa-Hunt syndrome Tolosa-Hunt syndrome is an idiopathic, sterile inflammation that primarily affects the cavernous sinus. Severe, "boring" pain is almost always present. Neuroimaging may show an enhancing mass within the cavernous sinus. Patients with Tolosa-Hunt syndrome respond dramatically to corticosteroid therapy, but a positive response may also occur with neoplastic mass lesions, especially lymphoma. Not infrequently, patients initially diagnosed with Tolosa-Hunt are later discovered to have a neoplastic cause of their painful ophthalmoplegia. Therefore, the Tolosa-Hunt syndrome is a diagnosis of exclusion. Other causes of cavernous sinus lesions include aneurysm, meningioma, lymphoma, schwan noma, pituitary adenoma (with or without apoplexy), carotid-cavernous fistula, metastasis, sarcoidosis, and cavernous sinus thrombosis. Kline LB,

Hoyt

WE The Tolosa-Hunt

syndrome. J Neurosurg Psychiatry. 2001;71:577-582.

Carotid-cavernous fistula Abnormal connections between the carotid artery (or its branches) and the cavernous sinus introduces high arterial pressures into the normally low-pressure cavernous sinus. This high-pressure connection may reverse the blood flow within the superior ophthalmic vein and produce venous congestion within the orbit. Arterialization of conjunctival vessels is a classic sign of this fistula (Fig 8-15). Patients with this condition typically have a high-flow fistula, which may produce a cranial bruit, as well as a typical cavernous sinus syndrome. High-flow fistulas most commonly occur after severe head trauma, whereas low-flow fistulas (see the following section) most often occur spontaneously in older women. Other than the telltale symptom of a cranial bruit, differentiating high flow from low flow is determined by angiographic studies. Dural sinus fistula Whereas a carotid-cavernous fistula typically has high blood flow, a dural sinus fistula typically has low blood flow, at least initially. The sequence of events that leads to a dural sinus fistula is not known. A dural sinus fistula develops spontaneously, perhaps following idiopathic thrombosis of small veins within the walls of the cavernous sinus. Then, ischemic, arterial collaterals may develop from adjacent arteries and extend to the cavernous sinus, which elevates the intraluminal pressure within the venous system. The clinical

CHAPTER 8: The

Patient

With

Diplopia

.

237

B Figure 8-15 Right produces enlarged. bus. 8, Tl-weighted (Photographs

courtesy

carotid-cavernous sinus fistula. A, The elevated orbital venous pressure corkscrew. arterialized conjunctival blood vessels that extend to the limaxial MRI reveals an enlarged. dilated superior ophthalmic vein (arrow). of Karl C. Gofnik.

MD.J

findings are almost always less dramatic than those of a carotid-cavernous fistula, although over time the low-flow state of the classic dural sinus fistula may develop greater flow as new arterial connections develop. Some dural sinus fistulas remain stable or close spontaneously. Carotid-cavernous fistulas and dural sinus fistulas almost always produce elevated intraocular pressure and proptosis but may also cause ocular motor neuropathy and diplopia, arterial or venous compromise to the retina and eye, ischemic optic neuropathy, choroidal effusions (which can push the iris forward and produce angle-closure glaucoma), and pain (which may partly result from ocular surface drying if proptosis is significant). Both types of fistula are successfully treated with interventional radiologic techniques. Angiography is required to detemine the location and configuration of the fistula, and then a variety of thrombogenic materials (eg, coils, beads, balloons) are employed to eliminate the abnormal vascular flow.

CHAPTER

9

The Patient With Nystagmus or Spontaneous Eye Movement Disorders

Introduction A variety of diseases, drugs, or other factors may disrupt the systems that control eye movements that provide ocular stability. Abnormal eye movements may occur because of inability to maintain fixation, loss of the normal inhibitory influences on the eye movement control system, or loss of the normally symmetric input from one of the vestibular pathways to the ocular motor nuclei. One form of excessive eye movements is known as nystagmus, a term that should be reserved for rhythmic, to-and-fro eye movements (horizontal, vertical, or torsional) with 2 phases: (1) a slow drift from the target of interest, followed by (2) a corrective saccade back to the target. This combination of 2 phases with differing speeds is often referred to as jerk nystagmus. Pendular nystagmus occurs when the back and forth movements are equal in amplitude and velocity (Fig 9-1). Other inappropriate saccadic movements may also affect the normal ability to fixate on a target. Collectively, these pathologic eye movements are known as saccadic intrusions or saccadic oscillations, as they do not conform to the definition of nystagmus. Spontaneous eye movements are often asymptomatic, especially in children who have congenital nystagmus. In contrast, patients with acquired nystagmus often report a sensation of movement in their environment termed oscillopsia. Acquired nystagmus that is present in primary position may reduce visual acuity. Patients should be asked about any associated neurologic symptoms (eg, vertigo, ataxia, motor, or sensory weakness) and any family history of abnormal eye movements. Examination of ocular motility begins with assessing ocular stability with the eyes in primary gaze while fixating on a target. Eye movements in the 9 cardinal positions should then be examined to determine if

. the eye movement disorder is monocular or binocular . . the abnormal eye movements are horizontal, vertical, torsional, or mixed the eyes behave similarly (conjugately)

. the abnormal eye movements are continuous or are induced by particular eye position 239

240

.

Neuro-Ophthalmology

A

c Figure 9-' Waveforms of some forms of nystagmus. A, This trace shows eye movements that are equal in speed and amplitude to the right (up)and left (down) of a central point. This is the pattern of pendular nystagmus. 8, This trace shows a gradually increasing eye movement speed the further the eye moves eccentrically to the right (up in the trace). followed by a rapid return of the eye to fixation(shown by the more vertical line that bringsthe eye back toward the left). This increasingly exponential waveform pattern is typical of congenital nystagmus. C, By comparison, this trace shows an eye movement with decreasing velocity the further the eye is moved eccentrically (that is, there is a concave appearing trace that flattens as the eye moves to the left, depicted as a downward inflection of the trace). This relatively slow, eccentric eye movement is followed by a more rapid return to the right. This is the pattern of gaze-evoked jerk nystagmus. The horizontal axis in ocular motor tracings of this type indicates time. (Modified from Leigh RJ, Zee OS. The Neurology of Eye Movements. 3rd ed. Contemporary Neurology Series. New York: Oxford

University

Press;

1999.)

. there is a fast or slow phase (vs. pendular movements)

·

there is a point at which the nystagmus is less evident (ie, a null point)

By convention, the direction of jerk nystagmus is reported as the direction of the fastphase component. When the size of oscillations differs in each eye, it is referred to as dissociated nystagmus. When the direction of the oscillations differs, the term disconjugate, or disjunctive, is applied. The amplitude of nystagmus often changes with gaze position. A few beats of nystagmus are normally present in the extremes of horizontal gaze (beyond 45°), especially in older patients. This should not be considered pathologic unless the nystagmus is persistent or asymmetric (present to the left but not the right, for instance). Assessment for nystagmus can be complemented by strategies that search for subtler, smaller-amplitude eye movements. Illuminated Frenzel (high-magnification) goggles are extremely useful in detecting eye movements, but a 20 0 lens or slit lamp or direct ophthalmoscope can also be used. Ocular motor recordings (electro-oculogram, infrared tracking, or electromagnetic coil technique) provide an objective and highly sensitive measure of eye movements but are rarely needed in standard clinical practice. The characteristics of eye movements can be easily recorded and effectively communicated in a drawing (Fig 9-2).

CHAPTER

9:

The Patient With Nystagmus.

--

Patient's left

--

241

Patient's right

--

Figure 9-2 One method for efficiently depicting the pattern of nystagmus. The 9 blocks represent the 9 cardinal positions of gaze. Within each block there are 2 lines or arrows, one atop the other. The upper line or arrow, by convention, signifies the right eye. Use of lines (rather than arrows) indicates that there is no nystagmus at that position of gaze. Arrows indicate the direction of the fast component of nystagmus (ie, horizontal, vertical, or oblique; rotary patterns can also be easily shown). The amplitude of nystagmus is indicated by the length of the lines (longer lines indicate larger amplitude nystagmus). With respect to such drawings, there is no absolute convention about the orientation of the drawing with respect to the patient's left and right sides. Therefore, it is important that the drawing be clearly labeled. (Courtesy of Joseph

F Rizzo,

Leigh New

MD.)

R), Zee OS. The Neurology York:

Serra A, Leigh

J Neurol

Early-Onset

Oxford

University

R). Diagnostic

Neurosurg

Psychiatry.

(Childhood)

of Eye Movements. Press;

3rd ed. Contemporary

Neurology

Series.

1999.

value of nystagmus:

spontaneous

and induced

ocular

oscillations.

2002;73:615-618.

Nystagmus

Several forms of nystagmus can be recognized in the first few months or years of life. Congenital Nystagmus Congenital nystagmus (CN) is usually recognized in the first few months of life, and there may be a family history of this disorder. Patients with CN are not bothered by the eye movements. CN may occur in the presence of poor vision or good acuity. Reduced acuity may be due to the nystagmus itself or related to an afferent visual pathway disorder. Therefore, the ophthalmologist must determine whether there is evidence of damage to the visual pathways. In young children, it is important to detect any impairment of visual tracking (ie, detect that the eyes cannot follow visual stimuli equally) or optic atrophy. The presence of such abnormalities should prompt neuroimaging. CN often occurs with such conditions as ocular albinism, achromatopsia, Leber congenital amaurosis, and aniridia. Frequently, electrophysiologic testing (ERG, VEP) is warranted. CN is almost always conjugate and horizontal. Its horizontal nature is maintained even in upgaze and downgaze. The nystagmus may be continuous or intermittent and can appear as jerk or pendular movements. There is frequently a null point, the field of gaze in which nystagmus intensity is minimal. If the null point is not in primary position, patients often adopt a head turn or other posture to improve vision. Visual fixation on

242

.

Neuro-Ophthalmology

a distant target usually amplifies CN (unlike the case with peripheral vestibular nystagmus, discussed later in the chapter), whereas convergence on a near target damps the amplitude of the nystagmus. Two characteristic signs of CN are 1. reversal of the normal pattern of optokinetic nystagmus characterized by the slow phase of eye movements moving in the direction opposite that of a rotating optokinetic drum 2. a unique pattern, identifiable only with eye movement recordings, in which the velocity of slow-phase movement increases exponentially with distance from fixation (see Fig 9-1) To summarize, the features of CN include

. · · ·. ·. .

jerk or pendular pattern present with or without normal acuity conjugate horizontal eye movements that remain horizontal in up- and downgaze presence of a null point no oscillopsia

accentuated by distant fixation; diminished by convergence 15% of patients have strabismus abolished in sleep

Gelbart SS. Hoyt CS. Congenital nystagmus: a clinical perspective in infancy. Graefes Arch Clin Exp Ophthalmol. 1988;226: 178-180.

latent Nystagmus Another form of nystagmus that appears very early in life is latent nystagmus (LN), which is a horizontal jerk nystagmus that appears only in monocular viewing conditions. Eyes with LN are stable until 1 eye is occluded, thus eliminating binocular fixation. The fast phase beats toward the viewing eye (ie, away from the occluded eye). Hence, the fast phase reverses direction each time the eyes are alternately covered. Use of an occluder when measuring visual acuity requires special care in patients with LN because the onset of the nystagmus will degrade acuity. Partial optical blurring of 1 eye (with a plus lens or filter) may permit better acuity measurements in the fellow eye without inducing nystagmus. LN should be ruled out in any case of unexplained subnormal visual acuity. LN is almost always associated with esotropia and, frequently, with dissociated vertical deviation. Clinical characteristics of LN include

. . ·. . . ·.

conjugate jerk nystagmus begins when binocular fusion is disrupted fast phase beats toward viewing eye esotropia almost always present esotropic eye usually has decreased acuity subnormal stereopsis variably present as the esotropic eye is suppressed may be present with CN in the same patient

CHAPTER

9: The Patient With Nystagmus.

243

Nystagmus with characteristics of LN that is present when both eyes are open is known as manifest latent nystagmus (MLN). Because most patients with LN have esotropia (which may be a subtle microtropia), MLN is initiated when the esotropic eye is physiologically suppressed. In other words, the nystagmus spontaneously and intermittently develops whenever physiological suppression occurs (ie, the examiner does not need to induce the abnormal movements with ocular occlusion). Both LN and MLN are benign entities. Neither shows the increasing exponential waveform of CN when studied with eye movement recordings. DelrOsso LF, Schmidt D. Daroff RB. Latent, manifest latent, and congenital Ophthalmol. 1979;97:1877-1885.

nystagmus.

Arch

Monocular Nystagmus of Childhood Monocular nystagmus of childhood is a rare but important form of nystagmus that usually manifests early in life. The eye movements are usually in 1 eye, vertical, and of small amplitude. The eye with nystagmus may have decreased vision with an afferent pupillary defect and optic atrophy. There usually is an associated optic nerve/chiasmal tumor (glioma) or trauma, and therefore neuroimaging is warranted. Such monocular nystagmus is called the Heimann-Bielschowsky phenomenon; it may also be seen in patients with profound amblyopia. Spasmus Nutans Spasmus nutans is a disorder that develops in the first year of life, manifesting as intermittent, binocular, very small amplitude, high-frequency, horizontal, pendular nystagmus. The nystagmus may be dissociated, even monocular, and the relationship of amplitude and phase of the eye movements may frequently vary between the eyes. Small-amplitude vertical nystagmus may be present as well. The nystagmus is accompanied by head nodding, which is often subtle. Many patients have an abnormal head posture or torticollis. In general, spasmus nutans is distinguished from CN by abnormal head movements and head posture. The intermittent and variable nature of the nystagmus and the relatively high frequency of eye movements are also typical of spasmus nutans. Spasmus nutans is a benign disorder, and patients generally have no other neurologic abnormalities, except perhaps strabismus and amblyopia. Typically, the abnormal eye and head movements disappear after one or several years and certainly by the end of the first decade of life. However, the nystagmus of spasmus nutans is sometimes monocular and thus virtually impossible to distinguish from the more ominous condition of monocular nystagmus of childhood (discussed in the preceding section). Therefore, patients with presumed spasmus nutans should undergo neuroimaging to exclude a glioma of the anterior visual pathway. Lack of the expected resolution of spasmus nutans or development of any neurologic problems should likewise prompt appropriate neuroimaging. Newman SA, Hedges TR III, Wall M, et al. Spasmus nutans-or is it? Surv Ophthalmol. 1990;34:453-456. YeeRD, JelksGW, Baloh RW.et al. Uniocular nystagmus in monocular visual loss. Ophthalmology. 1979;86:511-522.

244

.

Neuro-Ophthalmology

Gaze-Evoked

Nystagmus

Gaze-evoked nystagmus develops because of an inability to maintain fixation in eccentric gaze. The eyes drift back to the midline, and a corrective saccade is generated to reposition the eyes on the eccentric target. Hence, the fast phase is always in the direction of gaze. The amplitude of the nystagmus increases as the eyes are moved in the direction of the fast phase. This pattern is in accordance with Alexander's law, which states that nystagmus increases in intensity (amplitude and frequency) as the eyes are moved in the direction of the fast phase. Gaze-evoked nystagmus is caused by dysfunction of the neural integrator (see Chapter 1). For horizontal gaze, the neural integrator comprises the nucleus prepositus hypoglossi and the medial vestibular nuclei. For vertical gaze, the interstitial nucleus of Cajal (INC) serves as the neural integrator. The neural integrator receives a velocity signal from the appropriate gaze center and, through a mathematical process of integration, generates a "step" signal to maintain the eccentric position of the eyes (Fig 9-3). That is, the neural integrator ensures a level of neural activity adequate to maintain the eyes in an eccentric position of gaze against the elastic forces of the orbit. If the neural integrator fails to function properly (becomes "leaky"), eccentric eye position cannot be maintained. The flocculus and nodulus of the cerebellum also playa role in maintaining an eccentric position of gaze. Gaze-evoked nystagmus is usually symmetric in the horizontal plane (ie, is similar in appearance on right and left gaze). Advanced age is associated with deficient performance of the neural integrator and is the most common cause of horizontal gaze-evoked nystagmus. A few beats of jerk nystagmus at the extreme of far horizontal gaze is physiologic and of no clinical significance. However, sustained or asymmetric gaze-evoked nystagmus should prompt further evaluation. Metabolic and toxic etiologies include ethanol and a variety of medications, including anticonvulsants, sedatives, and hypnotics. Whenever gaze-evoked nystagmus is asymmetric, it can be presumed that a lesion of the brain stem or cerebellum-typically stroke, demyelination, or tumor-has asymmetrically affected the vestibular nuclei. This finding should prompt appropriate patient evaluation, including neuroimaging. End-organ disease such as extraocular myopathies and myasthenia can also cause gaze-evoked nystagmus, with a pattern similar to that seen with lesions of the central nervous system. Rebound Nystagmus Prolonged eccentric viewing may induce rebound nystagmus. Such eccentric viewing may produce a directional bias in ocular motor control in an attempt to counteract the centripetal tendency of the eyes to return to primary position (primarily due to elastic forces within the orbit). This induced bias becomes evident when the eyes return to primary position and then show a tendency to return to the prior eccentric direction of gaze. The bias induces corrective saccadic movement in the direction opposite to the initial eccentric position of gaze. A few beats of rebound nystagmus may be seen in normal individuals. More persistent rebound nystagmus is a manifestation of cerebellar disease.

CHAPTER

p

B

1111111

9: The Patient With Nystagmus

.

245

111111111

be

o M NIIIII'"IIIIIII In-step

.

Pulse

UL NI 1111111111111111111111

NI

~

Figure 9-3 The combined influence of the pulse and step signal that contributes to the generation of a saccadic eye movement. This schematic shows the coordination among omnipause cells (P), burst cells (8), and the cells of the neural integrator (Nt) in the generation of a saccade. The NI performs an integration of the amount of neural activity required to execute an eye movement over the duration of time (JdO.The omnipause cells (P)cease their discharge just before the onset of a saccade. At the same time, the burst cells (B)create the pulse that initiates the saccade. This pulse is received by the NI, which determines the appropriate step needed to maintain the eccentric position of the eyes. The pulse and step alter the firing of the ocular motoneurons (OMN) that activate an extraocular muscle to execute an eye movement. The lower right trace (E)represents the shift in eye position from baseline to a sustained eccentric position. Vertical lines represent individualdischarges of neurons. Underneath each schematized neural (spike) discharge are plots of discharge rate versus time. (Usedwithpermission from Leigh RJ, Zee OS. The Neurology of Eye Movements. University Press; 1999,)

3rd ed. Contemporary

Neurology Series. New York: Oxford

Vestibular Nystagmus Vestibular nystagmus can be caused by peripheral or central lesions. Peripheral

Vestibular

Nystagmus

Patients with peripheral vestibular nystagmus typically present with a sudden, sometimes dramatic, onset of dysequilibrium with vertigo, nausea, and vomiting (Table 9-1). Patients often recognize that their symptoms are worsened by particular head postures. Oscillopsia, tinnitus, and hearing loss may also be experienced. After the acute phase, which typically lasts days, patients experience a slow period (weeks to months) of gradually waning symptoms. Even patients who become asymptomatic may experience discomfort months to years later when their vestibular system is challenged, as when riding in a fast-moving car or boat, for instance.

246

.

Neuro-Ophthalmology

Table 9-' Clinical Symptom or Sign Vertigo Duration

Characteristics

of symptoms

Tinnitus or hearing loss Horizontal nystagmus with torsion Horizontal nystagmus without torsion Pure vertical or torsional nystagmus Visual fixation Common causes

of Peripheral

and Central

Vestibular

Nystagmus

Peripheral Dysfunction

Central

Severe Days to weeks, improving over time (may be recu rrent) Common Typical

Mild May be chronic

Typically absent Not typical

Rare

May be present

Almost

never

Damps nystagmus Labyrinthitis; Meniere trauma; toxicity

Dysfunction

Diagnostic

disease;

No effect Demyelination; drugs

vascular;

Peripheral vestibular nystagmus occurs in patients with dysfunction of the end organ (semicircular canals, otolithic structures, vestibular nerve). End-organ damage, which is usually unilateral or at least asymmetric (except in cases of toxicity), disrupts the otherwise symmetric vestibular afferent inputs to the neural integrator that stabilizes eye position in eccentric locations. The output of the neural integrator is routed to the contralateral PPRF. This loss of tonic symmetry produces a directional bias in eye position. A reduction in input from a left-sided vestibular lesion, for instance, produces a leftward bias, which then induces a corrective saccade away from the side of the lesion. Thus, a left-sided lesion would produce right jerk nystagmus. Typically, peripheral vestibular nystagmus disrupts output from all 3 semicircular canals and the otolithic organs; this produces a mixed pattern of nystagmus with horizontal, torsional, and vertical components, although the first predominates. The pattern of nystagmus changes depending on the direction of gaze. This follows Alexander's law: The nystagmus is more pronounced when gaze is directed toward the side of the fast-beating component. Depending on the severity of the lesion, the nystagmus may be evident in primary position. A skew deviation may also be present due to disruption of peripheral vestibular structures. Nystagmus that is purely vertical or torsional almost always signifies a central lesion (see the following section). A characteristic feature of peripheral vestibular nystagmus is the ability of visual fixation to damp the nystagmus. The effect of visual fixation on nystagmus can be evaluated during direct ophthalmoscopy by temporarily covering the contralateral fixing eye. Other methods for enhancing this form of nystagmus include vigorous head shaking, hyperventilation, mastoid vibration, or Valsalva maneuver. Peripheral vestibular nystagmus usually occurs in 1 of 4 clinical settings. The first is an acute, monophasic disorder that occurs secondary to a (presumed viral) vestibular neuronitis. The second is a recurrent form of vestibular dysfunction that is usually associated with auditory symptoms (tinnitus and hearing loss). This disorder, known as Meniere disease, is usually progressive, although typically there are long symptom-free intervals. The third clinical setting is a paroxysmal dysfunction of the vestibular system

CHAPTER

9: The Patient With Nystagmus.

247

that produces vertigo in response to certain postures of the head. This disorder, known as benign, paroxysmal, positional vertigo (BPPV), develops because of free movement of otoconia particles (calcium carbonate crystals normally contained within the utricle and saccule), which act as foreign debris within a semicircular canal. The Dix-Hallpike maneuver, during which the patient's head is turned in a particular direction and lowered below the horizontal plane of an examining table to induce symptoms, can be used to diagnose which semicircular canal is dysfunctional. Repositioning the patient for 30 seconds to the opposite side, while the head is still hanging, can move the otoconia to a position that eliminates the vestibular symptoms. After this therapeutic maneuver, patients should maintain an upright posture (including during sleep) for 24 hours to improve the likelihood of successful treatment. These patients often enjoy a remission after a bout of BPPV, but it is not uncommon for patients to be intermittently plagued by this disorder. A fourth clinical setting for the occurrence of peripheral vestibular nystagmus is from a toxic etiology, primarily the use of aminoglycosides. Baloh RW.Clinical practice: vestibular neuritis. N Ellgl f Med. 2003;348:1027-1032. Fife TO, Tusa Rj, Furman

jM, et al. Assessment:

children.

Report of the Therapeutics

American

Academy of Neurology. Neurology.

Hotson

jR, Baloh

RW. Acute

Central Forms of Vestibular

vestibular

vestibular

and Technology syndrome.

2000;55:

testing techniques Assessment

in adults and

Subcommittee

of the

1431-1441.

N Ellgl f Med. 1998;339:680-685.

Nystagmus

There are extensive interconnections between the central vestibular structures of the brain stem and the phylogenetically older regions of the cerebellum (flocculus, nodulus, and vermis). As such, it can be difficult, if not impossible, to determine by clinical examination alone the precise location of some lesions that produce central nystamus. Although some forms of central vestibular nystagmus do provide good localizing information (Table 9-2), it is often more appropriate to think of the central vestibular pathways as a single system and to obtain neuroimaging if more specific information about localization is desired. Central vestibular nystagmus Central vestibular nystagmus is of small amplitude, and patients usually have no visual complaints. With this form of nystagmus, the fast component is directed toward the side

Table 9-2 Selected lesion locations

Nystagmus/Oscillatory

Movements

and Their

Most

Abnormal Eye Movement

Probable

Downbeat nystagmus Upbeat nystagmus See-saw nystagmus Monocular nystagmus of childhood Periodic alternating nystagmus Convergence-retraction nystagmus Ocular bobbing Flutter/opsoclonus

Cervical-medullary junction Posterior fossa Diencephalon Optic nerve/chiasm/hypothalamus Posterior fossa Pretectum (dorsal midbrain) Pons Pons (pause cells)

location

of lesion

Common

248

.

Neuro-Ophthalmology

of gaze; hence, the direction of nystagmus changes as gaze turns right or left. The nystagmus is often symmetric (as opposed to peripheral vestibular nystagmus, which is usually biased toward one side). With central vestibular nystagmus, upbeat nystagmus may be present on upgaze, but eye position is usually stable in downgaze. Visual fixation has little effect on central vestibular nystagmus. Depending on the underlying cause, it may or may not be associated with other symptoms, and its appearance can remain unchanged for years. Central vestibular nystagmus occurs in 2 main settings. Most often it is due to medications (eg, anticonvulsants, sleeping aids, sedatives, and antianxiety medications) or alcohol, and the nystagmus pattern is usually symmetric. Less frequently, it may be seen with brain stem disease (tumor, trauma, stroke, demyelination), and in this setting the nystagmus is often asymmetric. Some patients with cerebellar pontine angle tumors (usually acoustic neurinoma or meningioma) may experience Bruns nystagmus, which is a combination of central and peripheral vestibular nystagmus. Initially, as the vestibular nerve is affected, the eyes drift toward the side of the lesion, with a corrective fast phase in the opposite direction. As the lesion enlarges, the ipsilateral brain stem may be compressed, which causes problems in maintaining ipsilateral eccentric gaze; thus, as the patient looks to the side of the lesion, the fast phase changes direction to ipsilateral, and the nystagmus becomes slower and coarser in amplitude toward the side of the lesion. Hotson JR, Baloh RW. Acute vestibular syndrome. N Engl J Med. 1998;339:680-685.

Downbeat nystagmus Downbeat nystagmus results from defective vertical gaze holding that allows for a pathologic upward drift of the eyes that is then corrected with a downward saccade. The drift is triggered by a reduction in tonic input to the vertically acting ocular motor nerves. Downbeat nystagmus is present in primary position, but in accordance with Alexander's law, the downbeating movements are accentuated in downgaze (especially downgaze to either side). Patients usually report oscillopsia, which can be debilitating. A structural lesion may be associated with downbeat nystagmus, in which case the lesion is almost always located at the cervical-medullary junction. An Arnold-Chiari type I malformation, in which the cerebellar tonsils herniate through the foramen magnum and compress the brain stem and spinal cord, is the most common structural etiology (Fig 9-4). Lesions at the foramen magnum are best assessed with sagittal MRI. Structural

Figure9.4 Arnold-Chiaritype I malformation. This 26-year-old patient reported a sense of movement of his environment. Downbeat nystagmus was identified as the explanation for his oscillopsia. This sagittal. Tl-weighted MRI scan shows herniation of the cerebellar tonsils (arrow)through the foramen magnum. (The level of the foramen magnum is shown by the dotted line.)

CHAPTER

9: The Patient With Nystagmus.

249

lesions that cause downbeat nystagmus compromise the vestibulocerebellum (nodulus, uvula, flocculus, and paraflocculus) and diminish the tonic output from the anterior semicircular canals to the ocular motor neurons. In some cases of unexplained downbeat nystagmus, antibodies to glutamic acid decarboxylase have been discovered in the blood of affected patients. These antibodies might produce downbeat nystagmus by interfering with the GABAergic neurons of the vestibular complex that normally inhibit the cells of the flocculus. The differential diagnosis of downbeat nystagmus includes:

.

Arnold-Chiari type I malformation tumors (meningioma, cerebellar hemangioma) at the foramen magnum

. . . . cranial trauma . drugs (alcohol, lithium, anticonvulsants) . . basilar impression . spinocerebellar degenerations . syrinx of the brain stem or upper cervical spinal cord . brain stem encephalitis . paraneoplastic syndrome . nutrition (Wernicke encephalopathy, parenteral feeding, magnesium . antibodies to glutamic acid decarboxylase . demyelination stroke

platybasia

deficiency)

idiopathic

Clonazepam, baclofen, gabapentin, and base-out prisms (to induce convergence) are the most common treatments for downbeat nystagmus, but they are frequently unsuccessful. One recent study demonstrated benefit by treating with 3,4-diaminopyridine, a potassium channel blocker that may enhance the inhibitory influence of the vestibulocerebellum on the vestibular nuclei by increasing the excitability of the cerebellar Purkinje cells. Strupp M. Schuler O. Krafczyk S. et al. Treatment pyridine: a placebo-controlled

of downbeat

nystagmus

with 3,4-diamino-

study. Neurology. 2003;61: 165-170.

Upbeat nystagmus Upbeat nystagmus is caused by an inappropriate downward drift of the eyes, followed by corrective, upward saccades. Upbeat nystagmus may be caused by lesions in the brain stem or the anterior cerebellar vermis; hence, the lesions may exist at variable locations within the posterior fossa. As such, the finding of upbeat nystagmus does not allow a clinician to localize the lesion as accurately as can often be done with downbeat nystagmus. Common causes of upbeat nystagmus include demyelination, stroke, cerebellar degeneration, and tobacco smoking. Torsional nystagmus In contrast to the mixed patterns of nystagmus seen with peripheral vestibular disease, nystagmus that is purely torsional is indicative of a central lesion. Nystagmus that is purely vertical also is indicative of a central lesion. Torsional nystagmus is usually associated

250

.

Neuro-Ophthalmology

with a medullary lesion (syringobulbia, lateral medullary infarction) may be part of an ocular tilt reaction. Periodic alternating nystagmus Periodic alternating nystagmus (PAN) is a strictly horizontal nystagmus that oscillates in direction, amplitude, and frequency. For instance, a rightward beating nystagmus develops progressively larger amplitudes and higher frequencies up to a certain point, then wanes, eventually leading to a short period without nystagmus. Then, the nystagmus reverses direction, with a crescendo-decrescendo pattern that again leads to a short period without nystagmus, to complete the cycle. PAN may be congenital or acquired. The acquired form has a characteristic oscillation cycle of 4 min (typical range: 2-4 minutes). A cursory or too brief examination often leads to the erroneous conclusion that the nystagmus is directed only to 1 side. For this reason, any presentation of nystagmus that is purely horizontal and is present in primary position should be observed for at least 2 minutes to be certain one is not dealing with PAN. A patient with PAN may also demonstrate periodic alternating head turn to minimize the nystagmus, according to Alexander's law. PAN may be associated with posterior fossa disease, especially of the vestibulocerebellum. In particular, lesions of the inferior cerebellar vermis, which contains the nodulus and uvula, remove the inhibition that these structures normally impart to the velocitystorage mechanisms mediated by the vestibular nuclei. An oscillatory shifting of the null point results. Common causes include multiple sclerosis, cerebellar degeneration, ArnoldChiari type I malformation, stroke, anticonvulsant therapy, and bilateral visual loss. If the last is reversible (eg, vitreous hemorrhage), PAN may be abolished. Lioresal can be effective for the acquired form of this nystagmus.

Acquired Pendular Nystagmus Acquired pendular nystagmus generally has different characteristics than the more common congenital form (discussed earlier). Acquired pendular nystagmus usually includes pendular movements in the horizontal and vertical planes, as well as torsional movements. (In contrast, congenital pendular nystagmus usually manifests only with horizontal movements.) In the acquired form, the relative dominance of the movement vectors determines the pattern of nystagmus, which can be elliptical, circular, or oblique. For instance, pendular nystagmus with both vertical and horizontal components will produce oblique nystagmus (if the components are in phase), or circular or elliptical nystagmus (if the components are out of phase). The pattern of nystagmus often shifts as the vectors move in and out of phase. The eye movements may be conjugate or disconjugate and often dissociated. The localizing value of acquired pendular nystagmus is poor. It is most commonly seen in patients with multiple sclerosis, who typically have numerous lesions throughout the posterior fossa. This form of nystagmus can also be seen following blindness secondary to optic nerve disease, including that due to multiple sclerosis. Assuming reduced vision in both eyes, the nystagmus is typically larger in the eye with poorer vision.

CHAPTER 9: The

Patient

With

Nystagmus.

251

Oculopalatal Myoclonus Acquired pendular vertical oscillations may accompany palatal myoclonus, an acquired oscillation of the palate. The eye movements are continuous and rhythmical, typically conjugate in the vertical plane, and persist during sleep. This eye movement disorder may also be associated with synchronous movements of the facial muscles, pharynx, tongue, larynx, diaphragm, trunk, and extremities. The condition usually occurs several months to years after a brain stem stroke that damages fibers of the central tegmental tract, which extends between the red nucleus and inferior olivary nucleus of the medulla. A stroke in this location can disrupt transmission between the cerebellum, specifically the flocculus, and the inferior olive. The lesion produces hypertrophy of the inferior olivary nucleus, which can be visualized with MRI scanning.

See-Saw Nystagmus See-saw nystagmus is a form of disconjugate nystagmus in which 1 eye elevates while the other eye depresses, which is reminiscent of the movement of a see-saw. The upward moving eye also intorts while the downward moving eye extorts. The eye movements typically are pendular, the frequency typically slow, and the amplitude similar between eyes. See-saw nystagmus may be congenital, but it is most commonly found in patients with large tumors in the region of the diencephalon. Craniopharyngioma is the most frequent cause. Other parasellar tumors and trauma may also produce see-saw nystagmus; congenital achiasma is a rare cause. There may be associated visual loss, often bitemporal hemianopia. Asymmetrical visual loss may influence the amplitude of the eye movements (ie, the amplitude may be larger in the poorer seeing eye). Daroff RB. See-saw nystagmus. Neurology. 1965; 15:874-877. Druckman

R, Ellis P, Kleinfeld J, et al. Seesaw nystagmus. Arch Ophthalmol.

1966;76:668-675.

Dissociated Nystagmus Nystagmus that is characterized by a difference in the size of the ocular oscillation is referred to as "dissociated:' Perhaps the most common form of dissociated nystagmus is seen with lesions of the medial longitudinal fasciculus (MLF), which produces an internuclear ophthalmoplegia (INO; see Chapter 8). Isolated slowing of adduction of the eye ipsilateral to an MLF lesion is the primary feature required to establish a diagnosis of INO. In addition, there is often nystagmus of the abducting eye when gaze is directed to the side opposite the lesion. One explanation for this pattern of dissociated nystagmus is the development of increased neural pulsing in an attempt to overcome the adduction weakness. Because of Hering's law, the increased neural signaling would also be delivered to the contralateral yoke muscle, which would create excessive saccadic movements in the contralateral lateral rectus muscle.

252 . Neuro-Ophthalmology

Saccadic Intrusions Saccades that disrupt visual fixation and are rapid and brief are referred to as saccadic intrusions. Several forms of saccadic intrusions have been identified. Based on eye movement recordings, 2 classes may be distinguished by the presence or absence of an intersaccadic interval, which is defined as the temporal separation between sequential saccades extending up to 200 msec. Saccadic Intrusions With Normallntersaccadic

Intervals

The most common eye movement of saccadic intrusions with normal intersaccadic intervals is square-wave jerks (amplitude co " co co

>!!!.

0.

--.J

Q

'"

:5 '"

::>. V) Q)

m COJ

t::

E C> OJ en

~" .~ o u o

.. '" >-

o OJ " :;E OJe "-0 ~

$1-:2 (/) '0; 0 .= > ::>"'0. 0.::> aioe. ~ ._

OJ>" "E

~

o, '" OJ -0" .: 0 ~:I:

I/J

"C

gg~ '"

".2 ~

~E

.!!? c ro '0 c .g ro .2 ro Q) > .2

" E co Q; '"

. "".c C>

0 ~"OJ'

OJ

(3.2'

'" ~::>

ro ~0 0 0

::> C>

'" E!:

_o~0 .!!!~ is

" 0

~

"

"E co )( >o i; >.c

+-' ro '..c

u

~ o u:: ....

o ....

Q)

0. ..2PC) UI1E

,.0. . DH'tT OCPTHIN 09 30 08 IIIIt. CENTRA..Ir[F UY[l

"",.. I

. .,,,,,..

.

..

IN 00

33 De

REF

.

CENTm..

(.

2 months) typically outweigh the benefit. Therapy should be tailored to the signs and symptoms. Many patients require only supportive care for ocular symptoms, such as topical ocular lubricant ointment at night and artificial tears during the day. Taping the eyelids at night may also be effective in patients with lagophthalmos. For acute cases, eyelid surgery is usually limited to those patients with severe corneal problems related to exposure. Tarsorrhaphy may be effective but gives poorer cosmetic results than procedures to recess the upper or lower eyelid retractors. Eyelid surgery should be deferred if orbital surgery or eye muscle surgery is contemplated. The diplopia associated with TAO is related to progressive muscular fibrosis. Although short-term corticosteroid therapy may help control active inflammation, no specific treatment can reverse fibrosis. In acute cases, double vision associated with restrictive strabismus can be eliminated by occlusion. After the deviation becomes stable, eye muscle surgery may achieve realignment. Optical realignment may be possible with spectacle prisms, either prisms ground into the lenses or Fresnel Press-On Prisms. The effect may be limited, as the deviation is usually significantly incomitant. Debate exists as to the efficacy of radiotherapy in mild to moderate TAO. It is unlikely that radiation will improve proptosis or extraocular motility, although it may help decrease the acute inflammatory symptoms. The presence of optic nerve dysfunction requires prompt therapeutic intervention. In most cases, a trial of moderately high doses of oral corticosteroids may result in substantial improvement in optic nerve function. Pulsed IV corticosteroids have also been employed. However, the optic nerve dysfunction usually recurs as corticosteroids are tapered. Radiation therapy (20 Gy in 2 Gy fractions) may provide some benefit, particularly if there is significant active inflammation present (conjunctival injection, chemosis). The definitive treatment is to surgically decompress the optic nerve in the orbital apex. Although any of the 4 orbital walls may be decompressed, removal of the

332

.

Neuro-Ophthalmology

posterior medial wall is usually most effective. This surgical maneuver may be accomplished endoscopically, as an external ethmoidectomy (through the caruncle), or through the maxillary sinus (Caldwell-Luc). When proptosis is the major feature, removal of the orbital floor (by way of an eyelid or conjunctival incision or through the maxillary sinus) and possibly the lateral wall may help decrease the globe prominence. Patients need to be aware that decompression surgery may adversely affect ocular motility and eyelid position. Thus, eyelid and extraocular muscle surgery should be deferred if orbital decompressive surgery is contemplated. See BCSC Section 7, Orbit, Eyelids, and Lacrimal System, for a more extensive discussion of TAO; and Section I, Update on General Medicine, for further coverage of thyroid abnormalities. Alpert TE, Alpert SG, Bersani TA, et al. Radiotherapy mopathy: improved outcomes with early treatment. Bartalena

for moderate-to-severe

Graves' ophthal-

Cancer j. 2003;9:472-475.

L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism

and

the course of Graves' ophthalmopathy.

N Engl j Med. 1998;338:73-78. Bartley GB, Fatourechi V, Kadrmas EF, et al. Long-term follow-up of Graves ophthalmopathy in an incidence cohort. Ophthalmology. 1996; I03:958-962. Bartley GB, Gorman CA. Diagnostic criteria for Graves' ophthalmopathy. 1995;119:792-795. Garrity JA, Fatourechi

V, Bergstralh

EJ, et al. Results of transantral

Am j Ophthalmol.

orbital decompression

in

428 patients with severe Graves' ophthalmopathy. Gorman

CA, Garrity

JA, Fatourechi

Am j Ophthalmol. 1993;116:533-547. V, et al. A prospective, randomized, double-blind,

placebo-controlled study of orbital radiotherapy 200 I; I 08: 1523-1534. Prabhakar

BS, Bahn RS, Smith TJ. Current perspective

and ophthalmopathy. Prummel

for Graves' ophthalmopathy. on the pathogenesis

Ophthalmology. of Graves' disease

Endoc Rev. 2003;24:802-835.

ME Terwee CB, Gerding MN, et al. A randomized

controlled

trial of orbital radio-

therapy versus sham irradiation in patients with mild Graves' ophthalmopathy. j Clin Endocr Metab. 2004;89: 15-20.

Sarcoidosis Sarcoidosis is a multisystem granulomatous disease of unknown origin. Middle-aged adults are most commonly affected; the annual incidence for blacks is about 3 times that for whites (2.4% vs 0.85%). Histopathology shows noncaseating granulomas with accumulation oflymphocytes (CD4). The lungs are involved most frequently, but the eye, liver, lymph node, skin, and musculoskeletal system are commonly affected. Neurologic manifestations occur in 5%-15% of patients and include meningitis, hydrocephalus, parenchymal involvement (hypothalamic most commonly), encephalopathy, seizures, dural venous thrombosis, vasculitis, and peripheral neuropathy. Gullapalli 0, Phillips LH. Neurologic manifestations of sarcoidosis. Neural

Clin.

2002;20:

59-83. Rybicki BA, Major M, Popovich J, et al. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am j Epidemiol. 1997;145:234-241.

CHAPTER

Intraocular

14: Selected

Systemic

Conditions

With Neuro-Ophthalmic

Signs.

333

Manifestations

Iritis, cataract, vitritis, retinal vasculitis ("candle wax drippings"), and chorioretinitis can occur in sarcoidosis. For further discussion of these manifestations, see BCSC Section 9, Intraocular Inflammation and Uveitis; and Section 12, Retina and Vitreous. Neuro-Ophthalmologic

Manifestations

Facial nerve palsy is the most common cranial neuropathy. Optic neuropathy also occurs and may manifest as either a papillitis or retrobulbar optic neuropathy. Less commonly, a sarcoid granuloma may occur at the optic nerve head (see Fig 4-17). Infrequently, sarcoid may cause neuroretinitis (disc swelling with a macular star of exudates), optic perineuritis (disc swelling without visual loss or increased intracranial pressure), or papilledema. Visual loss may also occur from chiasmal and retrochiasmal visual pathway involvement. Sarcoidosis can also cause ocular motor cranial nerve palsy, gaze palsy, and a variety of pupillary abnormalities, including tonic pupil, Horner syndrome, and Argyll-Robertson pupils. Frohman LP. Grigorian R. Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation. and management. I Neuro-Ophthalmol. 2001;21:132-137. Katz 1M, Bruno MK. Winterkorn IS, et al. The pathogenesis ing in neurosarcoidosis. Arch Neural. 2003;60:426-430.

and treatment

of optic disc swell-

Diagnosis Although most patients with neurosarcoidosis have abnormalities on MRI scan, about 18% do not. The most common neuroimaging abnormalities found are meningeal and leptomeningeal enhancing lesions. However, none of the abnormalities found on MRI scan are specific. Establishing a definite diagnosis can be difficult. Angiotensin-converting enzyme (ACE) is elevated in 52%-90% of patients if sarcoidosis is active. Gallium scan is not specific, but the combination of positive ACE and gallium scan is reported to be 100% specific and 73% sensitive. Bronchoalveolar lavage, lymph node biopsy, and conjunctival biopsy may be of value. A chest radiograph may direct the biopsy, but CT scan of the chest is indicated if clinical suspicion is high. Christoforidis GA, Spickler EM. Recio MV, et al. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AINR. 1999;20:655-659.

Treatment

Corticosteroids are the mainstay of treatment, but methotrexate, cyclosporine, cyclophosphamide, azathioprine, chlorambucil, and chloroquine are occasionally used. Radiotherapy has been proposed as an alternate or adjunctive treatment, but the long-term efficacy is not clear.

334

.

Neuro-Ophthalmology

Inherited Disorders Numerous inherited disorders result in neuro-ophthalmic signs. Certain myopathies and the phakomatoses are the most common inherited systemic conditions. Inherited optic neuropathies are discussed in Chapter 4 of this volume. Myopathies The extraocular muscles are affected by several inherited conditions that result in mitochondrial dysfunction. Chronic progressive external ophthalmoplegia Chronic progressive external ophthalmoplegia (CPEO) is an inherited mitochondrial myopathy characterized by slowly progressive, symmetric ophthalmoplegia and ptosis (Fig 14-5). Patients often present with ptosis and usually do not develop diplopia despite ophthalmoplegia. This condition is most often mistaken for myasthenia gravis. Family history and old photographs can be helpful in differentiating the 2 conditions. Clinical findings are usually evident by the second decade of life. Systemic symptoms may include generalized muscle weakness. Kearns-Sayre syndrome The Kearns-Sayre syndrome is also an inherited mitochondrial myopathy that includes CPEO, pigmentary retinopathy, and cardiac conduction abnormalities, and variably includes cerebellar ataxia, deafness, and elevated cerebrospinal fluid protein. Cardiac evaluation is essential to rule out conduction defects. Histopathology shows the characteristic "ragged red fibers" (Fig 14-6) and mitochondrial proliferation, and electron microscopic studies show inclusion body abnormalities of the affected mitochondria. Oculopharyngealdys"ophy This hereditary condition is usually autosomal dominant with onset in the fifth and sixth decades of life. The typical presentation is progressive dysphagia followed by ptosis. Most

Figure14-5 A 42-year-old with a 2-year history of progressive ptosis and ophthalmoplegia. Biopsy of the deltoid muscle showed ragged red fibers consistent with CPEO. (Photographs courtesy of Steven A. Newman.

MD.)

CHAPTER

Figure 14-6

14: Selected

Histopathology

red fibers. Specimen berger, DO)

Systemic

of muscle

Conditions

in a patient

With Neuro-Ophthalmic

with Kearns-Sayre

stained with modified Gomori trichrome.

syndrome

(Photograph

Signs.

shows

courtesy

335

ragged

of Eric Eggen-

patients develop CPEO. Pathologic studies show a vacuolar myopathy. The disease is classically seen in patients of French-Canadian ancestry. Myotonic dystrophy This dominantly inherited multisystem disorder also produces ophthalmoplegia that may mimic CPEO. Two types have been identified: type I, due to mutation on chromosome 19, and type 2, due to mutation on chromosome 3. Blood tests for these mutations can confirm the diagnosis. Symptoms usually start in late childhood or early adulthood with myotonia that is worsened by excitement, cold, and fatigue. It is easily detected by asking the patient to shake hands; the patient will not be able to release his or her grasp. This myopathy is unusual in that it affects distal limb musculature first. Wasting of the temporalis and masseter produces the typical "hatchet face:' The myopathic facies, frontal balding, and ptosis cause a distinct and remarkably similar appearance. Ocular findings include ptosis, pigmentary retinopathy, ophthalmoparesis, and polychromatic lenticular deposits ("Christmas tree" cataracts). The pupils are miotic and respond sluggishly to light. Other features include low intelligence, insulin resistance, hearing loss, cardiomyopathy, cardiac conduction abnormalities, testicular atrophy, and uterine atony. Electromyography provides the definite diagnosis by demonstrating the typical myotonic discharges. Neurocutaneous

Syndromes (Phakomatoses)

The phakomatoses are disorders characterized by the presence of hamartias and hamartomas involving different organ systems such as the skin, eyes, central nervous system, and viscera. Six entities are classically grouped under this category: neurofibromatosis, tuberous sclerosis (Bourneville syndrome), cerebrofacial angiomatosis (Sturge- Weber syndrome), retinal angiomatosis (von Hippel disease), ataxia-telangiectasia (Louis-Bar syndrome), and Wyburn-Mason syndrome (Table 14-2). Klippel-Trenaunay-Weber syndrome has been included by some authors. A syndrome of cavernous hemangioma of the retina associated with central nervous system angiomas (van Hippel-Lindau) is yet

o~ N NI .... oN N ~ '" ~ '" uc:

c

CI

'in .. 's.. c ca .=

.......

§ .sro .-....

a: ...

...

~ .- .-

c ca .. c

.0 1J

-

E~

.~ :c cCI

ro ro 0

E~ c: >ro '" ... ...

U ... .. ftj 'uCI

:J 0 Q) ro

c: ... ro C

....
~

.-

c:_

.~

0 Q) fJ'J.- c: o ~.;:: > 0

E Q).-

..C .~ :c cCI

o

ro

u

.::.cci'c:§ c: .-c: 0 ..... O~Q)CO

;;:a

.S!

'';::; ~

ro

OJ C ... S ca 'uCI .. ..

oc:~~'" >ro_..... ~

CII aI CII

o ... (II

E o

~ (II ..c D.. aI ..c

l-

N

.... GI :is

~

c

.~ :c cCI U

c: u

a ._'-g §

§ro~E E E 1JQ) E E .2 8 o 0)


.

'UlCtRI$ 11

>

mt:XI'm :III fNJ: 11:111':

JJ,· .

'. " " 0 . . It !~1!. e (.

\~tJ 11..11

~I

·

p oJ,

,\, 1.111td;r .II J t!) ,e, ,M .II. I~I " fa) J

:ts!1:C"JI

.

....JZ!I' '"'"

...,

~.l1.IJ.: ~ 1 I .. -It

n

."'"

B

.

...... ......

.

.' , .

::,c ::t

IUfU'f'I"IU

"II

/I

.'c n .'eu

«. .

..

'"

....... ... ...

4-3 -l".. I J.,J.j

.J!.JI ".14-1 .J.)!..!:! "...,.\1 .JI -I.JI .a ..1.:).4-44'" -1!-ll.lIoI,'.-I.11 .a-ll .. J J

~lIJI:rTUt!II')o'1 D,:T1:2 O'Q.L:~;15

I

.

.'

..... .!I '.1.

....". .JI.J.JI -I .J .1 .JI .1.:1 I .., .!S.31.~ oJ

81RTKlRTE 11-16-78 MU 13-23-" nC!(IIT:UJ ~ 113:IC li'1(1:9::J/I! 111IN tlll.!DU3 D 2; "':'::I(1Is".

0>1 II 0 r:s:'lJ1lr1m " It RlL"S1D r.LI'8E1DS1I~'

.. IIB'+li+--< 1" HI!, 01,. ,E,B, '

,!.. ,$, ,!!, ~, ,!!, ,Ii, ,I. " ,$, ,$, ,11,$,,j, ,Ii. 90%). Levin LA, Avery R, Shore )W, et al. The spectrum review. Surv Ophthalmol. 1996;41: 142-154.

of orbital aspergillosis:

Marr KA, Patterson T, Denning D. Aspergillosis: pathogenesis, therapy. Infect Dis Clin North Am. 2002;16:875-894.

a clinicopathological

clinical manifestations

and

366

.

Neuro-Ophthalmology

'.

l

...

A,

....

Figure 14-25 This 82-year-old woman presented with a 6-week history of left brow and orbital pain, A, 4 weeks prior to evaluation she suddenly lost vision in her left eye and 1 week later she developed ptosis and proptosis, B, CT scan revealed a destructive lesion at the orbital apex, which on fine-needle aspiration biopsy IC) proved to be an aspergilloma.

Mucormycosis Mucormycosis is caused by several different mold fungi of the Zygomycetes class. These fungi, which inhabit decaying matter, are ubiquitous but of such low virulence that infection occurs only in debilitated hosts. The mold enters the body through the respiratory tract and proliferates, causing hyphal invasion of tissues. It grows rapidly, producing a more acute infection than other fungi. These organisms have a predilection for blood vessels; and hemorrhage, thrombosis, and ischemic necrosis are hallmarks of mucormycosis. Aneurysm and pseudoaneurysm formation in the intracranial vasculature can produce devastating consequences when rupture occurs. The 2 types of mucormycosis producing ophthalmic involvement are rhinocerebral and CNS mucormycosis. Rhinocerebral mucormycosis usually occurs in patients with diabetes, patients taking corticosteroids, or neutropenic patients receiving antibiotics. The initial infection spreads from the facial skin, nasal mucosa, paranasal sinuses, or the hard palate (Fig 14-26). The fungus spreads to the nearby blood vessels, affecting the orbital vessels, carotid arteries, cavernous sinuses, or jugular veins. Orbital and neurologic signs are produced by infarction, thrombosis, or hemorrhage. Untreated, rhinocerebral mucormycosis may bring about rapid deterioration, leading to death within days. A few patients develop a chronic course with little indication of systemic illness.

CHAPTER

14: Selected

Systemic

Conditions

With Neuro-Ophthalmic

Signs.

367

A Figure 14-26 demonstrated

A, A patient typical

with

nonseptate

rhinocerebral hyphae.

mucormycosis (Photographs

courtesy

eroding of Lanning

the hard palate.

8, Biopsy

B. Kline, MD.!

Most patients have headache or facial pain. Other symptoms and signs depend on the location of the infection. Orbital involvement produces orbital swelling, pain on eye movement, conjunctival injection and chemosis, corneal ulceration, ophthalmoplegia, and visual loss. Retinal infarction, ophthalmic artery occlusion, and optic nerve infiltration are mechanisms of blindness. Other common presentations are painful diplopia and cranial neuropathy. An orbital apex, cavernous sinus, or chiasmal syndrome may be present. Neurologic signs include hemiparesis, aphasia, seizures, and altered mental status. Central nervous system mucormycosis is very rare. The fungus usually gains access to the CNS from the nose or paranasal sinus, but there is no nasal, sinus, ocular, or orbital disease when the neurologic manifestations appear. Infection of the orbit, palate, nose, and sinuses typically occurs secondarily. Meningitis, abscesses, cranial nerve involvement, and seizures are common. The diagnosis of mucormycosis requires a high index of suspicion, because many of the laboratory investigations are nonspecific. CT scan may demonstrate bone destruction, soft-tissue alteration in the paranasal sinuses and orbit, air-fluid levels in the sinuses and orbits, or brain abscess formation. MRI scan, MRA, and arteriography may be helpful for showing vascular thrombosis. The definitive test is a biopsy that demonstrates vascular invasion, tissue necrosis, eschar formation, inflammatory cells, and nonseptate hyphae. Mucormycosis has a mortality rate of about 50%. The underlying systemic disease should be treated and immunosuppressant agents eliminated, if possible. Therapy includes aggressive surgical debridement of necrotic tissue and administration of amphotericin B. Hyperbaric oxygen may be helpful. Exenteration may not be necessary in all cases. Talmi YP. Goldschmied-Reoven A. Bakon M, et al. Rhino-orbital and rhino-orbital-cerebral mucormycosis.

Otolaryngol

Head

Neck Surg.

2002; 127:22-31.

Cryptococcosis Cryptococcus neoformans, the most common fungus causing cryptococcosis, is found in pigeon droppings and contaminated soil. Although it is ubiquitous, it rarely causes infection in otherwise healthy people. However, infection does occur in approximately 10% of patients with AIDS, and it is the most common life-threatening mycosis in these patients.

368

.

Neuro-Ophthalmology

The most common neuro-ophthalmic abnormality is papilledema from cryptococcal meningitis. The onset of symptoms is usually insidious, with a waxing and waning course. Headache, nausea, vomiting, dizziness, and mental status changes are the most common complaints. Diplopia from unilateral or bilateral sixth nerve palsies may occur as a false-localizing sign of increased intracranial pressure. Inflammation at the base of the brain produces other cranial neuropathies. Photophobia, blurred vision, retrobulbar pain, homonymous visual field defects, or nystagmus may occur. Optic nerve involvement manifests as a retrobulbar neuritis producing gradual visual loss over hours to days. It is postulated that adhesive arachnoiditis is one cause of visual loss with cryptococcal infections. The infiltration of organisms within the visual pathways and the peri optic meninges has been shown postmortem. Other ophthalmic complications include retinochoroiditis and cotton-wool spots. The diagnosis is confirmed by demonstrating the C neoformans capsular antigen or by isolating the yeast in the cerebrospinal fluid. Most patients with CNS cryptococcosis have disseminated disease with evidence of infection in the blood, lungs, bone marrow, skin, kidneys, and other organs. Serum antigen titers are helpful for this reason. Antifungal treatment consists of amphotericin Band flucytosine. Intrathecal amphotericin treatment may be necessary. Fluconazole or itraconazole are used for maintenance therapy. Visual loss caused by papilledema can be prevented with cerebrospinal fluid shunting or optic nerve sheath fenestration. The mortality rate of patients with treated CNS cryptococcosis is 25%-30%. The prognosis is worse in patients with an underlying malignancy or AIDS. Perfect JR, Casadevall A. Cryptococcosis.

Infect Dis C/in North Am. 2002;16:837-874.

Cat-Scratch Disease Bartonella henselae (formerly Rochalimaea species) is a gram-negative rod that causes catscratch disease. The condition is transmitted by cats or by fleas from infected cats, usually through a scratch or bite. Fever with painful lymphadenopathy is common but not always present. A variety of ophthalmic manifestations occur with cat-scratch disease. The most common is Parinaud oculoglandular syndrome (granulomatous conjunctivitis and preauricular adenopathy). Neuroretinitis is the most frequent neuro-ophthalmic finding (see Fig 4-13). Visual loss with optic disc edema, peripapillary subretinal fluid, uveitis, retinal edema with exudates, and white retinal inflammatory lesions are observed. The diagnosis is confirmed by detecting high titers of B henselae in the serum. Cat-scratch disease is usually self-limited, and the neuroretinitis typically improves spontaneously. Various antibiotics have been used for treatment, including ciprofloxacin, trimethoprim-sulfamethoxazole, tetracycline, clindamycin, rifampin, and doxycycline. Conrad DA. Treatment of cat scratch disease. Curr Opin Pediatr. 2001;13:56-59. Golnik KC, Marotto ME, Fanous MM, et al. Ophthalmic manifestations of Rochalimaea cies. Am J Ophthalmol.

1994; 118: 145-151.

spe-

Basic Texts

Neuro-Ophthalmology Brodsky MC, Baker RS, Hamed LM. Pediatric Neuro-Ophthalmology. New York: SpringerVerlag; 1996. Burde RM, Savino PJ, Trobe JD. Clinical Decisions in Neuro-Ophthalmology. 3rd ed. St Louis: Mosby; 2002. DaroffRB. Eye Movement Disorders. Dallas: Medical1nformation Alternatives; [n.d.]. (Set of four videotapes containing 39 case film segments and diagrams, charts, graphs, and photographs.) Glaser JS. Neuro-Ophthalmology. 3rd ed. Philadelphia: Lippincott; 1999. Gold DH, Weingeist TA. Color Atlas of the Eye in Systemic Disease. Philadelphia; Lippincott; 2001. Harrington DO, Drake MY. The Visual Fields: Textbook and Atlas of Clinical Perimetry. 6th ed. St Louis: Mosby; 1990. Kline LB. Neuro-Ophthalmology Review Manual. 6th ed. Thorofare, NJ: Slack; 2008. Leigh RJ, Zee DS. The Neurology of Eye Movements. 3rd ed. New York: Oxford; 1999. Liu GT, Volpe NJ, Galetta SL. Neuro-Ophthalmology: Diagnosis and Management. Philadelphia: Saunders; 2001. Loewenfeld IE. The Pupil: Anatomy, Physiology, and Clinical Applications. 2nd ed. (2 vols). London: Butterworth-Heinemann; 1999. Miller NR, Newman NJ, eds. Walsh and Hoyt's Clinical Neuro-Ophthalmology (5 vols). 5th ed. Baltimore: Williams & Wilkins; 1997. Miller NR, Newman NJ, Biousse V, et aI., eds. Walsh and Hoyt's Clinical Neuro-Ophthalmology. 6th ed. (3 vols). Philadelphia: Lippincott Williams & Wilkins; 2005. Miller NR, Newman NJ, eds. The Essentials: Walsh and Hoyt's Clinical Neuro-Ophthalmology (l vol). Baltimore: Williams & Wilkins; 1999. Trobe JD. The Neurology of Vision. New York: Oxford; 2001.

369

Related Academy Materials

Focal Points: Clinical Modules for Ophthalmologists Arnold AC Optic nerve meningioma. Module 7, 2004. Arnold AC Differential diagnosis of optic disc edema. Module 1, 1999. Borchert MS. Nystagmus in childhood. Module 8, 1991. Brazia PW, Lee AG. Neuro-ophthalmic problems caused by medications. Module 11, 1998. Chung SM. Update on NAION: the Ischemic Optic Neuropathy Decompression Trial. Module 6, 1998. Dresner SC Ophthalmic management of facial nerve paralysis. Module 4, 2000. Ellis BD, Hogg JP. Neuroimaging for the general ophthalmologist. Module 8, 1998. Farris BK. Temporal artery biopsy. Module 7, 2003. Lee AG, Brazis pw. Giant cell arteritis. Module 6, 2005. Lee AG, Brazis PW, Curry RC Neuro-ophthalmic complications of cardiac surgery. Module 6, 2001. Lesser RL, Boghen DR. Diagnosis and management of pituitary adenoma. Module 8, 200 I. Newman SA. Automated perimetry in neuro-ophthalmology. Module 6, 1995. Pardo G. Multiple sclerosis and optic neuritis. Module 12,2003. Patel BCK, Anderson RL. Essential blepharospasm and related diseases. Module 5, 2000. Read RW. Sympathetic ophthalmia. Module 5, 2004. Siatkowski RM. Third, fourth, and sixth nerve palsies. Module 8, 1996. Smith KH. Myasthenia gravis. Module 4, 2003. Spector RH. Migraine. Module 1, 2000. Tang RA, Pardo G. Ocular and periocular pain. Module 2, 1996. Trobe JD. Neuro-ophthalmic diagnoses you don't want to miss. Module 9, 1999. Vaphiades MS, Kline LB. Functional visual loss. Module 1, 2005. Volpe NJ, Liu GT, Galetta SL. Idiopathic intracranial hypertension (IIH) pseudotumor cerebri. Module 3, 2004.

Publications Fishman GA, Birch DG, Holder GE, et al. Electrophysiologic Testing in Disorders of the Retina, Optic Nerve, and Visual Pathway. 2nd ed. Ophthalmology Monograph 2, 2001. Kline LB, ed. Optic Nerve Disorders. 2nd ed. Ophthalmology Monograph 10, 2006. Lane SS, Skuta GS, eds. Pro Vision: Preferred Responses in Ophthalmology, Series 3. SelfAssessment Program, 1999. Skuta GL, ed. Pro Vision: Preferred Responses in Ophthalmology, Series 2. Self-Assessment Program, 1996. 371

372

.

Related Academy Materials

Wilson FM II, ed. Practical Ophthalmology: A Manual for Beginning Residents. 5th ed. 2005. Wirtschafter JD, Berman EL, McDonald CS. Magnetic Resonance Imaging and Computed Tomography: Clinical Neuro-Orbital Anatomy. Ophthalmology Monograph 6, 1992.

Multimedia Chung SM, Gordon ogy. (CD-ROM, Frohman

LK, Lee MS, et al. LEO Clinical 2005).

LP, Lee AG, eds. AAO/NANOS

for Ophthalmic

Practitioners

Specialty Arnold AC.

Neuro-Ophthalmology

(CD-ROM, 1999). Clinical Update

Lee AG, Arnold AC, Kardon RH. LEO Part I: Afferent System (CD-ROM, Lee AG, Arnold AC, Kardon RH. LEO Part II: Efferent System (CD-ROM, Pro Vision Interactive: Clinical (CD-ROM, 1996).

Clinical

Update Course on Neuro-OphthalmolImage Collection

Course on Neuro-Ophthalmology.

2001). Clinical

Update

Course on Neuro-Ophthalmology.

2002).

Case Studies.

Volume

1: Cornea

and Neuro-Ophthalmology

Clinical Update Online Ischemic

Friedman Dr. Migraine.

Optic

Neuropathy.

Module 4, 2004.

Module 9, 2005.

Galetta SL. Optic Neuritis: Management and the Risk of Multiple Sclerosis. Module 6, 2004. Golnik KC. Hereditary and Genetic Disease. Module 8, 2004. Lee AG. Oculomotor Nerve Palsies. Module 2, 2004. Lee MS. Transient Vision Loss, Stroke, and Carotid Disease. Module 3, 2004. Moster ML. Myasthenia Gravis. Module 5, 2004. Vaphiades MS, Balcer LJ. Imaging in Neuro-Ophthalmology. Module 7, 2004. Volpe NJ. Idiopathic Intracranial Hypertension. Module 1, 2004.

Continuing Ophthalmic Video Education Wilson ME Jr. Ocular Motility

Evaluation

of Strabismus

and Myasthenia

Gravis

To order any of these materials, please call the Academy's Customer number at (415) 561-8540, or order online at www.aao.org.

(1993).

Service

Credit Reporting Form Basicand

Clinical

Science

Course, 2008-2009

Section 5 The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this educational activity for a maximum of 40 AMA PRA Category 1 Credits TM. Physicians should only claim credit commensurate with the extent of their participation

in the activity.

If you wish to claim continuing medical education credit for your study of this Section, you may claim your credit online or fill in the required forms and mail or fax them to the Academy. To use the forms: 1. 2. 3. 4.

Complete the study questions and mark your answers on the Section Completion Form. Complete the Section Evaluation. Fill in and sign the statement below. Return this page and the required forms by mail or fax to the CME Registrar (see below).

To claim credit online: 1. Log on to the Academy website (www.aao.org/cme). 2. Select Review/Claim CME. 3. Follow the instructions. Important: These completed forms or the online claim must be received at the Academy by June 20 I I.

_

I hereby certify that I have spent (up to 40) hours of study on the curriculum of this Section and that I have completed the study questions. Signature: Date Name: Address: City and State:

Zip:

) Telephone: ( area code

Academy Member 10#

Please return completed forms to: American Academy of Ophthalmology P.O. Box 7424 San Francisco, CA 94120-7424 Attn: CME Registrar, Customer Service

Or you may fax them to: 415-561-8575

373

374

.

Credit Reporting Form

2008-2009 Section

Completion

Form

Basic and Clinical Science Course Answer Sheet for Section 5

Question

Answer

Question

Answer

a bed

21

a bed

2

a bed

22

a bed

3

a bed

23

a bed

4

a bed

24

a bed

5

a bed

25

a bed

6

a bed

26

a bed

7

a bed

27

a bed

8

a bed

28

a bed

9

a bed

29

a bed

10

a bed

30

a bed

11

a bed

31

a bed

12

a bed

32

a bed

13

a bed

33

a bed

14

a bed

34

a bed

15

a bed

35

a bed

16

a bed

36

a bed

17

a bed

37

a bed

18

a bed

38

a bed

19

a bed

39

a bed

20

a bed

40

a bed

Credit

Reporting

Form

.

375

Section Evaluation Please complete this CME questionnaire. 1. To what degree will you use knowledge from Bese Section 5 in your practice? D Regularly D Sometimes D Rarely 2. Please review the stated objectives for BeSe Section 5. How effective was the material at meeting those objectives? D All objectives were met. D Most objectives were met. D Some objectives were met. D Few or no objectives were met.

3. To what degree is BeSe Section 5 likely to have a positive impact on health outcomes of your patients? D Extremely likely D Highly likely D Somewhat likely D Not at all likely 4. After you review the stated objectives for BeSe Section 5, please let us know of any additional knowledge, skills, or information useful to your practice that were acquired but were not included in the objectives. [Optional]

5. Was BeSe Section 5 free of commercial bias? DYes D No 6. If you selected "No" in the previous question, please comment.

7. Please tell us what might improve the applicability of sese

[Optional]

to your practice. [Optional]

Study Questions Although a concerted effort has been made to avoid ambiguity and redundancy in these questions, the authors recognize that differences of opinion may occur regarding the "best" answer. The discussions are provided to demonstrate the rationale used to derive the answer. They may also be helpful in confirming that your approach to the problem was correct or, if necessary, in fixing the principle in your memory. I. The most common cause of binocular transient visual loss lasting 30 minutes in a 29-year-old woman is a. migraine b. thromboembolism c. pseudotumor cerebri d. giant cell arteritis 2. A 69-year-old woman reports awakening 2 days earlier with blurred vision in the inferior visual field OS. This morning, she noted extension of visual loss to the superior visual field OS. Over the past month, she has felt weak and tired, and recently she developed a headache. Examination reveals visual acuity of hand motions in the affected eye, with an afferent pupillary defect and pale optic disc edema. The following statements are true except a. This clinical scenario most likely represents arteritic anterior ischemic optic neuropathy (AI ON). b. Initial management includes evaluation of sedimentation rate and C-reactive protein. c. Corticosteroid therapy should be initiated after return of a positive temporal artery result. d. The major ophthalmic goal of therapy in arteritic AION is to prevent visual loss in the fellow eye. 3. Which of the following is most useful in distinguishing the cause of anisocoria that is greater in dark than in light? a. cocaine 10% b. pilocarpine 0.1% c. pilocarpine 1% d. pilocarpine 2.5% 4. Parasympathetic fibers destined for the pupil reside in the a. medulla b. medial portion of CN III c. posterior communicating

artery

d. pons 5. A 65-year-old male presents with a I-hour history of acute right homonymous hemianopia. Which imaging modality would best demonstrate an acute infarct of the left occipital lobe? a. CT with contrast b. cerebral angiogram c. TI-weighted MRI d. diffusion-weighted

MRI 377

378

.

Study Questions

6. A lesion of the left occipital lobe a. results in an incongruous right homonymous hemianopic visual field defect, which may demonstrate sparing of the fixation region b. is usually associated with impaired visual acuity c. is typically associated with impaired optokinetic nystagmus with targets moving to the left d. may show a monocular right temporal visual field defect 7. A 27-year-old man was struck in the right forehead during a fight. He presented to the emergency department complaining of inability to see out of his right eye. The examination results revealed vision of light perception in the right eye, 20/20 in the left eye. Confrontation field testing was normal in the left eye. Eye movements were full, and there was no evidence of orbital trauma. Pupils were equal in size and reacted well, with no evidence of an afferent pupillary defect. Which of the following is the most likely diagnosis? a. indirect traumatic optic neuropathy b. optic tract injury c. occipital lobe contusion d. functional visual loss 8. Which of the following is not a typical feature of the dorsal midbrain syndrome (also known as Parinaud syndrome or pretectal syndrome)? a. lid retraction b. convergence-retraction

nystagmus

c. small pupils that react poorly to light and briskly to near d. saccadic paresis of up gaze 9. The Optic Neuritis Treatment Trial (ONTT) and follow-up studies indicate all of the following except a. Intravenous methylprednisolone may speed visual recovery during the first 2-3 weeks after onset but has no lasting visual benefit. b. Oral prednisone alone at I mg/kg/day may increase recurrence rate. c. The overall 10-year risk of developing multiple sclerosis after isolated optic neuritis is approximately 38%. d. Intravenous methylprednisolone administered within 8 days after visual loss significantly reduces the lO-year risk of developing MS. 10. A 22-year-old woman was referred due to anisocoria. The patient had not been aware of the problem. The right pupil was 3 mm and slightly oval in shape, and the left pupil was 5 mm and round. The right pupil reacted poorly to light but promptly to near, whereas the left pupil reacted normally to both light and near. Which of the following is the most likely diagnosis? a. old Adie's pupil, right eye b. acute Adie's pupil, left eye c. Argyll-Robertson

pupils

d. physiologic anisocoria

Study Questions

.

379

11. All of the following are true about cerebrovascular disease causing transient monocular visual loss except a. The incidence of permanent blindness is low. b. The transient visual loss may be a harbinger of stroke. c. Depending on the degree of carotid stenosis, carotid endarterectomy may be warranted. d. Visual loss generally lasts more than 15 minutes. 12. All of the following would be expected to show restriction during forced duction testing except a. thyroid-associated

orbitopathy

b. internuclear ophthalmoplegia c. orbital fracture with inferior rectus entrapment d. congenital fibrosis of the extraocular muscles 13. Which of the following is not a feature of myotonic dystrophy? a. hatchet face b. inability to relax one's grasp c. subluxed lenses d. ophthalmoplegia 14. Which of the following is not considered to be an illusion? a. Pulfrich phenomenon b. metamorphopsia c. micropsia d. palinopsia 15. A previously healthy 25-year-old woman presents with acute visual loss 00 (20/200) and a right relative afferent pupillary defect (RAPD). MRI shows 2 ovoid peri ventricular T2 hyperintensities. Which of the following statements isfalse? a. She has 50%-60% chance of developing multiple sclerosis over the next 10 years. b. Her vision will most likely not recover. c. Treatment with oral corticosteroids alone will increase her risk of future attacks of visual loss. d. She will have clinically definite multiple sclerosis if she experiences even one more unexplained neurologic event lasting 48 hours. 16. Which of the following is most likely to prompt additional evaluation in a patient with facial palsy? a. simultaneous bilateral facial palsy b. recovery of facial nerve function that occurs 3 weeks after the facial palsy c. facial palsy occurring in a patient older than 50 years of age d. upper and lower facial musculature equally affected 17. An underlying condition is most likely to be determined in a patient with isolated eye pain and a. pain for greater than 2 years b. ipsilateral facial numbness c. normal neuroimaging of the brain and orbits d. poor response to tricyclic antidepressants

380

.

Study Questions

18. A l-year-old child presents with monocular vertical nystagmus. What is the best course of action? a. Follow the case to see whether head nodding develops. b. Follow the case to see whether abnormal head position develops. c. Undertake drug toxicology screening. d. Undertake neuroimaging (preferably MRI). 19. In automated perimetry a. static technique, indicating a nonmoving target of varying intensity, is commonly used b. for displayed decibel values, a higher number indicates worse visual sensitivity c. the mean deviation is a measure of localized deviations from normal d. the visual threshold is the maximum visual stimulus seen at a point 20. Optic disc drusen typically demonstrate all of the following features except a. arcuate visual field defects b. high reflective signal on B-scan ultrasonography c. visual acuity loss d. optic disc elevation and blurred margins 21. After a motor vehicle accident, a young man presents with unilateral marked proptosis. diplopia, and prominent episcleral vessels. He complains of a rushing sound in his head. Which of the following is the most likely possibility? a. posteriorly draining dural shunt b. carotid-cavernous

fistula

c. retro-orbital hemorrhage d. orbital floor fracture 22. A 45-year-old presents with painful left Horner syndrome of 3 days' duration. The most appropriate imaging would be a. CT, head b. MRl, neck c. catheter angiography d. MRI/MRA, brain and neck 23. All of the following are common causes of transient visual loss except a. nonarteritic ischemic optic neuropathy b. migraine c. giant cell arteritis d. pseudotumor cerebri 24. Which eye movement disorder is most commonly syndromes? a. downbeat nystagmus b. upbeat nystagmus c. superior oblique myokymia d. opsoclonus

seen in patients with paraneoplastic

Study

Questions.

381

25. Lesions involving the optic chiasm a. commonly include pituitary adenomas, meningiomas, craniopharyngiomas,

and stroke

b. may show markedly asymmetric involvement of the temporal visual fields c. do not demonstrate afferent pupillary defects d. often are associated with papilledema 26. Diplopia with associated bilateral abduction defects and pupillary constriction upon attempted lateral gaze is most likely due to a. bilateral sixth nerve palsies b. myasthenia gravis c. spasm of the near reflex d. Graves disease 27. Interruption of visual information between the occipital lobe and the dominant angular gyrus causes a. Gerstmann syndrome b. alexia without agraphia c. simultanagnosia d. Balint syndrome 28. A patient presents with CN VI and CN VII palsies. The most likely lesion location is the a. midbrain b. pons c. cavernous sinus d. medulla 29. Optic atrophy a. is an early sign of outer retinal layer damage b. usually requires 4-8 weeks to develop after optic nerve injury c. is never segmental d. is always associated with a central scotoma 30. A 32-year-old woman develops visual loss in the right eye. She has a right RAPD and a moderately swollen optic nerve with flame-shaped hemorrhages. Previous history includes Bell's palsy on 2 occasions and several episodes of "pink eye" over the last 5 years. The most helpful diagnostic testing would be a. Bartonella henselae titers b. an MRI c. a chest x-ray and angiotensin-converting d. lumbar puncture

enzyme

382

.

Study Questions

31. A 30-year-old woman reports a 2-month history of headaches and progressive visual loss as. She takes no medications and is not obese. Examination reveals visual acuity of 20/20 00 and 20/70 as, with a generally depressed visual field as. There is an afferent pupillary defect as, and the optic discs show bilateral edema, slightly paler on the left. The most important next diagnostic step is a. MR scan of the brain b. a lumbar puncture c. CBC with sedimentation rate d. ultrasonography of the orbits 32. A 55-year-old patient with diabetes presents with double vision. Which of the following findings would lead you to order MRI of the brain as the initial diagnostic test? a. isolated pupil-sparing complete third cranial nerve palsy of 3 days' duration b. right fourth cranial nerve palsy with bilateral ptosis that clearly gets worse as the day progresses, present for 1 week c. isolated pupil-sparing complete third cranial nerve palsy of 8 months' duration d. lid retraction au, restriction of upgaze au, injection over the medial and lateral recti muscles au, and elevation of intraocular pressure from 16 to 28 mm Hg in both eyes with upgaze 33. The clinical history and findings most typical of optic nerve sheath meningioma include all of the following except a. female b. marked proptosis c. slowly progressive visual loss d. atrophy or swelling of the optic disc 34. Which finding would most likely prompt additional evaluation in a patient with headaches? a. headache that recurs in a different location b. transient positive visual phenomena headache

that occur 20-30 minutes before the onset of the

c. persistent visual field defect after the headache resolves d. a family history of headaches 35. Which of the following is indicated if aberrant regeneration occurs in a resolving oculomotor (CN III) nerve palsy that had been presumed to be due to diabetes mellitus? a. No further workup is indicated. b. Westergren erythrocyte sedimentation rate and C-reactive protein c. cranial MRI scanning d. lumbar puncture

Study Questions

.

383

36. Which of the following is true regarding sympathetic innervation of the iris sphincter muscle? a. Sympathetic fibers synapse at the ciliary ganglion and travel with the short posterior ciliary nerves. b. Sympathetic fibers synapse at the ciliary ganglion and travel with the long posterior ciliary nerves. c. Sympathetic fibers synapse at the superior cervical ganglion and travel with the long posterior ciliary nerves. d. Sympathetic fibers synapse at the superior cervical ganglion and travel with the short posterior ciliary nerves. 37. With a horizontal gaze palsy to the right, all the following may be true except a. The lesion may be in the right CN VI nucleus. b. The eye movement pattern could be functional in origin. c. Caloric testing may be useful in patient evaluation. d. Cerebral angiography should be performed urgently. 38. Which of the following causes of facial nerve dysfunction onset?

is more commonly bilateral at

a. hemifacial spasm b. essential blepharospasm c. apraxia of the eyelid opening d. Bell's palsy 39. Congruity of homonymous visual field defects a. indicates a lesion of the optic chiasm b. is seen with occipital lobe disease c. is of little help in topographic localization d. requires assessment of the optokinetic responses 40. A 24-year-old smoker presents with painless, semiacute, progressive visual loss in his right eye. Both eyes are normal on fundus evaluation, and MRI results are normal. Three months later, the affected eye has not improved, and vision in the patient's left eye has deteriorated. Repeated MRI and a lumbar puncture yield negative results. The complete blood count and assays for antinuclear antibody, fluorescent treponemal antibody absorption, angiotensin-converting enzyme, Lyme titer, vitamin B12,and folate are normal. What is the most likely diagnosis? a. multiple sclerosis (MS) b. tobacco-alcohol

optic neuropathy

c. posterior ischemic optic neuropathy (PION) d. Leber hereditary optic neuropathy (LHON)

Answers 1. a. Typical migraine aura is a binocular, positive visual phenomenon lasting between 15 and 30 minutes. It is most common in patients younger than 50 years of age, and females are more frequently affected. Transient visual loss associated with thromboemboli rarely lasts more than 10 minutes and is almost always unilateral. Papilledema due to pseudotumor cerebri can cause transient bilateral visual "gray-outs" that last only seconds. Giant cell arteritis is not a diagnostic consideration in a patient 29 years of age. 2. c. In a case of AlaN suspected ated symptoms, corticosteroid opsy results. The sedimentation be performed, but abnormality primarily useful for preserving occurs in the affected eye.

to be arteritic based on the severity of visual loss and associtherapy should be begun immediately, without waiting for birate and C-reactive protein are helpful if elevated and should is not required for diagnosis of temporal arteritis. Therapy is vision in the fellow eye, although in some cases, improvement

3. a. Increasing anisocoria in dark vs light is suggestive of either physiologic anisocoria or Horner syndrome. By blocking the reuptake of norepinephrine at the myoneural junction of the pupillary dilator muscle, cocaine will dilate a normal pupil but will fail to do so if the oculosympathetic pathway is interrupted. 4. b. Parasympathetic fibers reside in the medial portion of the oculomotor nerve. Sympathetic fibers destined for the pupil traverse the medulla and pons and ascend along the carotid artery, whereas parasympathetic fibers originate in the Edinger- Westphal oculomotor subnucleus and travel with the third nerve to the pupil. 5. d. A diffusion-weighted imaging (OWl) sequence ofMRI demonstrates infarcts even in the hyperacute stages, whereas CT and other MRI modalities are often still unremarkable. A cerebral angiogram would demonstrate the vascular anatomy but would not show the acute lesion. 6. d. Lesions of the anterior occipital cortex may produce a defect in the temporal crescent of the far peripheral (60°-90°) field in the contralateral eye. Because the involved visual radiation fibers do not have corresponding fibers subserving the nasal field coursing with them, the defect is monocular. Occipital lobe lesions otherwise produce congruous homonymous defects, do not affect visual acuity unless bilateral, and are not associated with optokinetic defects unless the adjacent parietal lobe is involved. 7. d. Injury to the anterior visual pathway sufficient to reduce monocular visual acuity to this level is associated with a relative afferent pupillary defect. Injury to the optic tract or occipital lobe gives rise to visual field abnormalities in both eyes. 8. c. Lid retraction, convergence-retraction nystagmus, and saccadic paresis of upgaze are all well-known features of the dorsal midbrain syndrome. Pupils in this syndrome do show lightnear dissociation (they react to near better than they react to light) but, in this case, they are typically large.

384

Answers

.

385

9. d. The ONTT data indicate that intravenous methylprednisolone speeds recovery early but has no long-term visual benefit. Oral prednisone at doses administered in the ONTT is associated with an increased recurrence rate double that of the other groups. The overall risk of multiple sclerosis (MS) at JOyears in the ONTT was 38%, and MRI aided in predicting risk: those with at least one typical white matter lesion showed a 56% risk, whereas those with no lesions demonstrated a 22% risk. After the initial optic neuritis, intravenous methylprednisolone had no proven effect past 2 years of reducing the risk of MS. 10. a. Adie's pupils tend to become small over time but still retain light-near dissociation and sector palsies of the iris sphincter muscle. 11. d. Typically, the transient visual loss associated with retinal microembolic disease from cerebrovascular atheromatous disease lasts less than 15 minutes. Within that period of time, there is retinal reperfusion and restitution of normal visual function. The incidence of permanent visual impairment in this clinical setting is low, in the range of 1% per year. Certainly transient monocular blindness due to cerebrovascular disease should be considered a transient ischemic attack, and appropriate patient evaluation is indicated. 12. b. Thyroid-associated orbitopathy, orbital fracture with extraocular muscle entrapment, and congenital fibrosis of the extraocular muscles are all associated with structural muscular abnormalities. These all lead to restriction with forced duction testing. The limited eye movements seen with internuclear ophthalmoplegia is on a neuropathic basis due to a lesion in the medial longitudinal fasciculus. 13. c. Myotonic dystrophy is typified by myotonia, a hallmark of which is the inability to relax muscle contraction-hence, the inability to release a grasp. Hatchet face is a classic finding, and ophthalmoplegia is common. The lenticular abnormality in myotonic dystrophy is not subluxation but rather polychromatic crystalline cataracts. 14. d. Palinopsia or visual perseveration is seeing the afterimage of a previously viewed object (a hallucination). The Pulfrich phenomenon, metamorphopsia, and micropsia are illusions; an object is seen in a distorted fashion. 15. b. Most patients (93%) will experience recovery of vision to 20/40 or better without treatment. Ten-year data from the Optic Neuritis Treatment Trial show that even with one T2 plaque, the risk of developing multiple sclerosis is 56% over 10 years following an episode of isolated optic neuritis. Oral prednisone without preceding intravenous SoluMedrol has been shown to increase the risk of recurrent optic neuritis. The diagnosis of clinically definite multiple sclerosis is made after 2 episodes of otherwise unexplained neurologic dysfunction. 16. a. Bell's (idiopathic facial) palsy occurs unilaterally and affects the muscles of both the upper and lower face. Bell's palsy most commonly affects patients over the age of 50 years. Recovery of facial nerve function typically occurs within the first 3-6 weeks after the onset of the deficit. 17. b. Eye pain in the absence of other signs or symptoms is often a chronic condition characterized by normal neuroimaging; it often responds poorly to medical management. Ipsilateral facial numbness, as may be seen with infiltrating lesions such as cutaneous malignancy, make an underlying cause more likely. 18. d. The recommendation is to image and rule out a chiasmal glioma, which can present with monocular vertical nystagmus. Although head nodding and torticollis can occur along with monocular nystagmus in spasmus nutans, it is better to proceed with neuroimaging when neither of these findings is initially present. Nystagmus secondary to medication is usually bilateral.

386

.

Answers

19. a. The term static refers to the fact that the stimulus varies in intensity but is static in location. Higher decibel values indicate higher visual sensitivity. The mean deviation is a centerweighted mean of all deviation from normal values in the visual field and is a measure of overall field sensitivity, not localized abnormalities. The visual threshold is the minimal visual stimulus seen at a point. The standard test object for most automated perimeters is a Goldmann size III white target. 20. c. Optic disc drusen typically do not produce visual acuity loss, and if acuity is diminished, another cause should be sought. Drusen do typically result in arcuate visual field loss. The presence of drusen elevates the optic nerve head and blurs the margin. Calcified drusen are highly reflective on B-scan ultrasonography. 21. b. This patient has the clinical signs and symptoms of a high-flow (ie, carotid-cavernous) shunt. A low-flow, posteriorly draining, dural shunt would not be present with such dramatic signs. Retro-orbital hemorrhage is not usually associated with dilated episcleral vessels and pulsatile tinnitus. An orbital floor fracture would more likely present with enophthalmos and restricted upgaze. 22. d. The acute presentation of a painful Horner syndrome should raise suspicion of an internal carotid artery dissection, which will not be well demonstrated by CT. Contrast angiography is typically diagnostic for this entity, but this is invasive and carries more risk than MRI/MRA. The Tl-weighted MRI often demonstrates a crescent of bright methemoglobin within the carotid artery and is typically diagnostic; MRA can be used to further characterize the extent of the dissection. The exact combination of MRI and MRA depends on institution-specific protocols and a discussion with the neuroradiologist. 23. a. Migraine, giant cell arteritis, and pseudo tumor cerebri can all cause transient visual loss either in one or both eyes. Nonarteritic ischemic optic neuropathy is not associated with any prodromal visual symptoms but rather with an acute apoplectic event leading to reduction in visual acuity with visual field loss. 24. d. Opsoclonus is most commonly seen in patients with paraneoplastic syndromes. Downbeat and upbeat nystagmus are typically due to congenital or acquired abnormalities within the posterior fossa, or, on occasion, are secondary to drug toxicity. The precise cause of superior oblique myokymia remains uncertain, although it may be due to neurovascular compression of the trochlear nerve, similar to the pathogenesis of hemifacial spasm. 25. b. Chiasmal lesions often result in asymmetric They produce heteronymous visual field loss and when there is asymmetric damage of the input ledema is uncommon, and strokes of the chiasm

involvement of the 2 temporal visual fields. commonly produce afferent pupillary defects from the fibers of the 2 optic nerves. Papilare rare.

26. c. Although all the entities listed can give rise to unilateral or bilateral abduction defects, the associated pupillary constriction on attempted lateral gaze suggests spasm of the near reflex-that is, a combination of miosis, convergence, and accommodation. Dynamic retinoscopy on attempted lateral gaze with associated myopic shift would further confirm the correct diagnosis. 27. b. Interruption of visual information between the occipital lobe and the dominant angular gyrus causes visual-verbal disconnection (alexia without agraphia). Gerstmann syndrome (alexia with agraphia, acalculia, right-left confusion, and finger agnosia) occurs with damage to the left angular gyrus itself. Simultanagnosia is the failure to integrate multiple elements of a scene to form the total picture. Balint syndrome is the triad of simultanagnosia, optic ataxia, and acquired oculomotor apraxia.

Answers.

387

28. b. The sixth and seventh nerves are in close proximity at the pons; in fact, the seventh nerve winds around the nucleus of the sixth nerve within the pons. The seventh nerve does not traverse the midbrain, cavernous sinus, or medulla. 29. b. Optic atrophy usually occurs after ganglion cell damage, developing late with outer retinal diseases such as retinitis pigmentosa. It may be segmental; associated with many patterns of visual field loss, including altitudinal, arcuate, and bitemporal; and is rarely reversible to any substantial degree. After an injury such as trauma or ischemia, optic atrophy usually develops in 4-8 weeks. 30. c. Sarcoidosis can cause iritis, facial nerve palsy, and optic neuropathy with moderate optic disc swelling. MRI and lumbar puncture may show abnormalities, but they will most likely be nonspecific. Cat-scratch disease may produce a swollen optic nerve but will not cause seventh nerve palsies over 5 years. 31. a. The most important first step in evaluating a patient with bilateral papilledema is to rule out intracranial mass with a neuroimaging study. 32. c. In a patient with diabetes, it is highly likely that an acute isolated pupil-sparing complete third cranial nerve palsy is vasculopathic; thus, no neuroimaging is initially indicated, and observation is the rule. Of course, if the pupil becomes involved or if new neurologic signs develop, urgent imaging is indicated. A combination of a fourth cranial nerve palsy and bilateral ptosis, even without the diurnal variation, should raise suspicion of myasthenia gravis. In such a patient, Tensilon testing (assuming no contraindications to Tensilon) is a better initial step than neuroimaging. The presence of bilateral lid retraction, bilateral restriction of upgaze, bilateral injection over the medial and lateral recti muscles, and elevation of intraocular pressure from 16 to 28 mm Hg in both eyes with upgaze points to thryroid-associated orbitopathy. Orbital imaging is the procedure of choice. If the isolated pupil-sparing complete third cranial nerve palsy becomes chronic (ie, no recovery after 3 months)-even if the patient has diabetes-the clinician must rule out a structural lesion; MRI of the brain should be performed. 33. b. Optic nerve sheath meningiomas generally occur in middle-aged females and present with gradual visual loss, with either a swollen or a pale disc. Proptosis is usually minimal or absent. 34. c. The pain from headaches without underlying structural lesions, including that from migraine, tends to differ in location when it recurs. Transient neurologic symptoms, including transient visual loss, are common with migraine; however, when they persist, additional evaluation is necessary. A family history may be supportive of migraine and other primary headache syndromes. 35. c. Aberrant regeneration is never seen on a microvascular basis. It occurs with traumatic and compressive lesions. The situation necessitates neuroimaging. 36. c. Sympathic fibers to the eye pass through the superior cervical ganglion and travel with the long posterior ciliary nerves. The ciliary ganglion and short posterior ciliary nerves transmit parasympathetic innervation to the eye. 37. d. Typically, a horizontal gaze palsy is due to a lesion in the region of the sixth nerve nucleus or neighboring paramedian pontine reticular formation (PPRF). On occasion, this eye movement pattern can be seen in a patient with functional eye movement complaints. The appropriate neuroimaging study is MRI. 38. b. Hemifacial spasm occurs unilaterally 90%-95% of the time, and when it is bilateral, it is asynchronous, differentiating it from essential blepharospasm, which may be asymmetric but nearly always bilateral. Bell's palsy and apraxia of the eyelid opening are more commonly unilateral.

388

.

Answers

39. b. Congruity of homonymous visual field defects is seen with occipital lobe disease. Because of the high correlation of point-to-point representation of the visual field in the occipital cortex, congruous visual field defects are a hallmark of an occipital lobe lesion, and this visual field characteristic is extremely helpful in localization of the disease process. 40. d. LHON is the most likely diagnosis. Hematologic testing for mitochondrial DNA mutation confirms the diagnosis in a high percentage of cases. Tobacco-alcohol amblyopia, like most toxic optic neuropathies, are bilateral, simultaneous, and symmetric. The normal MRI and lumbar puncture results, without other neurologic symptoms, argue against MS. The patient is very young for PION, especially without any stated risk factors, and the progressive nature would be most unusual for PION.

Index (i

= image;

1

= table)

a-wave. of electroretinogram. 101 AAION (arteritic anterior ischemic optic neuropathy), 120-122,121;,121t Abducens nerve. See Cranial nerve VI (abducens nerve) Accommodation changes in. 314 pupils and. 313-314 Accuracy. in saccades testing. 202 Acephalgic migraine (migraine equivalent), 294-295. See also Migraine headache Acetazolamide, for idiopathic intracranial hypertension, 119 Acetylcholine receptor antibody tests. for myasthenia gravis. 328 Achromatopsia, cerebral, 194 Acoustic neurofibromatosis, bilateral. 337 Acoustic neuroma. of cerebellopontine angle, 284. 285; Acquired immunodeficiency syndrome. See HIV infection/ AIDS Acquired nystagmus. 239 pendular.250-251 Acquired ocular motor apraxia, 194,207-208 Acquired ptosis, 277-278, 2781. See also Ptosis Acuity. visual. See Visual acuity Acuity meter. potential. in low vision evaluation. 97 -98 Acute idiopathic blind-spot syndrome, 107 Acute zonal occult outer retinopathy (AZOOR), 107 Adenoma pituitary chiasmal syndromes caused by. 161-162. 162; MR imaging of. 73; sebaceous. in tuberous sclerosis. 338, 339; Adie's tonic pupil. 266-267. 267;, 268; Adjunctive testing, of visuallosslimpairment. 96-102 Afferent pupillary defect. testing for. in evaluation of functional visual disorders. 307 Afferent visual pathways. 23-31. 269 cortex, 28-29, 30;. 31. 3li in evaluation of functional visual disorders, 305-311 optic chiasm, 27 optic nerve. 25-27 optic tract. 27-28. 28; retina, 23-25, 25; Age/aging macular degeneration with. 104 transient visual loss and. 17] Agnosia object, 192 parietal lobe lesions and. 166 Agraphia. alexia without. 192, 193;, 194 AIDS. See HIV infection/AIDS AIDS dementia complex. 361 AION. See Anterior ischemic optic neuropathy (AION) Air cells. ethmoidal. 9, 9; Akinetopsia, 192 Alcohol. abuse of, optic neuropathy caused by, 152 Alexander's law, 244. 246, 248 Alexia. without agraphia, 192. 193;, 194

Allergic aspergillosis. 365 Alternating cross-over test, for ocular misalignment. 214 Alternating gaze deviation. periodic. in comatose patients. 256 Alternating skew deviation. 223 Alternative charts. use of. in evaluation of functional visual disorders, 309 Alveolar nerve. posterior, 52. 53; Amacrine cells, 24 Amaurosis fugax, 175. See also Monocular transient visual loss carotid artery disease and, 172 embolic cause of, 176 Horner syndrome and. 265 hypoperfusion causing, 183 vasculitis causing, 183 Amblyopia. 111 Amiodarone toxicity. optic neuropathy caused by, 152 Amphotericin B, for aspergillosis, 365 Amsler grid testing, in low vision evaluation, 90 Analgesic rebound headache. 296 Anderson-Kestenbaum procedure. for congenital nystagmus. 255 Aneurysm basilar artery, 355 berry (saccular), 350 cerebral, 350-354. 350; clinical presentation of, 351, 352; laboratory investigation of, 351-352, 353; prognosis of, 352-353 ruptured. 351, 352; treatment of. 353-354 contrast angiogram of, 68; internal carotid, 350-351 chiasma I syndromes caused by. 162 third nerve palsy and, 228-229, 229; intracavernous carotid, 351 Angiography of carotid stenosis. 179 computerized tomographic. 67 -68 definition of. 78 limitations of, 771 conventional/catheter/contrast, 66, 68; fluorescein in differentiating drusen from papilledema, 131-132,132;.133; in low vision evaluation. 98, 99; magnetic resonance, 66-67 definition of. 80 limitations of. 771 Angioma (angiomatosis). See also Hemangioma (hemangiomatosis) cerebellar, 340 encephalofacial (Sturge- Weber syndrome), 3361, 340, 34li racemose (Wyburn-Mason syndrome). 3361, 342-343.343; retinal (von Hippel-Lindau disease). 3361, 340. 342;

389

390

. Index

Angle-closure glaucoma, pain caused by. 298 Angular artery. 13 Angular vein, 20. 22; Anhidrosis. 262 Aniridia. 259 Anisocoria. 260-269 Adie's tonic pupil and, 266-267, 267;, 268; equal in dim and bright light, 260 evaluation of. flowchart in. 261; greater in bright light, 265-269 greater in dim light, 260. 262-265. 263; in Horner syndrome. 262-265. 263;. 264; iris damage in. 265-266 pharmacologic. 262, 266 physiologic (simple/essential). 260, 261;. 262 post-cocaine, 262 in posterior synechiae, 262 third nerve palsy in, 267. 269 Annulus of Zinn, 26.41 Ansa subclavia. 57 Anterior cerebral artery, 16 Anterior chiasmal syndrome. 158, 159; Anterior choroidal artery, 16 Anterior ciliary artery. 15 Anterior clinoid process, 13. 15. 26 Anterior communicating artery, 16 Anterior ethmoidal air cells, 9. 9; Anterior ethmoidal artery. 13, 15 Anterior ethmoidal foramen, 10 Anterior inferior cerebellar artery. 18. 19; Anterior ischemic optic neuropathy (AION). 120-124, 1211.347 arteritic. 120-122, 121;. 1211 nonarteritic, 1211. 122-124. 123;. 124t Anterior optic neuropathy with optic disc edema, 111-113. 115-129 without optic disc edema. 129-141 Anterior segment, 23 slit-lamp examination of. 258-259 Anterior vestibular artery, 18 Antibiotics for cat-scratch disease, 368 for Lyme disease, 364 Anticholinergic agents. for ocular deviation. 212 Anticoagulant therapy. for carotid artery disease, 182 Antiemetic agents, for migraine, 296 Antifungal agents for aspergillosis. 365 for cryptococcosis. 368 Antiplatelet therapy. for carotid artery disease, 182 Antipsychotic agents. idiosyncratic reaction to, 212 Antiviral agents. for Bell's palsy, 284 Anton syndrome. 195 Aortic arch. 17. 178; Apraclonidine drops, in Horner syndrome diagnosis. 263 Apraxia definition of. 207 of eyelid opening, 278-279 ocular motor. 207-208 acquired,207-208 congenital, 207 parietal lobe lesions and. 166 Arachnoid membrane, of optic nerve, 26

Arachnoid villus(i), 20 Arcade retinal artery. inferior/superior, 15 Arcade retinal vein. 20. 21-22; Archeocerebellum, 39 Arcuate fibers, Ill, 114; Argyll-Robertson pupil, 270 Argyll-Robertson-like pupils. 270 Arion sling. 286 Arnold-Chiari malformation, downbeat nystagmus caused by, 248-249, 248; Arterial circle, greater/lesser. 15 Arterial dissection. 354-355. 354; Arterial system. See also named artery anatomy of. 11- 20 Arteriography. See Angiography Arteriovenous malformations (AVMs). 355. 356;.357 diagnosis of. 357 migraine with, 295, 295; transient visual loss and, 185 treatment of. 357 in Wyburn-Mason syndrome, 342-343 Arteritic anterior ischemic optic neuropathy (AAION). 120-122. 12li. 1211 Arteritis. giant cell (temporal) anterior ischemic optic neuropathy and. 120-122 facial pain associated with, 299 headache with, 292 Ascending tract of Deiters, 34 Aseptic cavernous sinus thrombosis. 357 Aseptic superior sagittal sinus thrombosis, 358 Ash-leaf spot, in tuberous sclerosis. 339 Aspergilloma (fungus ball). 365. 366; Aspergillosis, 365, 366; Aspergillus, 365 Astrocytes. retinal. 24 Astrocytoma (astrocytic hamartoma). See also Optic nerve glioma calcified. in tuberous sclerosis. 339 malignant, 151 pilocytic, 148-151, 149;, 150t retinal, versus optic disc drusen, 132-134. 133; Ataxia, optic. 194 Ataxia-telangiectasia (Louis-Bar syndrome), 336t. 340. 342,342; Atheroma, transient visual loss and. 176-177, 178; Auditory artery, internal, 18 Auditory nerve. See Cranial nerve VIII (auditory nerve) Aura migraine (classic) headache with, 185.293-294.293; migraine (common) headache without, 294 Autofluorescence. in drusen. 131 Automated perimetry in evaluation of functional visual disorder, 310. 311; static, 92-93, 93;. 94;, 95;, 96 Autonomic pathways, ocular. 56-60 parasympathetic, 57. 59-60. 59;, 60; sympathetic, 56-57, 58; Autosomal dominant optic atrophy. 136-137, 137; AVMs. See Arteriovenous malformations (AVMs) Awareness of vision, problems with, 195-196 AZOOR (acute zonal occult outer retinopathy). 107 B-scan ultrasonography, in differentiating papilledema, 131, 132;

drusen from

Index. b-wave, of electroretinogram, 101 Baclofen, for nystagmus, 255 Balint syndrome, 195, 208 Bartonella /tense/ae, cat-scratch disease caused by. 368 Base-out prism test, in evaluation of functional visual disorders, 307 Basilar artery. 11, 18. 19i, 178i aneurysm of. 355 caudal. 18 dissection of, 354 median perforators of, 18 Basilar-type (complicated) migraine, 293-294. See a/so Migraine headache Basilar vein of Rosenthal, 22 Battle's sign. 285 Bell's palsy, 280. 283-284 Benedikt syndrome. 227 Benign episodic pupillary mydriasis. 270-271 Benign paroxysmal positional vertigo. 247 Benign retinal vasculitis, 128, 128i Bernasconi-Cassinari artery, 13 Berry (saccular) aneurysm, 350 Bilateral acoustic neurofibromatosis, 337 Bilateral complete blindness, evaluation of, as functional disorder, 305-306, 306i Bilateral ptosis. 226. See a/so Ptosis Bilateral visual loss, versus unilateral visual loss. 83 Binocular transient visual loss. 185-186 versus monocular transient visual loss, 171 Binocular vision. reduced, 308-309 Bipolar cells, 24 Blepharospasm essential. 286-288. 287i, 287t treatment of. 288 functional (nonorganic/nonphysiologic). 314-315 reflex. 290 transient visual loss and, 173 Blind spot. 23 idiopathic enlargement of, 107 Blindness. See a/so Visuallosslimpairment cerebral (cortical), occipital lobe lesion causing. 170 complete bilateral, evaluation of. as functional disorder. 305-306. 306i day, in cone dystrophy. 104 monocular, evaluation of, as functional disorder, 306- 307. 308i Blindsight, 196 Blink, abnormal. illusions caused by, 188 Blood oxygenation level-dependent (BOLD). 68 definition of, 78 Blow-out fractures. orbital, diplopia with, 218-219 Blurred vision/blurring. 213 vertebrobasilar insufficiency and, 186 Bobbing, ocular, 208, 256 BOLD (blood oxygenation level-dependent), 68 definition of. 78 Borrelia burgdorferi. 284. 362. See a/so Lyme disease/ Lyme borreliosis Bottom-up acuity. in evaluation of functional visual disorders, 308-309 Botulinum toxin type A for blepharospasm, 288 for hemifacial spasm, 289 for ptosis. 286

391

Botulism poisoning. ptosis caused by, 277 Bourneville syndrome (tuberous sclerosis). 336t. 338-340. 339i Brachium conjunctivum. 34 Brain. See Cerebral entries; specific part Brain stem arteriovenous malformations in, 355 lesions of facial weakness/paralysis caused by, 282-283 horizontal gaze palsy with. 208, 209i Brain stones (calcified astrocytic hamartomas). in tuberous sclerosis, 339 Breast carcinoma, metastatic. numb chin associated with,301 Brodmann area 8, 34 Brodmann area 17 (striate cortex), 29. 30i Brodmann area 18 (parastriate cortex), 29. 31 Brown syndrome, 219-220. 220i Bruit. carotid, 179, 354 Brun nystagmus. 248 Buccal nerve, 56 Budge- Waller. ciliospinal nucleus of, 56. 58i Bull's-eye depigmentation. in cone dystrophy, 104 C-reactive protein. in giant cell arteritis, 122 c-wave. of electroretinogram, 101 CAOASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) headache in. 289 transient visual loss and. 179 Cafe-au-lait spots in neurofibromatosis, 337 in tuberous sclerosis, 338 CajaI. interstitial nucleus of, 34. 202 skew deviation and, 223 Calcarine artery. 20. 20i Calcarine fissure, 29, 30i Calcified astrocytic hamartomas (brain stones), in tuberous sclerosis, 339 Calcium embolus, transient visual loss and. 175. 176i. 177t Caldwell-Luc procedure, for thyroid-associated orbitopathy, 332 Cancer-associated retinopathy (CAR). 101. 108-109 CAR antigen (recoverin). 109 Cardiac disease. transient visual loss and, 177 Cardinal positions of gaze. 241 i Carotid artery common, 11, 178i dissection of pain associated with, 299 pain caused by. 300 external. II-12i. 178i internal. 11-12i. 13, 14i. 178i aneurysm of. 350-351 chiasmal syndromes caused by, 162 third nerve palsy and, 228-229. 229i dissection of, 354-355 Horner syndrome caused by, 263-264, 264i supraclinoid. 16 stenting of, 182 Carotid bruits. 179. 354 Carotid-cavernous fistula, 236. 237i Carotid endarterectomy. for carotid stenosis. 181-182

392

. Index

Carotid-ophthalmic anastomosis, 178; Carotid siphon. 178; Carotid stenosis evaluation of. 179 prognosis for. 180-181 Carotid territory ischemia, 177 evaluation of, 179-180 Carotid ultrasonography (duplex scanning), 179 Carotidynia. 300 Cat-scratch disease, 368 Cataract. "Christmas tree;' in myotonic dystrophy. 335 Cataract surgery illusions caused by. 188 pupillary irregularity caused by, 259 Catheter angiography. 66 Caudal basilar artery. 18 Cavernous sinus, 10. 23 lesions of. MR imaging of. 74. 74; ophthalmoplegia and. 235-236 Cavernous sinus thrombosis, 357-358 Ceftriaxone, for Lyme disease, 364 Cefuroxime. for Lyme disease, 364 Cellophane maculopathy, 105 Central caudal nucleus, in ptosis. 226 Central nervous system (CNS) infection of, papilledema caused by, 116 lymphoma of, in HIV infection/AIDS. 359 mucormycosis of. 367 Central retinal artery. 11-12;. 15, 16; occlusion of. 105-106. 106i Central retinal vein. 16i. 20, 21-22i occlusion of. 106-107. 106; Central serous chorioretinopathy, 105 Central vestibular nystagmus. 2461. 247-248 Cerebellar angioma. 340 Cerebellar artery anterior inferior, 18, 19i posterior inferior, 18. 19; superior, 18 Cerebellar hemangioblastoma, in retinal angiomatosis, 340 Cerebellopontine angle tumors, 234, 283, 284, 285; Cerebellum, 39 dysfunction of. in multiple sclerosis. 320 Cerebral achromatopsia, 194 Cerebral aneurysm. 350-354. 350i clinical presentation of. 351, 352; laboratory investigation of. 351-352. 353i prognosis of. 352-353 ruptured. 351, 352i treatment of. 353-354 Cerebral artery anterior. 16 middle. 16. 17, 20i posterior, 11. 16. 18, 20i Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) headache in. 298 transient visual loss and. 179 Cerebral blindness. occipital lobe lesion causing. 170 Cerebral ptosis. 277 Cerebral venous thrombosis. 357-358 Cerebrospinal fluid, in syphilitic serology. 362

Cerebrovascular circulation, 178i Cerebrovascular disease. See a/so specific disease neuro-ophthalmic signs of. 345-358 in pregnancy, 344 transient visual loss caused by. 345-346 Cervical ganglion, superior, 57 Cervicofacial trunk, of cranial nerve VII. 56 CFEOM 1 (congenital fibrosis of extraocular muscles type 1) syndrome, 220 CHAMPS (Controlled High-Risk Subjects Avonex Multiple Sclerosis Prevention Study), 324 Charles Bonnet syndrome. 191 Chemotherapy. for optic nerve glioma. 151 Cherry-red spot. in central retinal artery occlusion. 105. 106; Chiasm (optic) anterior. lesions of, 158, 159; gliomas involving. 149. 150. 163 lesions of. 158-163 in multiple sclerosis, 321 parasellar, 160-163, 162; treatment of, 163, 160-163, 162i visual field patterns in. 158. 159i. 160;, 161 i mid, lesions of. 158. 160i posterior, lesions of, 158, 161; Children drusen in. 133-134 nystagmus in congenital,241-242 latent, 242-243 monocular. 243 spasmus nutans and, 243 optic nerve sheath meningioma in, 148 third nerve palsy in, 231 Cholesterol emboli (Hollenhorst plaques), transient visual loss and, 173, 173i. 1771 Chorda tympani, 55 Chorioretinitis, 299. 333 Chorioretinopathy. See a/so Retinopathy central serous, 105 Choristoma, 337 Choroid, 24 Choroidal artery anterior. 16 lateral, 18 Choroidal inflammation, pained caused by, 298 Choroidal vein, 20, 21-22; "Christmas tree" cataracts. in myotonic dystrophy. 335 Chronic progressive external ophthalmoplegia (CPEO). 334, 334; Cigarette smoking, as risk factor for thyroid-associated orbitopathy. 331 Ciliary artery anterior, 15 posterior, 15, 16; Ciliary ganglion. 49 Cilioretinal artery. 15 Ciliospinal nucleus, of Budge- Waller, 56, 58i Cingulate gyrus. 56 Circle of Willis, 16 intracranial aneurysm on. 350i Circle ofZinn-Haller, 15 Circulation. cerebrovascular, 178; Claude syndrome. 227

Index. Clinoid process, anterior, 13, 15, 26 Clivus,S Clonazepam, for nystagmus, 255 Cluster headache, 297 CNS. See Central nervous system (CNS) Cocaine, in Horner syndrome diagnosis, 262 Cochlear artery, 18 Cochlear nerve, 32, 54 Coenzyme QIO' for Leber hereditary optic neuropathy, 136 Cogan's lid-twitch, 275, 325 Cogwheel pursuit, 210 Coil embolization, of aneurysm, 353-354 Collateral vessels, retinochoroidal, in papilledema, 116-117 Colliculus facial, 227 superficial superior, 34 superior, 27, 31, 54 Collier's sign, 209, 254, 270, 279 Colloid bodies. See Optic disc drusen (ODD) Coloboma, 259 tilted disc, 139 Color plate testing, pseudoisochromatic, in low vision evaluation, 96 Color vision defects in, 96 in dominant optic atrophy, 136 testing of, in low vision evaluation, 96 Coma, 256 Comatose patients, eye movements in, 256 Comitant deviations, 213, 216-217 Commissure, posterior, 39 Common carotid artery, 11, 178i Common migraine, 294. See also Migraine headache Communicating artery anterior, 16 posterior, 20 Complex cells, 29 Compressive lesions, orbital, 128-129, 130i Compressive optic neuropathy intraorbital/intracanalicular, 145-151 in thyroid-associated orbitopathy, 330, 330i Computed tomography (CT), 61-62 indications for, 75-78, 751, 76i of intra parenchymal hemorrhage, 771 limitations of, 771 Computerized tomographic angiography (CTA), 67-68 definition of, 78 limitations of, 771 Cone dystrophy, 104 Confrontation testing in evaluation of functional visual disorder, 310 of vision, 89-90 Confusion tests, in evaluation of functional visual disorders, 307, 308i monocular reduced vision and, 308 Congenital anomalies, of optic disc, 138-141 Congenital fibrosis of extraocular muscles type 1 (CFEOMI) syndrome, 220 Congenital fibrosis syndrome, 220-221, 221i Congenital Horner syndrome, 264 Congenital nystagmus, 241-242 characteristic signs of, 242

393

Congenital ocular motor apraxia, 207 Congenital tilted disc syndrome, 139-140, 140i Conjugacy, in saccades testing, 202-203 Conjunctival telangiectasia, 342, 342i Consensual response, in pupillary reaction to light, 258 Contralateral thalamus, 50, 50i Contrast angiography, 66, 68i Contrast sensitivity function, 97 Contrast sensitivity testing, spatial, in low vision evaluation, 97 Contrast threshold, 97 Controlled High-Risk Subjects Avonex Multiple Sclerosis Prevention Study (CHAMPS), 324 Convergence assessment of, 203-204 disorders of, 210-211 Convergence-retraction nystagmus, 254 Convergence spasm, 211 Converse bobbing, 256 Corectopia, midbrain, 260 Cornea irregularities of, illusions caused by, 188 lesions of, decreased vision with, 103 Cortical blindness. See Cerebral blindness Corticosteroids for Bell's palsy, 284 for idiopathic intracranial hypertension, 119 for thyroid-associated orbitopathy, 331 Cotton-wool spots in central retinal vein occlusion, 106, 106i, 107 in H1V infection, 361 CPEO (chronic progressive external ophthalmoplegia), 334,334i Cranial fossa, anterior, 9, 10 Cranial nerve II (optic nerve). See Optic nerve (cranial nerve II) Cranial nerve III (oculomotor nerve) aberrant regeneration of, 232, 232i, 270 anatomy of, 43, 44i, 45-49, 45-49i palsy of. See Third nerve (oculomotor) palsy Cranial nerve IV (trochlear nerve) anatomy of, 43, 44i, 45-49i palsy of. See Fourth nerve (t rochlear) palsy Cranial nerve V (trigeminal nerve), anatomy of, 50, 50i, 51 i, 52, 53i, 54 Cranial nerve VI (abducens nerve) anatomy of, 43, 44i palsy of. See Sixth nerve (abducens) palsy Cranial nerve Vll (facial nerve) anatomy of, 54-56, 55i brain stem lesions involving, 282-283 disorders of, 281-290 diagnosis of, 281, 282i overactivity, 286-290, 2871 treatment of, 286 underactivity, 281-286, 2831 distribution of, 282i essential blepharospasm and, 286-288, 287i facial myokymia and, 289 habit spasm and, 290 hemifacial spasm and, 288-289, 288i paralysis/weakness of, 280-281, 280i etiologies of, 2831 peripheral lesions involving, 283-285, 284i

394

. Index

reflex blepharospasm and. 290 spastic paretic facial contracture and. 289 supranuclear lesions involving. 281 synkinesis of. 280. 280;, 284 Cranial nerve VlII (auditory nerve). 54. 55i Cranial nerves. 42-49 palsy/paralysis of isolated. 235 multiple. 235 neuroimaging of. 74. 74; Craniopharyngioma chiasmal syndromes caused by. 161i. 162 see-saw nystagmus caused by. 251 Crocodile tears. 281 Cross-over test. alternating. for ocular misalignment. 214 Cryptococcosis. 367-368 Cryptococcus Ileoformatls. 367 CT. See Computed tomography (CT) CTA. See Computerized tomographic angiography (CTA) Cystoid macular edema. 104-105 Cytomegalovirus. in HIV infection/AIDS. 359. 360; Darkschewitsch. nucleus of. 39 Day blindness (hemeralopia). in cone dystrophy. 104 de Morsier syndrome. 139 Decibels. in perimetry. 92 Decompression surgery. for thyroid-associated orbitopathy. 331-332 Decreased vision. See Low vision; Visual loss/impairment Deiters tract. ascending. 34 Dementia. AIDS-associated. 361 Demyelinating disease. MR imaging of. 66i Demyelinating plaques. in multiple sclerosis. 318. 319i Dentate nucleus. 40 Depigmentation. bull's-eye. in cone dystrophy. 104 Desaturated IS-hue test. Lanthony, in low vision evaluation. 96 Diabetic papillopathy, 127. 127; Diffusion-weighted imaging (DWI). 64. 67; definition of. 78 Diplopia. 213-237 comitant deviations with. 213. 216-217 divergence insufficiency and. 216 history of. 213 incomitant deviations with. 213. 217, 218; monocular. 216 in multiple sclerosis. 321 in myasthenia gravis, 326 ocular motor cranial nerve lesions and central, 221-227, 223t peripheral. 227-237 paretic syndromes causing, 221, 222i restrictive syndromes versus, 217, 218; physical examination of. 213-214, 214;. 215i restrictive syndromes causing. 217-221 paretic syndromes versus. 217. 218i posttraumatic. 218-219 skew deviation and. 223-224 Dipping. ocular. 256 Direct response. in pupillary reaction to light. 258

Disc edema. See Optic disc (optic nerve head). edema of Disconnection syndrome. 192 Dissections (arterial). See u/lder /lamed artery Dissociated/disconjugate/disjunctive nystagmus. 240 Divergence insufficiency. 211. 216 Divergence paralysis. 211 Dix-Hallpike maneuver. 247 DNA mutation. in Leber hereditary optic neuropathy. 134-135 DOA (OPAl) gene. 136 Doll's head maneuver/phenomenon. 313 in saccadic dysfunction. 206 Dominance columns. ocular. 29 Dorello's canal, 23. 234 Dorsal midbrain (Parinaud) syndrome. 208-209. 210i eyelid retraction in. 279 Dorsal subnucleus. of cranial nerve VII. 54 Dorsal vermis. 41 Dorsal visual processing stream. in pursuit system. 203 Dorsolateral pontine nuclei. 34 Dot-and-blot retinal hemorrhage. 183. 184i Double-ring sign. in optic nerve hypoplasia. 139. 139; Double simultaneous stimulation, in confrontation testing. 90 Double vision. See Diplopia Downbeat nystagmus. 248-249. 248; differential diagnosis of. 249 Doxycycline. for Lyme disease, 364 Drugs. See also specific drug or dTllg group mydriasis caused by, 266 for parasellar tumors, 163 toxicity of. optic neuropathy caused by. 152

Drusen in children, 133-134 extruded. 129 giant, 132 optic disc. 115. 115;. 129-134. 131 i versus astrocytic hamartoma. 132-134. 133; versus papilledema. 130-132. 132;. 133; pseudopapilledema and. 115. 115i Dry eye (keratitis sicca). 188. 298 Duane retraction syndrome. 220. 221 i variants of. 220-221 Duplex ultrasonography. in carotid evaluation. 179 Dural sheath. of optic disc. 26 Dural sinus fistula. 236-237 Dural sinus thrombosis. 357-358 DWI. See Diffusion-weighted imaging (DWI) Dynamic imbalance. of vestibulo-ocular reflex. 200 Dyschromatopsia. See Color vision. defects in Dysgeusia. Horner syndrome and. 265 Dyskinesia. tardive, 286 Early-onset (childhood) nystagmus. congenital,241-242 latent, 242-243 monocular. 243 spasmus nutans in. 243 Echocardiography. 179-180 Eclampsia. 343 Edema cystoid macular. 104-105 of optic disc. 26

241-243

Index. 395 Edinger- Westphal complex/nucleus, 45, 57, 59i Edrophonium chloride (Tensilon) test, 224 for myasthenia gravis, 326-327 Efferent visual pathways/efferent visual system, 32-49. See a/so Ocular motor pathways ocular motility and, 197 Electromyography, in myasthenia gravis, 328 Electrophysiologic testing in evaluation of functional visual disorders, 306 in low vision evaluation, 99-102 Electroretinography, in low vision evaluation, 101-102, 102i Emboli calcium, transient visual loss and, 175, 176i, 177t cholesterol (Hollenhorst plaques), transient visual loss and, 173, 173i, 177t platelet-fibrin, transient visual loss and, 175, 176i, 177t transient visual loss caused by, 174t, 175-183, 176i, 178i clinical and laboratory evaluation of, 179-180 clinical aspects of, 177t prognosis for, 180-18 \, 180t treatment of, 181-182, 182t Embolization, coil, of aneurysm, 353-354 Encephalitis, herpes, 360, 361i Encephalofacial angiomatosis (Sturge- Weber syndrome), 336t, 340,341 i Encephalopathy H1V, 361 inherited, resembling migraine, 297-298 Encephalot rigem inail cerebrofac ia I a ngi omat os is. See Sturge- Weber syndrome (encephalofacial angiomatosis) End-stopped cells, 29 Endarterectomy, carotid, for carotid stenosis, 181-182 Environmental triggers, of migraine, 296 EOMs. See Extraocular muscles (EOMs) Epilepsy hallucinations and, 190 ocular deviation with, 211 Epiretinal membrane, 105 Erosion syndrome, recurrent, pain caused by, 298 Erythema chronicum migrans, in Lyme disease, 363, 364i Erythrocyte sedimentation rate, in giant cell arteritis, 121-122 Erythromycin, for Lyme disease, 364 Esodeviations, thalamic, 224 Essential blepharospasm, 286-288, 287i, 287t treatment of, 288 Ethanol. See Alcohol Ethmoid sinus, 9, 9i Ethmoidal air cells, 9, 9i Ethmoidal artery, anterior/posterior, 13, 15 Ethmoidal bone (lamina papyracea), 10 Ethmoidal foramina, anterior/posterior, 10 Ethmoidal suture, frontal, 9 Ethmoidectomy, for thyroid-associated orbitopathy, 332 Ethylene glycol toxicity, optic neuropathy caused by, 152 EW complex. See Edinger- Westphal complex External carotid artery, 11-12i, 178i

External jugular vein, 23 Extracranial trunk, of cranial nerve Vll, 56 Extraction restriction, post -cataract, 219 Extraocular muscles (EOMs) anatomy of, 41-42, 42i congenital fibrosis type [ syndrome of, 220 Extraocular myopathy, in thyroid-associated orbitopathy, 329i, 330 Extruded drusen, 129 Eye. See a/so Ocular entries; specific part dry (keratitis sicca), 188, 298 elevation of. See Upgaze trauma to, 259 Eye fields, frontal, 202, 208, 211 Eye movements. See also specific type; Ocular motility assessment of, 199-204 in diplopia, 213-214, 214i. 215i control of fundamental principles in, 197-199 supranuclear, 33-34, 35-38i, 39 disorders of in comatose patients, 256 nystagmus/spontaneous, 239-256. See a/so Nystagmus ocular bobbing and, 256 vergence, 203- 204 disorders of, 210-211 Eye ointment, lubricating, 286 "Eye strain;' 298 Eyedrop testing, for mydriasis, 265 Eyedrops, steroid, ptosis caused by, 278 Eyelid droop. See Ptosis Eyelid weights, 286 Eyelids disorders of, 273-279. See a/so specific disorder evaluation of, 273-276, 274i, 275i, 276i examination of, 273-276, 274i, 275i, 276i excursion of, 273-274, 275i muscles of, 56 opening of, apraxia of, 278-279 position and function of, disturbances in, 314-315 retraction of, 145, 279, 279t in thyroid-associated orbitopathy, 274-275, 276i. 329,329i shape and appearance of, 273, 274i superficial venous structures of, 22i Facial artery, 11, 13 Facial colliculus, 227 Facial contracture, spastic paretic, 289 Facial diplegia, in Guillain-Barre syndrome, 285 Facial fasciculations, benign, 289 Facial grimacing, blepharospasm associated with, 286 Facial motor and sensory anatomy, 49-56 Facial movements, abnormalities of, 280-290, 280i, 282i evaluation in, 273-276, 274i, 275i, 276i Facial myokymia, 287t, 289 Facial nerve. See Cranial nerve Vll (facial nerve) Facial numbness, pain associated with, 301 Facial pain, 299-301 atypical. 299 Facial paralysis/weakness, 280-281, 280i etiologies of, 283t

396

. Index

Facial synkinesis, 280, 280i, 284 Facial tic (habit spasm), 290 Facial vein, 20, 22i. 23 Falciform ligament, 26 Fallopian canal, 54 False-negative response, in perimetry, 93 False-positive response, in perimetry, 93 Farnsworth-MunsellIOO-hue test, in low vision evaluation, 96 Farnsworth Panel D-I 5 test, in low vision evaluation, 96 Fascicular lesions, diplopia and, 227 Fasciculations, facial, 289 Fasciculus, medial longitudinal, 34 disruption of, 224 rostral interstitial nucleus of, 34, 37i Fast twitch fibers, 41 Fastigial nucleus, 40 Fibroma, periungal, in tuberous sclerosis, 338 Fibrosis syndrome, congenital, 220-221, 221i Fifteen-hue test, Lanthony desaturated, in low vision evaluation, 96 First-order neuron lesions, Horner syndrome caused by, 263,264 Fissure calcarine, 29, 30i orbital. See Orbital fissure Fistula carotid-cavernous, 236, 237i dural sinus, 236-237 Fixation loss, in perimetry, 93 FLAIR (fluid-attenuated inversion recovery) image, 63-64, 66i definition of, 78 parameters of, 64 t signal intensity on, 65t Flocculonodular lobe, 39 Flucytosine, for aspergillosis, 365 Fluid-attenuated inversion recovery (FLAIR) image, 63-64, 66i definition of, 78 parameters of, 64t signal intensity on, 65t Fluorescein angiography in differentiating drusen from papilledema, 131-132, 132i. 133i in low vision evaluation, 98, 99i Flutter, ocular, 253 fMRI. See Functional magnetic resonance imaging (fMRI) Focal electroretinography, 101 Fogging test, in evaluation of functional visual disorders, 307 Folate deficiency, optic neuropathy caused by. 152 Foods, headaches caused by, 296 Foramen (foramina) ethmoidal, anterior/posterior, 10 ovale, 13 spinosum, II Foramen magnum, 5 Forced duction test, in diplopia, 217, 218i Foster Kennedy syndrome, 123, 123i Fourth nerve (trochlear) palsy, 232-234, 234i bilateral, 233

congenital,

233, 234i

Parks-Bielschowsky

3-step

test for, 232-233

Fovea. 24 Foville syndrome, 227 Fractures, blow-out, orbital, diplopia with, 218-219 Frenzel goggles, in ocular motility assessment, 200, 240 Frequency-encoding analysis, definition of, 79 Fresnel Press-On Prisms, for thyroid-associated orbitopathy, 331 Frontal artery, 15 Frontal bone, 9, 10 Frontal branch, of cerebral artery, 16 Frontal ethmoidal suture, 9 Frontal eye fields. 202. 208, 211 Frontal nerve, 52, 53i Frontal sinus. 9, 9i Frontopolar branch, of cerebral artery, 16 Frontozygomatic suture, 10 Full- field electroretinography, 101, 102 Functional magnetic resonance imaging (fMRI), 68 definition of, 78 Functional visual loss. 303-315 categories of, 303 diagnosis of, 304 examination techniques in, 305-315 identification of patient with, 303-304 management of, 315 Fundus examination of, in low vision evaluation, 87-89. 88i, 89i,89t in Leber hereditary optic neuropathy, 134, 135i in multiple sclerosis, 321 Fungi, infections caused by. See a/so specific infection neuro-ophthalmic signs of, 364-368 Fungus ball (aspergilloma), 365, 366i Furosemide. for idiopathic intracranial hypertension, 119 Fusiform gyrus, 31 GABA agonists, for nystagmus, 255 Gadolinium definition of, 79 magnetic resonance angiography with, 67 Gain, ocular movement, definition of, 39 Galen vein, 23 Gamma cells, 27 Ganglion ciliary, 49 gasserian (semilunar/trigeminal), 52 parasympathetic, of head and neck, 60i sphenopalatine, 9 superior cervical, 57 Ganglion cells, 24 Gasserian ganglion (semilunar/trigeminal ganglion), Gaze cardinal positions of, 241 i horizontal, 34, 37i, 38i. 39 psychic paralysis of, 194 vertical. 37i. 39, 40i Gaze deviation, periodic alternating, in comatose patients, 256 Gaze-evoked nystagmus, 39, 224, 225i, 244. 245i Gaze palsy/preference, 208-209, 209i, 210i. 313 functional (nonorganic/nonphysiologic), 313

52

Index. 397 GDx nerve fiber analysis, 69 Geniculate body, lateral, 16. 17;,27-28 Gennari line. 29 Gerstmann syndrome, 166. 194 Giant aneurysm, 351 Giant cell (temporal) arteritis anterior ischemic optic neuropathy and. 120-122 facial pain associated with. 299 headache with. 292 Giant drusen, 132 Glatiramer acetate for multiple sclerosis. 324 for relapsing-remitting multiple sclerosis. 144 Glaucoma, 138, 138i angle-closure. pain caused by. 298 in central retinal vein occlusion. 107 normal-tension. 138 open-angle. in Sturge- Weber syndrome. 340 Glial cells, retinal. 24 Glioma involving optic chiasm. 149. 150, 163 optic nerve. 148-151, 149i. 1501 malignant, 151 relationship of neurofibromatosis I to. 149 Gliosis. of peripapillary nerve fiber layer, 116, 116i Gliotic (sclerotic) lesions. in multiple sclerosis, 318 Glossopharyngeal neuralgia, 300 Gold eye weights, 286 Goldmann perimetry, 91-92. 93; in evaluation of functional visual disorder. 310, 312; Gradenigo syndrome, 234. 358 Granulations, pacchionian, 20 Granuloma. sarcoid, 333 Graves disease. euthyroid. 330 Graves ophthalmopathy, 145. 146i, 329-332 compressive optic neuropathy in. 330, 330; diagnosis of. 330-331 extraocular myopathy in, 329i. 330 eyelid retraction in. 274-275. 276;. 279 eyelid signs in. 329, 329; proptosis and, 329 strabismus and, 217-218 treatment of, 331-332 Grayscale map. 92, 94; Greater arterial circle, 15 Greater superficial petrosal nerve, 55 Gruber's ligament, 43 Guillain-Barre syndrome bulbar variant of, 277 facial diplegia in, 285 Gyrus cingulate. 56 fusiform. 31 lingual. 31 postcentral. 50. 50;. 51; precentral. 54 Gyrus rectus. 26 Gyrus subangularis, 31 Habit spasm, 290 Hallucinations. 189-191 cortical origin of. 190-191 definition of. 187 nonvisual causes of, 1881

ocular origin of, 189-190 optic nerve origin of, 190 primary visual cortex lesions causing, 170 Hallucinatory palinopsia. 190-191 Hamartia, 337 Hamartin, 338 Hamartoma, 337 astrocytic (astrocytoma) malignant. 151 pilocytic. 148-151, 149i. 1501 retinal, versus optic disc drusen, 132-134. 133i in tuberous sclerosis. 339 "Hatchet face;' in myotonic dystrophy, 335 Head bony anatomy of, 5-10 parasympathetic ganglia of, 60; vascular anatomy of, 10-23 arterial, 11-20 venous, 20- 23 Head-shaking nystagmus, 200 Head shaking test, 200 Head thrust maneuver. 200 Head trauma. seventh nerve palsy in. 285 Headache analgesic rebound, 296 cluster. 297 elevated intracranial pressure causing. 292 evaluation of, 291-298 giant cell arteritis with. 292 history of. clinical points in. 291 t idiopathic intracranial hypertension and, 119 idiopathic stabbing. icepick pains and. 297 intracranial hemorrhage causing, 292 migraine. See Migraine headache migraine aura without, 294-295 with postganglionic Horner syndrome, 264-265 primary. 291 of ruptured aneurysm, 351 secondary, 291 tension-type. 296 treatment of. 296-297 with visual loss. 84 transient. 172 Hearing loss. in peripheral vestibular nystagmus. 246 Heart disease, transient visual loss and, 177 Heidelberg retina tomography, 69 Hemangioblastoma, cerebellar, in retinal angiomatosis, 340 Hemangioma (hemangiomatosis). See a/so Angioma (angiomatosis) orbital in pregnancy, 345 transient visual loss and. 175 Hemeralopia (day blindness), in cone dystrophy. 104 Hemianopia homonymous arteriovenous malformations causing. 355. 356i cortical injury causing. 29 hallucinations and, 190 occipital lobe lesions causing, 168-169, 168;. 169;. 170i parietal lobe lesions causing, 167 retrochiasmallesions causing. 164. 165; in vertebrobasilar disease. 348

398

. Index

temporal. chiasmallesions causing. 158. 160i Hemifacial spasm. 287t. 288-289. 288i Hemispatial neglect. 196 Hemorrhage intracranial headache caused by. 292 ruptured aneurysm causing. 351 intraparenchymal. MRI/CT appearance of. 77t MR imaging of. 63i ocular. with subarachnoid hemorrhage. 351 retinal. dot-and-blot. 183. 184i subarachnoid. 353 with ocular hemorrhage. 351 Henley's layer. 24 Herpes simplex virus. in HIV infection/AIDS. 359-360. 361i Herpes zoster ophthalmic us. 300-30 I. 300i Herpes zoster virus cranial nerve VII involvement and. 284 in HIV infection/AIDS. 359-360. 361i ophthalmic manifestations in. 300-301. 300i HIV encephalopathy. 361 HIV infection/AIDS. 360-361 CNS lymphoma in. 359 cytomegalovirus infection in. 359. 360i herpesvirus infection in. 359-360. 361 i Mycobacterium tuberculosis in. 361 neuro-ophthalmic signs of. 359-362 progressive multi focal leukoencephalopathy in. 362. 363i seventh nerve palsy in. 284 syphilis in. 361-362 toxoplasmosis in. 362 HLA antigens. in multiple sclerosis. 317 Hollenhorst plaques (cholesterol emboli). transient visual loss and. 173. 173i Homonymous hemianopia. 83 arteriovenous malformations causing. 355. 356i cortical injury causing. 29 hallucinations and. 190 occipital lobe lesions causing. 168-169. 168i. 169i. 170i parietal lobe lesions causing. 167 retrochiasmallesions causing. 164. 165i in vertebrobasilar disease. 348 Horizontal cells. 24 Horizontal gaze. 34. 37i. 38i. 39 Horizontal gaze palsy. 208. 209i congenital. 208 Hormone therapy. headaches caused by. 296 Horner syndrome. 262-265. 263i. 264i. 300 congenital. 264 internal carotid artery dissection causing. 263-264. 264i localization oflesions causing. 263. 263i pharmacologic testing for. 262-263 postganglionic. 264-265 isolated. 264 preganglionic. 263 underlying disorders causing. 265 Hounsfield unit. definition of. 79 Hundred-hue test. Farnsworth-Munsell. in low vision evaluation. 96 Hyaline bodies. See Optic disease drusen (ODD)

Hydrocephalus. otitic. 358 Hydroxyamphetamine. in Horner syndrome diagnosis. 263 Hypercoagulability. transient visual loss and. 185 Hypermetric saccades. 206. 207 Hyperviscosity. transient visual loss and. 185 Hyphema. recurrent. transient visual loss and. 174 Hypobaric oxygen therapy. for nonarteritic anterior ischemic optic neuropathy. 124 Hypofusion. transient visual loss caused by. 174t. 183-184.184i Hypometric sacca des. 206. 207 Hypoperfusion. systemic. 170 scotoma caused by. 170 Hypophyseal artery. inferior. of tentorium. 13 Hypoplasia. of optic nerve. 138-139. 139i Hypothalamus. 56. 58i Hysteria. 303 Ice-pack test. for myasthenia gravis. 326. 327. 327i Icepick pain. idiopathic stabbing headache and. 297 Idiopathic intracranial hypertension (pseudotumor cerebri).118-120 diagnosis of. criteria for. 118t treatment of. 119-120 Idiopathic multiple cranial neuropathy syndrome. 235 Illusions. 187-189 cortical origin of. 189 definition of. 187 nonvisual causes of. 188t ocular origin of. 187-189 optic nerve origin of. 189 1mmodulation therapy. for relapsing-remitting multiple sclerosis. 144 Immunologic disease. See a/so specific disease neuro-ophthalmic signs of. 317-332 INC. See Interstitial nucleus of Cajal (lNC) Incomitant deviations. 213. 217. 218i Indocyanine green (lCG) angiography. in low vision evaluation. 98 INF. See Interferon (lNF) Infectious diseases. See a/so specific infection neuro-ophthalmic signs of. 358-368 Inferior hypophyseal artery. of tentorium. 13 Inferior meatus. of nose. 10 Inferior muscular artery. 15 Inferior oblique muscle. 41. 42. 42i Inferior oblique subnucleus. 45 Inferior ophthalmic vein. 20. 22i Inferior orbital fissure. 8i. 10 Inferior petrosal sinus. 23 Inferior rectus muscle. 42. 42i Inferior rectus subnucleus. 45 Inferior turbinate. 10 Inferior vestibular nerve. 32. 54 Inferolateral trunk. 13 Inferonasal crescent. in congenital tilted disc syndrome. 139.140i Infiltrative lesions. orbital. 129. 130i Infiltrative optic neuropathy. 156 Inflammation pained caused by choroidal. 298 retinal. 298

Index. pupil irregularity caused by, 259 Infranuclear pathways. in ocular motility, 19i Infraorbital artery, 13. 15-16 Infraorbital nerve. 52, 56 Infratrochlear artery. 13 Inherited disorders. neuro-ophthalmic signs of. 334-343. See also specific disorder Innominate artery, I i, Ii8i INO. See Internuclear ophthalmoplegia (lNO) Interferon (lNF) for multiple sclerosis, 324 for relapsing-remitting multiple sclerosis, 144 Internal carotid artery, 11-12i. 13, 14i. li8i aneurysm of, 350-351 chiasmal syndromes caused by. 162 third nerve palsy and. 228-229. 229i dissection of. 354-355 Horner syndrome caused by. 263-264. 264i supraclinoid. 16 Internal maxillary artery, 9 Internuclear ophthalmoplegia (lNO), 39. 210,224-225, 225i, 226i myasthenia gravis and. 224 nystagmus in. 224, 225i unilateral. 225, 226i wall-eyed bilateral, 224, 225i Interplexiform cells. 24 Interpulse time (1'1). definition of. 81 Interstitial nucleus of Cajal (lNC). 34, 202 skew deviation and, 223 Intracanalicular optic nerve, compressive lesions of, 145-151 Intracranial hemorrhage headache caused by, 292 ruptured aneurysm causing, 351 Intracranial pressure. elevated headache caused by, 292 symptoms associated with. 112-113 Intraocular inflammation. pupillary irregularity caused by, 259 Intraorbital optic nerve. 26 compressive lesions of. 145-151 Intraparenchymal hemorrhage. MRI/CT appearance of, iil Intrusions, saccadic. 199.204,252-254 with normal intersaccadic intervals, 252-253. 252i without normal intersaccadic intervals, 253 Invasive aspergillosis. 365 Inversion recovery (lR), definition of. i9 Iridodialysis. 259 Iris altered innervation of. pupillary irregularity caused by. 259-260 assessment of. 258-259 damage to. anisocoria and. 265-266 malformation of. 259 Iris nodules. in neurofibromatosis. 33i, 338i Iritis, 299, 333 Ischemia carotid territory. Iii occipital. transient visual loss caused by, 185-186 ocular, 183-184, 184i Ischemic optic neuropathy anterior, 120-124. 121t, 34 i arteritic. 120-122, 121 i. 1211

399

nonarteritic. 121 t. 122-124, 123i. 1241 posterior. 155 Island of vision. in low vision evaluation, 91 Isopter. 91 Itraconazole. for aspergillosis, 365 Jabs and jolts syndrome, 29i Janetta procedure, for hemifacial spasm, 289 Jaw winking. in ptosis. 2i6, 2iii JC virus. in progressive multi focal leukoencephalopathy. 362 Jerk nystagmus, 239 Jugular bulb. 22 Jugular vein. external. 23 Kearns-Sayre syndrome, 334. 335i Keratitis. 299 Keratitis sicca (dry eye), 188.298 Kinetic perimetry. 90-91 Klippel- Trcnaunay- Weber syndrome,

335. 340

Labbe vein. 22 Labyrinthine bone, 54 Lacrimal artery. 15 Lacrimal bone, 6i. 10 Lacrimal gland. parasympathetic innervation of, 59-60, 60i Lacrimal nerve, 52, 53i Lacrimopalato-nasal nucleus. 59 Lambdoid suture, 9 Lamina cribrosa. 26 Lamina granularis interna. 29 Lamour frequency, definition of. 80 Lanthony desaturated 15-hue test. in low vision evaluation. 96 Lanthony tritan plates. in low vision evaluation, 96 Latency, in saccades testing, 202 Latent nystagmus. 242-243 manifest, 243 Lateral choroidal artery. 18 Lateral rectus muscle. 42, 42i Lateral (transverse) sinus thrombosis. 358 Lateral subnucleus. of cranial nerve VII, 54 Lateropulsion ocular. 205 in Wallenberg syndrome. 205 Leao, spreading depression of, 191 Leber hereditary optic neuropathy (LHON), 134-136, 135i Lens (crystalline), disorders of, illusions caused by, 188 Lenticular irregularities. decreased vision with, 103 Lesser arterial circle, 15 Leukocoria (white pupil). 259 Leukoencephalopathy, progressive multifocal. in H IV infection/AIDS, 362, 363i Levator aponeurotic defects. ptosis caused by, 2i8 Levator complex, 45 LHON (Leber hereditary optic neuropathy). 134-136, 135i Ligament. See /lamed ligame/lt Light bright, anisocoria greater in, 265-269 dim, anisocoria greater in. 260, 262-265, 263i dim and bright. anisocoria equal in, 260

400

. Index

pupillary reaction to, 57, 59; pupillary response to, 85, 86; Light-near dissociation, of pupils, 269-270, 2691 Lightning streaks of Moore, 189 Limbic system (cingulate gyrus), 56 Line of Gennari, 29 Lingual gyrus, 31 Lisch nodules, in neurofibromatosis, 337, 338; Longitudinal fasciculus, medial, 34 rostral interstitial nucleus of, 34, 37; Loop of Meyer, 29, 166 Louis-Bar syndrome (ataxia-telangiectasia), 3361, 340, 342, 342; Low vision, 83-102. See also Visual loss/impairment adjunctive testing for, 96-102 best-corrected visual acuity in, 84 binocular, 308-309 classification and management of, 103-170 color vision testing for, 96 electrophysiologic testing for, 99-102 electroretinography in, 10 1-102, 102; examination of, 84-102 fluorescein angiography in, 98, 99; fundus examination for, 87-89, 88;, 89;, 891 history in, 83-84 photostress recovery test for, 97 potential acuity meter testing for, 97-98 pupillary testing for, 84-87, 86; spatial contrast sensitivity testing for, 97 visual evoked potential testing for, 100-101 visual field testing for, 89-96. See also Visual field testing Lumboperitoneal shunting, for idiopathic intracranial hypertension, 119-120 Lyme disease/Lyme borreliosis cranial nerve VII involvement in, 284 ocular manifestations of, 362-364 stages of, 363 Lymphoma central nervous system, in HIV infection/ AIDS, 359 numb chin associated with, 301 M-cells (magnocellular cells), 24 Macroadenoma, pituitary, in pregnancy, 344 Macropsia, 188, 189 Macrosaccadic oscillations, 204, 252-253, 252; Macrosquare-wave jerks, 252, 252; Macular degeneration, age-related, 104 Macular disorders, transient visual loss and, 174 Macular edema, cystoid, 104-105 Macular electroretinography, 10 1 Macular hole, 105 Macular pucker, 105 Maculopathy, 104-105 cellophane, 105 Maddox rod test, for strabismus, 214, 214;, 215; Magnetic resonance angiography (MRA) of carotid stenosis, 179 definition of, 80 limitations of, 771 Magnetic resonance imaging (MRI), 62-65 basic principles of, 62 diffusion-weighted image in, 64, 67; functional. 68 definition of, 78

of intraparenchymal hemorrhage, 771 limitations of, 771 parameters in, 64 t of retrobulbar optic neuritis, 143 signal intensity in, 65t TI- and T2-weighted images in, 62-63, 63;, 64;, 65;, 66; Magnetic resonance spectroscopy (MRS), 68 definition of, 80 Magnocellular cells (M-cells), 24 Main sensory nucleus, of cranial nerve V, 50, 50;, 51; Malingering, 303 Mandibular division, of cranial nerve V, 52, 53; Manifest latent nystagmus, 243 MAR (melanoma-associated retinopathy), 101, 109 Marcus Gunn jaw-winking syndrome, 276, 277;, 279, 281 Marcus Gunn pupil (relative afferent pupillary defect) in central retinal artery occlusion, 106 in central retinal vein occlusion, 107 in multiple evanescent white dot syndrome, 107 retrochiasmallesions causing, 165 testing for, 84-87, 86; in evaluation of functional visual disorders, 307 practical tips in, 85-86 Mastoid bone, 54 Maxilla/maxillary bone,S, 6;, 10 Maxillary artery, 11 internal, 9 Maxillary division, of cranial nerve V, 52, 53; Maxillary nerve, 52 Maxillary sinus, 9 McDonald diagnostic criteria, for multiple sclerosis, 3231, 324 Meatus, inferior, of nose, 10 Medial complex, 45 Medial longitudinal fasciculus, 34 disruption of, 224 rostral interstitial nucleus of, 34, 37;, 202 Medial rectus muscle, 42, 42; Medial superior temporal area, 34 Median perforators, of basilar artery, 18 Median thalamostriate branch, of posterior cerebral artery, 18 Meige syndrome, 286, 287; Melanoma-associated retinopathy (MAR), 101, 109 MELAS (mitochondrial myopathy with encephalopathy/lactic acidosis/stroke-like episodes), 297 Melkersson-Rosenthal syndrome, 285 Meniere disease, 246 Meningeal artery dorsal, 13 middle, 11, 13 Meningeal nerve, middle, 52 Meningioma of cerebellopontine angle, 284 MR imaging of, 76; optic nerve sheath, 130;,145-148,147;,1481 in children, 148 orbital, transient visual loss and, 175 parasellar, chiasmal syndromes caused by, 162 Meningitis cranial nerve VII involvement in, 284

Index. cryptococcal, 368 headache and, 291 Mental acuity disturbances, in multiple sclerosis, 320 Mental nerve neuropathy, 301 Mesencephalic nucleus, of cranial nerve V, 50, 50; Metamorphopsia, 90 illusions and, 188-189 Metastatic breast carcinoma, numb chin associated with,301 Methanol toxicity, optic neuropathy caused by, 152 Methylprednisolone for giant cell arteritis, 122 for optic neuritis, 143 for traumatic optic neuropathy, 154 MEWDS (multiple evanescent white dot syndrome), 107,108i Meyer's loop, 29, 166 Micropsia, 188, 189 Microsaccadic refixation movements, 199 Microvascular cranial nerve palsy, pain associated with, 299 Mid chiasmal syndrome, 158, 160; Midbrain, damage to, pupils and, 270 Midbrain corectopia, 260 Middle cerebral artery, 16, 17, 20i Migraine aura, without headache, 294-295 Migraine headache, 292-295 acephalgic,294-295 with aura (classic migraine), 185,293-294, 293i basilar-type (complicated migraine), 293-294 evaluation of, 295, 295i inherited encephalopathies resembling, 297-298 ophthalmoplegic, 231 pathophysiology of, 294 retinal, 294-295 transient visual loss caused by, 185 treatment of acute, 296 prophylactic,296-297 without aura (common migraine), 294 Millard-Gubler syndrome, 227 Miller Fisher syndrome, 277, 285 Mirror test, in evaluation of functional visual disorders, 305,306; Mitochondrial DNA mutation, in Leber hereditary optic neuropathy, 134-135 Mitochondrial myopathy with encephalopathy/lactic acidosis/stroke-like episodes (MELAS), 297 Mitoxantrone, for multiple sclerosis, 324 Mobius syndrome, 283 Molds, 365 Monocular blindness, evaluation of, as functional disorder, 306-307, 308i Monocular diplopia, 216 Monocular nystagmus, in children, 243 Monocular transient visual loss, 173-184. See a/so Transient visual loss versus binocular visual loss, 171 embolic causes of, 174t, 175-183, 176;, 178i clinical and laboratory evaluation of, 179-180 clinical aspects of, 1nt prognosis for, 180-181, 180t treatment of, 181-182, 182t hypoperfusion causing, 174t, 183-184, 184i

401

ocular causes of, 173-175, 174t orbital causes of, 174t, 175 systemic causes of, 174t, 175-184 vasculitis causing, 174t, 183 Monocular vision, reduced, 308 Moore, lightning streaks of, 189 Morning glory disc anomaly, 140-141 Motor apraxia, ocular. See Ocular motor apraxia Motor nerves, facial, anatomy of, 49-56 Motor symptoms, in multiple sclerosis, 320 MOTSA (multiple overlapping thin slab acquisition), for magnetic resonance angiography, 66 MRA. See Magnetic resonance angiography (MRA) MRI. See Magnetic resonance imaging (MRJ) MRS. See Magnetic resonance spectroscopy (MRS) Mucormycosis, neuro-ophthalmic signs of, 366-367, 367; Mulberry lesions, 132 Muller cells, retinal, 24 Muller's muscle, 57, 58i paresis of, 262 Multifocal electroretinography, 102, 102i Multiple evanescent white dot syndrome (MEWDS), 107, 108; Multiple overlapping thin slab acquisition (MOTSA), for magnetic resonance angiography, 66 Multiple sclerosis, 317-325 chiasmallretrochiasmal abnormalities in, 321 clinical course of, 318 clinical presentation of, 318-320 diagnosis of, 324 criteria in, 323t epidemiology of, 317 fundoscopic abnormalities in, 321 genetics of, 317 HLA association in, 317 laboratory evaluation of, 322, 323t neuroimaging in, 322 ocular flutter caused by, 253 ocular motility disturbances in, 321-322 optic nerve involvement in, 143,320-321 treatment of, 143-144 pathology of, 318, 319i prognosis of, 318 treatment of, 324-325 Munchausen syndrome, 303 Muscles. See a/so named muscle

extraocular anatomy of, 41-42, 42i congenital fibrosis type I syndrome of, 220 of eyelid, 56 Muscular artery, inferior/superior, 15 Myasthenia gravis, 224 clinical presentation of, 325-326 diagnosis of, 326-328, 327; neuro-ophthalmic signs of, 325-328 ptosis in, 274i, 275 treatment of, 328 Mycobacterium av;um-intracel/u/are, 361 Mycobacterium tuberculosis, in HIV infection/AIDS, 361 Mydriasis benign episodic, 270-271 blunt trauma causing, 265

402

. Index

drug-induced,266 Myokymia facial, 287/, 289 superior oblique, 254 Myopathy extraocular, in thyroid-associated orbitopathy, 329;, 330 mitochondrial, with encephalopathy/lactic acidosis/ stroke-like episodes, 297 neuro-ophthalmic signs of, 334-335 Myositis, orbital, 219 Myotonic dystrophy, 335 NAION (nonarteritic anterior ischemic optic neuropathy), 121/, 122-124, 123;, 124/ Nasal radiating fibers, III NASCET (North American Symptomatic Carotid Endarterectomy Trial), 181-182, 182/ Nasociliary nerve, 52, 53; terminal branches of, 54 Nasolacrimal duct, 10 Natalizumab, for multiple sclerosis, 324 Near reflex, spasm of, 3 \3 Near response, in pupillary examination, 258 Neocerebellum, 39 Neoplastic disease facial pain associated with, 30 I ocular flutter caused by, 253 orbital. 219 Neostigimine methylsulfate (Prostigmin) test, for myasthenia gravis, 327 Neovascularization, impaired pupillary reactivity and, 259 Nerve fiber layer (NFL) defects of, in optic atrophy, 87-88, 88; in papilledema, 112, 115-116, 115; peripapillary, gliosis of, 116, 116; retinal homonymous, 164 imaging of, 69 Nerves, cranial. See Cranial nerves; specific Ilerve Neuralgia glossopharyngeal, 300 postherpetic, 301 trigeminal (tic douloureux), 299 Neural integrator, 244 Neuritis. See Optic neuritis Neurocutaneous syndromes (phakomatoses), 335, 336/, 337-343 ataxia-telangiectasia, 336/, 340,342,342; neurofibromatosis, 336/,337-338,338; retinal angiomatosis, 336/, 340, 342; Sturge- Weber syndrome, 336/, 340, 341; tuberous sclerosis, 336/, 338-340, 339; Wyburn-Mason syndrome, 336/, 342-343,343; Neurofibromatosis bilateral acoustic (type 2), 337 von Recklinghausen (type 1),336/,337-338,338; ptosis in, 274; relationship of, to optic nerve glioma, 149 Neuroimaging, 61-81. See also specific modality choice of clinical locations in, 71/ clinical situations in, 721 of cranial nerves palsy/paralysis, 74, 74;

critical questioning in, 71-78 how to order as, 78 what to order as, 75-78, 75/, 76;, 77t when to order as, 71-75, 73;,74; diagnostic goal of, fundamental concepts of localization in, 70, 71/, 72/ in differentiating drusen from papilledema, 132, 133; in evaluation of multiple sclerosis, 322 in evaluation of optic neuritis, 73 in evaluation of visual field defects, 73, 73; glossary of terms in, 78-81 history of, 61 metabolic and functional, 68-69 negative studies in, 78, 79;, 80;, 81; noninvasive techniques of, 69 vascular, 65-69 Neuroleptic drugs, idiosyncratic reaction to, 212 Neuroma, acoustic, of cerebellopontine angle, 284, 285; Neuron lesions, Horner syndrome caused by, 263-264, 263;, 264; Neuro-ophthalmology anatomy in afferent

visual

pathways

in, 23-3

I

bony, 5-10 efferent visual ( ocular motor) pathways and, 32-49 facial motor and sensory, 49-56 ocular anatomic pathways and, 56-60 cerebrovascular, 345-358 neuroimaging in, 61-81. See also Neuroimaging systemic conditions important in, 317-368 cerebrovascular disorders, 345-358 immunologic disorders, 317-332 infectious disorders, 358-368 inherited disorders, 334-343 pregnancy and, 343-345 sarcoidosis and, 332-333 Neuropathy mental,301 optic. See Optic neuropathy Neuroretinitis, 125, 126; cat-scratch disease causing, 368 Nevus flammeus (port-wine stain), in Sturge-Weber syndrome, 340, 341; NFL. See Nerve fiber layer (NFL) Nodules iris, 337, 338; Lisch, 337, 338; Nodulus, 33 Nonarteritic anterior ischemic optic neuropathy (NAION), 1211,122-124,123;,124/ Non-field testing, in evaluation of functional visual disorder, 310 Nonsteroidal anti-inflammatory drugs, for headache, 296 Nonvisual tasks, evaluation of functional visual disorders in, 305 North American Symptomatic Carotid Endarterectomy Trial (NASCET), 181-182, 182/ Nose, inferior meatus of, 10 Nothnagel syndrome, 227 Nuclear lesions, diplopia and, 226 Nucleus of Darkschewitsch, 39 Nucleus prepositus hypoglossi, 39, 202

Index. 403 Nucleus raphe interpositus. 34 Nucleus reticularis tegmenti pontis. 34 "Numb chin" syndrome. 301 Numbness. facial. pain associated with. 301 Nutritional deficiency. optic neuropathy caused by. 152. 153i Nystagmus. 239-256 acquired. 239 Alexander's law for. 244. 246. 248 amplitude of. 240 Bruns. 248 central vestibular. 247-248 congenital. 241-242 convergence-retraction. 254 dissociated (disconjugate/disjunctive). 240. 251 downbeat. 248-249. 248i early-onset (childhood). 241-243 congenital. 241-242 latent. 242-243 monocular. 243 spasmus nutans in. 243 gaze-evoked. 39. 224. 225i. 244. 245i head-shaking. 200 introduction to. 239-240. 240i. 241 i

jerk. 239 latent. 242-243 in multiple sclerosis. 322 oculopalatal. 251 optokinetic. 167. 198 assessment of. 201-202 dysfunction of. 205-206 evaluation of functional visual disorders patterns of. 241 i pendular. 239. 240i acquired. 250-251 periodic alternating. 250 peripheral vestibular. 245-247. 246t rebound. 244 saccadic intrusions and. 252-254. 252i see-saw. 251 spasmus nutans in. 243 spontaneous. 200 torsional. 249-250 treatment of. 255 upbeat. 249 vestibular. 245-250 central forms of. 247-250. 247t peripheral. 245-247. 246t voluntary. 253-254. 312

retrochiasmal. 167-170. 168i. 169i. 170i transient visual loss caused by. 185 Occipital seizures. transient visual loss caused by. 186 Occlusive retinal disease arterial. central. 105-106. 106i venous. central. 106-107. 106i Ocular autonomic pathways. 56-60 parasympathetic. 57. 59-60. 59i. 60i sympathetic. 56-57. 58i Ocular bobbing. 208. 256 reverse. 256 Ocular deviation conjugate. in comatose patients. 256 tonic. 211-212 Ocular dipping. 256 Ocular dominance columns. 29 Ocular flutter. 253 Ocular hemorrhage. with subarachnoid hemorrhage. 351 Ocular ischemic syndrome. 183-184. 184i Ocular lateropulsion. 205 Ocular media. abnormalities of. 103-104 Ocular migraine. 184. See a/so Migraine headache Ocular motility assessment of. 197-212 convergence in. 203-204 in evaluation of functional visual disorders. 311-313 eye movement

in. 305

Object agnosia. 192 Oblique muscle. inferior/superior. 41. 42. 42i Oblique myokymia. superior. 254 Oblique subnucleus. inferior. 45 Occipital bone. 9 Occipital (primary visual/calcarine/striate) cortex. 28-29. 30i. 31. 31i disorders of. 191-196. 193t problems of object recognition in. 192. 193i. 194 vision or vision deficit awareness in. 195-196 visual-spatial relationships in. 194-195 Occipital ischemia. transient visual loss caused by. 185-186 Occipital lobe lesions hallucinations and. 190-191

and.

199-204.

See a/so Eye

movements optokinetic nystagmus in. 201-202 pursuit system in. 203 saccadic system in. 202-203 stability in. 199 vestibulo-ocular reflex in. 200-201 disorders of. 204-212 in ataxia-telangiectasia. 342 in multiple sclerosis. 321-322 optokinetic nystagmus. 205-206 pursuit. 210 saccadic. 206-209 gaze palsy and. 208-209. 209i. 210i ocular motor apraxia and. 207-208 stability. 204-212 tonic eye deviation and. 211-212 vergence. 210- 211 vestibulo-ocular. 205 efferent visual system and. 197 examination of. 239-240 fundamental principles of. 197-199 infranuclear pathways in. 197 supranuclear pathways in. 197 Ocular motor apraxia. 207-208 acquired. 194.207-208 congenital. 207 Ocular motor pathways. 32-49 cranial nerves of. 42-43. 44i. 45-49. 45-49i extraocular muscles of. 41-42. 42i infranuclear. 197 supranuclear. 197 Ocular stability assessment of. 199 dysfunction of. 204-212 Ocular tilt reaction. 205

404

. Index

Oculogyric crisis, 212 Oculomasticatory myorhythmia, 255 Oculomotor nerve. See Cranial nerve III (oculomotor nerve) Oculopalatal nystagmus, 251 Oculopharyngeal dystrophy, 334-335 ODD. See Optic disc drusen (ODD) Olivary nucleus inferior, 40 superior, 43 One-and-a-half syndrome, 225, 226; OPA 1 gene, 136 Open-angle glaucoma, in Sturge- Weber syndrome, 340 Ophthalmic artery, 10, 13, 15, 178; terminal,15 Ophthalmic division, of cranial nerve V, 52, 53; Ophthalmic vein, inferior/superior, 20, 22; Ophthalmoplegia, internuclear, 39, 210, 224-225, 225;, 226; myasthenia gravis and, 224 nystagmus in, 224, 225; unilateral, 225, 226; wall-eyed bilateral. 224, 225; Ophthalmoplegic migraine, 231. See also Migraine headache Opsoclonus, 253 Opsoclonus-myoclonus syndrome. 253 Optic ataxia, 194 Optic atrophy, 87-88. 88; autosomal dominant. 136-137, 137; retrochiasmallesions causing, 164, 166; Optic canal. 5, 10, 26 Optic chiasm. See Chiasm (optic) Optic disc (optic nerve head) atrophy of, 123 congenital anomalies of, 138-141 in diabetic papillopathy, 127, 127; edema of, 26, 88-89, 89;. 891 in acute papilledema, 112-113 in anterior optic neuropathy, 111-113, 115-129 in papillitis, 125-126 evacuated anomalies of, 140-141 in Foster Kennedy syndrome, 123, 123; hypoplasia of. 138-139, 139; retinal nerve fibers entering, III, 112; tilted syndrome of. 139-140, 140; vasculitis of. 128, 128; Optic disc drusen (000).115,115;,129-134,131; versus astrocytic hamartoma, 132-134, 133; in children, 133-134 versus papilledema, 130-132, 132;. 133; pseudopapilledema and, 115, 115; Optic nerve (cranial nerve II) anatomy of. 25-27 disorders of illusions and. 189 relative afferent pupillary defect in, 86-87 hypoplasia of, 138-139, 139; intracanalicular portion of, compressive lesions of, 145-151 intraorbital portion of, 26 compressive lesions of, 145-151 traumatic damage to, 153-155, 154; Optic nerve glioma, 148-151, 149;, 1501 malignant, 151

relationship of neurofibromatosis 1 to, 149 Optic nerve sheath decompression surgery, for nonarteritic anterior ischemic optic neuropathy, 124 Optic nerve sheath fenestration, for idiopathic intracranial hypertension. 119 Optic nerve sheath meningioma, 130;, 145-148, 147;, 1481 in children, 148 Optic neuritis, 298 atypical, tests for, 143 hallucinations and, 190 in multiple sclerosis, 320-321 neuroimaging in evaluation of, 73 versus nonarteritic anterior ischemic optic neuropathy, 1241 postviral, 141 retrobulbar, 141-144, 142; treatment of. 143-144 Optic neuropathy. 111-157 anterior with optic disc edema, 111-113. 115-129 without optic disc edema, 129-141 anterior ischemic, 120-124, 1211,347 arteritic, 120-122, 121;, 1211 nonarteritic, 1211, 122-124,123;.1241 compressive, intraorbital/intracanalicular, 145-151 in increased intracranial pressure. See Papilledema infiltrative, 156 Leber hereditary, 134-136, 135; nutritional, 152, 153; posterior, 141-156 ischemic, 155 radiation-induced. MR imaging of, 65; sarcoid, 129, 130; in sarcoidosis, 333 thyroid-related, 145 toxic, 152 traumatic, 153-155, 154; direct, 153, 154; indirect, 154 visual field patterns in. Ill, 112;, 1131. 114; Optic pit, 140 Optic radiations, 28 Optic tract, 27-28, 28; retrochiasmallesions of, 164-165, 165;, 166; Optic tract syndrome, 16, 164 Optical coherence tomography. 69 Optociliary shunt vessels. in papilledema, 116-117 Optokinetic nystagmus, 167, 198 assessment of, 201-202 dysfunction of, 205-206 evaluation of functional visual disorders in, 305 Orbicularis oculi weakness, in myasthenia gravis, 326 Orbit anatomy of, 9-10, 9; bony, 6-7; vascular arterial supply in, 11-12;, 15 venous drainage in, 20, 21; cancer infiltration of. 219 Orbital apex syndrome, 236 Orbital canal. 10 Orbital compressive lesions, 128-129, 130;

Index. 405 Orbital fissure. 10 inferior. 8i, 10 superior. 8i cranial nerve VI in. 43. 45-49i lesions of. 236 Orbital infiltrative lesions. 129. 130i Orbital inflammation. idiopathic. 298 Orbital myositis. 219 Orbital rim. anatomy of. 10 Orbital roof. bony anatomy of. 6i Orbital tumors MR imaging of. 64i pain caused by. 298-299 Orbital walls. bony anatomy of. 7i Orbitomeatalline. definition of. 80 Orbitopathy. thyroid-associated. 145. 146i, 329-332 compressive optic neuropathy in. 330. 330i diagnosis of. 330-331 extraocular myopathy in. 329i. 330 eyelid retraction from. 274-275. 276i. 279 eyelid signs in. 329. 329i proptosis and. 329 strabismus and. 217-218 treatment of. 331-332 Oscillations disconjugate/disjunctive.240 macrosaccadic. 204.252-253. 252i Oscillopsia. 239 Otitic hydrocephalus. 358 Overactivity disorders. of cranial nerve VII. 286-290. 287t Oxygen therapy. hypobaric. for nonarteritic anterior ischemic optic neuropathy. 124 P-cells (parvocellular cells). 24 Pacchionian granulations. 20 Pain. See a/so specific pain facial. 299-30 I atypical. 299 icepick. idiopathic stabbing headache and. 297 ocular causes of. 298-299 orbital causes of. 298-299 periorbital. 298 in optic neuritis. 141 with visual loss. 83-84 Palatine bone. 10 Paleocerebellum. 39 Palinopsia, 191 hallucinatory. 190-191 Palsy. See specific palsy Pancoast syndrome. 263 Papilledema. from cryptococcal meningitis. 368 acute. 112-113. 115-116. 115i. 116i chronic. 116-117. 116i. 117i versus optic disc drusen. 130-132. 132i. 133i versus pseudopapilledema. 113. 115 transient visual loss and. 174-175 Papillitis. 125-126. 126i Papillomacular bundle. 25. 25i Papillomacular fibers. Ill. 114i Papillopathy. diabetic. 127. 127i Papillophlebitis. 128. 128i Paracallosal branch. of cerebral artery. 16 Paradoxical pupillary reactions. 270

Paraflocculus.39 Paralysis (paresis) divergence. 211 facial. 280-281. 280i of gaze. psychic. 194 Todd's. 289 Paramedian pontine reticular formation. 34. 202 Paranasal sinuses. 9. 9i. See a/so llamed sinus Paraneoplastic retinopathy. 10 I. 108- 109 Parasellar lesions. affecting chiasm. 160-163. 162i treatment of. 163 Parasellar meningioma. chiasmal syndromes caused by. 162 Parasellar region. 5 Parastriate cortex (Brodmann area 18). 29. 31 Parasympathetic ganglia. of head and neck. 60i Parasympathetic nerve pathways. autonomic. 57. 59-60. 59i.60i Paravertebral sympathetic plexus. 56 Paretic syndromes. diplopia caused by. 221. 222i restrictive syndromes versus. 217. 218i Parietal bone. 9 Parietal lobe lesions hallucinations and. 190 retrochiasmal. 166-167 Parieto-occipital artery. 20. 20i Parinaud (dorsal midbrain) syndrome. 208-209, 210i eyelid retraction in. 279 Parkinson syndromes. saccadic disorders in. 206 Parkinsonism. postencephalitis. oculogyric crisis in. 212 Parks- Bielschowsky

3-step

test. for fourth

nerve

palsy.

232-233 Pars reticulata. of substantia nigra. 54 Parvocellular cells (P-cells). 24 Pattern electroretinography. 101-102 Pelli-Robson chart. 97 Pelopsia. 189 Pendular nystagmus. 239. 240i acquired. 250-251 Penicillin. for Lyme disease. 364 Perceptual distortion (metamorphopsia). 90 illusions and. 188-189 Percheron artery. 18 Pericallosal branch. of cerebral artery. 16 Perimetry. 90-96 automated in evaluation of functional visual disorder. 310. 31li static. 92-93. 93i, 94i. 95i. 96 Goldmann. 91-92. 93i in evaluation of functional visual disorder. 310. 312i kinetic. 90-91 static. 90-91 automated. 92-93. 93i. 94i, 95i. 96 tangent screen in. 91 Periodic alternating gaze deviation. in comatose patients. 256 Periodic alternating nystagmus. 250 Peripheral lesions. facial weakness/paralysis caused by. 227-237. 283-285. 284i Periungal fibroma. in tuberous sclerosis. 338 PERRLA mnemonic. 257

406

. Index

PET. See Positron emission tomography (PET) Petrosal nerve. greater superficial. 55 Petrosal sinus. inferior/superior. 23 Phakoma/phakomatosis. 335, 3361, 337-343 ataxia-telangiectasia. 3361, 340.342.342; neurofibromatosis. 3361, 337-338. 338i retinal angiomatosis. 3361. 340, 342; Sturge- Weber syndrome. 3361. 340. 341 i tuberous sclerosis. 3361, 338-340. 339i Wyburn-Mason syndrome, 3361, 342-343. 343i Pharmacologic anisocoria. 262. 266 Pharmacologic testing, for Horner syndrome. 262-263 Photophobia. 299 in cone dystrophy, 104 Photostress recovery test, in low vision evaluation. 97 Physiologic (simple/essential) anisocoria. 260. 261;. 262 Pie in the sky defects, 166 Pilocarpine in Adie's tonic pupil diagnosis. 266 in anisocoria diagnosis. 262 Pilocytic astrocytoma (optic nerve glioma). 148-151, 149;,1501 PION (posterior ischemic optic neuropathy), 155 Pituitary adenoma chiasmal syndromes caused by. 161-162, 162; MR imaging of. 73i Pituitary macroadenoma. in pregnancy. 344 Pituitary necrosis. postpartum (Sheenan syndrome). 345 Pixel. definition of. 80 Plaques. Hollenhorst. transient visual loss and. 173. 173; Platelet-fibrin embolus. transient visual loss and. 175. 176i,1771 Poisoning. botulism. ptosis caused by. 277 Polaroid slide test. in evaluation of functional visual disorders. 307. 308i Pontine nuclei, dorsolateral. 34 Pontine reticular formation, paramedian. 34, 202 Port-wine stain (nevus flammeus). in Sturge-Weber syndrome. 340, 341; Positron emission tomography (PET). 69 Post-cocaine anisocoria. 262 Post-cataract extraction restriction, 219 Postcentral gyrus (primary sensory cortex). 50. 50i. 51; Postencephalitis parkinsonism, oculogyric crisis in, 212 Posterior cerebral artery. 11. 16, 18, 20; Posterior chiasmal syndrome. 158, 161; Posterior ciliary artery. IS. 16i Posterior commissure. 39 Posterior communicating artery. 20 Posterior ethmoidal air cells. 9, 9; Posterior ethmoidal artery. 13, 15 Posterior ethmoidal foramen. 10 Posterior inferior cerebellar artery, 18, 19i Posterior ischemic optic neuropathy (PION). 155 Posterior optic neuropathy. 141-156 Posterior synechiae. anisocoria and. 262 Posterior vestibular artery. 18 Postganglionic Horner syndrome. 264-265 isolated, 264 Postpartum pituitary necrosis (Sheenan syndrome), 345 Potential acuity meter. in low vision evaluation. 97-98

Precentral gyrus, 54 Prednisone for cluster headaches, 297 for giant cell arteritis. 122 for optic neuritis. 143 for thyroid-associated orbitopathy. 331 Preeclampsia (toxemia of pregnancy). 343. 344i Preganglionic Horner syndrome, 263 Pregnancy neuro-ophthalmic disorders associated with. 343-345, 344;, 345; toxemia of (preeclampsia). 343. 344i transient visual loss in. 343-344. 344i. 345; Preseptal muscle. 56 Pretarsal muscle. 56 Pretectal (Parinaud/dorsal midbrain) syndrome. 208-209,210; Pretectum/pretectal nuclei, 27 vertical gaze palsy caused by, damage to. 209. 210; Primary sensory cortex (postcentral gyrus). 50. 50;. 51i Prism tests. in evaluation of functional visual disorders. 307 Progressive multi focal leukoencephalopathy. in HIV infection/ AIDS. 362. 363i Progressive supranuclear palsy. 199 slowed sacca des in. 206 Proptosis, in thyroid-associated orbitopathy. 329 Prosopagnosia. 192 Prostigmin (neostigimine methyl sulfate) test. for myasthenia gravis, 327 Proton density MRI. 62. 63;. 64i parameters of, 641 signal intensity on. 651 Pseudo-Foster Kennedy syndrome, 123 Pseudoisochromatic color plate testing. in low vision evaluation, 96 Pseudopapilledema. 113. liS optic disc drusen in, 115, 115; Pseudoptosis. 278 Pseudotumor cerebri (idiopathic intracranial hypertension). 118-120 diagnosis of, criteria for, 1181 treatment of, 119-120 Psychic paralysis of gaze. 194 Pterygoid process. of sphenoid bone,S. 9 Pterygoid venous plexus. 20. 22i Pterygomaxillary area. 9. 10 Pterygopalatine fossa. II Pterygopalatine nerves. 52 Ptosis. 276-279 acquired. 277-278. 2781 bilateral, 226 botulism poisoning causing. 277 cerebra\' 277 in chronic progressive external ophthalmoplegia. 334. 334i congenital, 276, 277; induction of. botulinum toxin in. 286 levator aponeurotic defects causing. 278 Marcus Gunn jaw-winking, 276. 277; in myasthenia gravis. 274;. 275. 327. 327; in neurofibromatosis. 274i nonphysiologic causes of. 314 steroid eyedrops causing. 278

Index. traumatic and mechanical causes of, 278 Pulfrich phenomenon. 189 Pupil-sparing third nerve (oculomotor) palsy. 230-231 Pupillary defect, 257-271 relative afferent (Marcus Gunn pupil) in central retinal artery occlusion. 106 in central retinal vein occlusion, 107 in multiple evanescent white dot syndrome. 107 retrochiasmallesions causing, 165 testing for. 84-87. 86i in evaluation of functional visual disorders. 307 practical tips in. 85-86 Pupillary light-near dissociation. 269-270. 269t Pupillary reactivity disorders of, 269-270. 269t evaluation of functional visual disorders and. 305 to light, 57, 59i consensual response in. 258 direct response in, 258 paradoxical. 270 Pupils abnormalities of. 257-271. See also specific abllormality examination of, 258-259 rare, 270-271 and accommodation. 313-314 Adie's tonic, 266-267. 267i, 268i Argyll-Robertson, 270 Argyll-Robertson-like.270 examination of. 258-259 PERRLA mnemonic in, 257 fixed. dilated. 313-314 irregularity of. 259-260 Marcus Gunn. See Marcus Gunn pupil (relative afferent pupillary defect) size of baseline. 259 change in. 314 evaluation of, 258 springing, 270-271 tadpole, 259-260 in third nerve palsy. 228-230. 229i white (leukocoria), 259 Purkinje cells, 40 Pursuit eye movement system, 198 assessment of. 203 dysfunction of. 210 smooth, 34. 35-36i Racemose angioma (Wyburn-Mason syndrome), 336t. 342-343. 343i Radiation-induced optic neuropathy, MR imaging of. 65i Radiation therapy. 69-70 complications of. 70 for optic nerve glioma, 151 for optic nerve sheath meningioma. 148 for parasellar tumors. 163 for thyroid-associated orbitopathy. 331 Radiations. optic, 28 Radiculitis, herpes. 360 Raeder paratrigeminal syndrome, 265 Ramsay Hunt syndrome, 284 RAPD. See Relative afferent pupillary defect (Marcus Gunn pupil)

407

Rebleeding, after cerebral aneurysm rupture. 352 Rebound headache. analgesic. 296 Rebound nystagmus, 244 Recoverin (CAR antigen), 109 Rectus muscle. 41 inferior/superior, 42. 42i lateral/medial, 42, 42i Rectus subnucleus inferior, 45 superior. 45-46 Recurrent erosion syndrome. pain caused by, 298 Red-green test, in evaluation of functional visual disorders. 307 Refixation movements, microsaccadic. 199 Reflex. vestibulo-ocular. See Vestibulo-ocular reflex (VOR) Reflex blepharospasm, 290 Reflexive saccades, in Parkinson syndromes, 206 Refractile bodies. in papilledema. 117. 117i Reid's line. definition of. 80 Relative afferent pupillary defect (Marcus Gunn pupil) in central retinal artery occlusion. 106 in central retinal vein occlusion. 107 in multiple evanescent white dot syndrome. 107 retrochiasmallesions causing. 165 testing for. 84-87. 86i in evaluation of functional visual disorders. 307 practical tips in. 85-86 Relaxation. definition of. 80 Restrictive syndromes diplopia caused by. 217-221 paretic syndromes versus, 217, 218i posttraumatic. 218-219 Reticular formation, paramedian pontine, 34 Retina anatomy of, 23-25. 25i astrocytic hamartoma of, versus optic disc drusen. 132-134,133i disorders of decreased vision with, 104 hallucinations caused by. 189-190 illusions caused by. 188 emboli in. See also Emboli clinical aspects of. Int clinical implications of. 180-181 Retinal angiomatosis (von Hippel-Lindau disease), 336t, 340. 342i Retinal artery, central. 11-12i. 15, 16i occlusion of. 105-106, 106i Retinal hemorrhage. dot-and-blot, 183. 184i Retinal inflammation, pained caused by, 298 Retinal migraine. 184,294-295. See also Migraine headache Retinal nerve fiber layer homonymous, 164 imaging of. 69 Retinal nerve fibers, III, 112i Retinal pigment epithelium, anatomy of. 24 Retinal vasculitis, benign, 128. 128i Retinal vasospasm (migraine). 190 Retinal vein arcade. 20. 21-22i central. 16i. 20. 21-22i occlusion of. 106-107. 106i

408

.

Index

Retinitis pigmentosa, decreased vision in, 110, llOi Retinitis pigmentosa sine pigmentum, 110 Retinochoroidal collateral vessels, in papilledema, 116-117 Retinopathy, 105-110 acute zonal occult outer, 107 cancer-associated, 101, 108-109 central retinal artery occlusion and, 105-106, 106i central retinal vein occlusion and, 106-107, 106i central serous, 105 melanoma-associated, 10 I, 109 multiple evanescent white dot syndrome and, 107, 108i retinitis pigmentosa and. 110. llOi surface wrinkling. 105 venous stasis, 184 Retraction, eyelid, 145,279,279/ in thyroid-associated orbitopathy, 274-275, 276i. 329, 329i Retrobulbar optic neuritis. 141-144, 142i treatment of, 143-144 Retrochiasmallesions, 164-170 in multiple sclerosis, 321 of occipital lobe. 167-170, 168i, 169i. 170i of optic tract. 164-165, 165i, 166i of parietal lobe. 166-167 of temporal lobe. 166, 167i visual field loss patterns in, 164 Reverse ocular bobbing. 256 Reverse ocular dipping, 256 Rhinocerebral mucormycosis, 366, 367i Riddoch phenomenon. 170, 196 Ring scotoma, in retinitis pigmentosa. 110 Rosenthal. basilar vein of, 22 Rostral interstitial nucleus, of medial longitudinal fasciculus, 34. 37i, 202 Rubeosis. in central retinal vein occlusion, 107 Saccades/saccadic system, 198 assessment of, 202-203 dysfunction of, 206-209 gaze palsy and, 208-209. 209i, 210i ocular motor apraxia and, 207-208 hypermetric. 203, 207 hypometric. 203, 207 intrusions in. 199,204.252-254 with normal intersaccadic intervals, 252-253, 252i without normal intersaccadic intervals, 253 reflexive, 206 visually guided, 34 Saccadic intrusions. 199, 204 Saccadomania. 253 Saccular (berry) aneurysm, 350 Sagittal sinus, superior, 20 thrombosis of. 358 SAM (selective adhesion molecule) inhibitor. for multiple sclerosis, 324 Sarcoid granuloma, 333 Sarcoidosis, 332-333 cranial nerve VII involvement in. 285 diagnosis and treatment of. 333 intraocular manifestations in, 333 neuro-ophthalmologic manifestations in, 333 numb chin associated with, 301

Saturation recovery (SR), definition of, 81 Schirmer test, 173, 298 Scleritis, 298 Sclerosis, tuberous (Bourneville syndrome). 336/, 338-340, 339i Sclerotic (gliotic) lesions, in multiple sclerosis, 318 Scotoma definition of, 113/ in multiple evanescent white dot syndrome. 107 ring, in retinitis pigmentosa. 110 systemic hypoperfusion causing. 170 SE (spin echo), definition of. 80 Sebaceous adenoma, in tuberous sclerosis. 338. 339i Second-order neuron lesions. Horner syndrome caused by, 263, 263i. 264 See-saw nystagmus, 25 I Seizures facial weakness/paralysis caused by. 289 occipital, transient visual loss caused by, 186 Selective adhesion molecule (SAM) inhibitor, for multiple sclerosis, 324 Sella turcica, 5 Semilunar ganglion, 52 Sensitivity testing, spatial contrast, in low vision evaluation, 97 Sensitivity threshold, in perimetry, 91. 92 Sensory nerves, of orbit, anatomy of. 49-56, 53i Sensory nucleus. main, of cranial nerve V, 50, 50i, 51 i Sensory symptoms, in multiple sclerosis, 320 Septic cavernous sinus thrombosis, 357 Septic superior sagittal sinus thrombosis, 358 Septo-optic dysplasia, 139 Serotonin receptor agonists, for migraine, 296 Serous chorioretinopathy, central. 105 Setting sun sign, 211 Seventh nerve (facial) palsy in head trauma, 285 in HIV infection/AIDS. 284 progressive, 285 recurrent, 285 in sarcoidosis, 333 Shagreen patches. in tuberous sclerosis, 338-339 Sheenan syndrome (postpartum pituitary necrosis), 345 Shock value, in evaluation of functional visual disorders. 305-306 Short tau inversion recovery (STIR) image, 63 signal intensity on, 65/ Short-term fluctuation, in perimetry, 96 Shunt (shunting). lumboperitoneal. for idiopathic intracranial hypertension. 119-120 Sigmoid sinus, 22 Simple cells, 29 Simultanagnosia. 194. 195i, 208 Single-photon emission computed tomography (SPECT), 69 Sinus(es). See named sinus Sinus thrombosis, 357-358 lateral (transverse), 358 superior sagittal, 358 Sixth nerve (abducens) palsy, 234-235 divergence spasm initiating, 211 Skew deviation, 223-224 alternating. 223

Index. in multiple sclerosis, 321 Sleep test, for myasthenia gravis, 326, 327 Slit-lamp examination, of anterior segment, 258-259 Slow twitch fibers, 41 Smoking, as risk factor for thyroid-associated orbitopathy, 331 Sonography. See Ultrasonography Spasm convergence,

211

habit, 290 hemifacial, 2871, 288-289, 288i Spasm of accommodation, 314 Spasm of fixation, 194 Spasm of near reflex, 313 Spasmus nutans, 243 Spastic paretic facial contracture, 289 Spatial contrast sensitivity testing, in low vision evaluation, 97 Specialty charts, in evaluation of functional visual disorders, 309 SPECT. See Single-photon emission computed tomography (SPECT) Spectacle prisms, for thyroid-associated orbitopathy, 331 Spheno-cavernous syndrome, 236 Sphenoid bone, 5, 6i, 10 pterygoid process of, 5, 9 Sphenoid sinus, 9, 9; Sphenopalatine ganglion, 9 Sphincter muscle, of iris, damage to, 265 Spin echo (SE), definition of, 80 Spin-lattice relaxation time (Tl), definition of, 81 Spin-spin relaxation time (T2), definition of, 81 Spinal nucleus, of cranial nerve V, 50, 50; Spiral ofTillaux, 41 Spreading depression of Leao, 191 Springing pupils, 270-271 Square-wave jerks, 199,204,252,252; Square-wave oscillations, 199 SR (saturation recovery), definition of, 81 Stabbing headache, idiopathic, icepick pains and, 297 Stapedial nerve, 55 Static imbalance, of vestibulo-ocular reflex, 200 Static perimetry, 90-91 automated, 92-93, 93;, 94;, 95;, 96 Stenosis, carotid evaluation of, 179 prognosis for, 180- 181 Stent (stenting) of aneurysm, 353-354 of carotid artery, 182 Stereopsis monocular reduced vision and, 308, 3091 testing of, in evaluation of functional visual disorders, 307 Steroid eyedrops, ptosis caused by, 278 STIR (short tau inversion recovery) image, 63 signal intensity on, 651 Strabismus comitant,216 incomitant, 217, 218; testing for, 214, 214;, 215; Straight sinus, 23 Stratum album profundum, 34

409

Stratum griseum profundum, 34 Striate cortex (Brodmann area 17),29, 30i Stroke gaze palsy and, 208 homonymous hemianopia caused by, 168;, 169 risk for, 180-181, 1801 transient visual loss and, 177, 179-180 without paralysis, 205 Sturge- Weber syndrome (encephalofacial angiomatosis), 3361, 340, 341; Subarachnoid hemorrhage, 353 ocular hemorrhage with, 351 Subarachnoid peripheral lesions, 227-235 Subclavian artery, proximal, 17 Subclavian steal, 349 Subnucleus, of cranial nerve VII, dorsal/lateral, 54 Substantia nigra, pars reticulata of, 54 Succinate, for Leber hereditary optic neuropathy, 136 Sulcus, temporal, 31 Superficial petrosal nerve, greater, 55 Superficial superior colliculus, 34 Superficial temporal artery, 11-12;, 15-16 Superior cerebellar artery, 18 Superior colliculus, superficial, 34 Superior muscular artery, 15 Superior oblique muscle, 41,42, 42; Superior oblique myokymia, 254 Superior ophthalmic vein, 20, 22; Superior orbital fissure, 8i cranial nerve VI in, 43, 45-49; lesions of, 236 Superior petrosal sinus, 23 Superior rectus muscle, 42, 42i Superior rectus subnucleus, 45-46 Superior sagittal sinus, 20 thrombosis of, 358 Superior vestibular nerve, 32, 54 Supranuclear eye movement systems, 33-34, 35-38i, 39 lesions of, diplopia and, 222-223, 2231 Supranuclear lesions, facial weakness/paralysis caused by, 281 Supranuclear palsy, progressive, 199 slowed saccades in, 206 Supranuclear pathways, in ocular motility, 197 Supraorbital artery, 13, 15 Supraorbital nerve, 52, 53i Supratrochlear artery, 13, 15 Supratrochlear nerve, 52, 53i Surface wrinkling retinopathy, 105 Surgical clipping, of aneurysm, 353 Surgical excision, for optic nerve sheath meningioma, 148 Suture. See named sulure Swinging flashlight test, for relative afferent pupillary defect, 84-85, 86i Sympathetic nerve pathways, autonomic, 56-57, 58i Sympathetic plexus, paravertebral, 56 Synechiae, posterior, anisocoria and, 262 Synkinesis, facial, 280, 280i, 284 Syphilis, in HIV infection/AIDS, 361-362 TI (interpulse time), definition of, 81 TI (spin-lattice relaxation time), definition TI-weighted images, 62-63, 63;, 64i, 65i parameters of, 641

of, 81

410

. Index

signal intensity on. 651 T2 (spin-spin relaxation time). definition of. 81 T2-weighted images. 62-63. 63;. 64;. 65;. 66; parameters of. 641 signal intensity on. 651 Tadpole pupil. 259-260 Tangent screen. 91 TAG. See Thyroid-associated orbitopathy (TAG) Tardive dyskinesia. 286 Target screen testing. in evaluation of functional visual disorders. 311, 313; Tarsorrhaphy, for thyroid-associated orbitopathy. 331 TE (time to echo). definition of, 81 Tear film (tears). dysfunction/alterations of. illusions caused by, 188 Tear preparations, artificial. 286 Telangiectasia, conjunctival, 342, 342; Teleopsia. 189 Temporal (giant cell) arteritis anterior ischemic optic neuropathy and, 120-122 facial pain associated with. 299 headache with, 292 Temporal artery, superficial. 11-12;. 15-16 Temporal bone,S Temporal crescent. 29 occipital lobe lesions causing, 168 Temporal fossa, 9 Temporal lobe lesions hallucinations and, 190 retrochiasmal, 166. 167; Temporal nerve, 56 Temporal sulcus, 31 Temporofacial trunk. of cranial nerve VII. 56 Temporomandibular joint disease, 300 Tensilon (edrophonium chloride) test. 224 for myasthenia gravis. 326-327 Tension-type headache. 296 treatment of. 297 Tentorium, inferior hypophyseal artery of. 13 Terson syndrome. 351, 352; Tesla, definition of, 81 Tetracycline, for Lyme disease. 364 Thalamic esodeviations. 224 Thalamostriate branch. of posterior cerebral artery. median. 18 Thalamus. contralateral. 50, 50; Thiamine deficiency. optic neuropathy caused by, 152 Third nerve (oculomotor) palsy. 228-232, 229; aberrant regeneration of third nerve and, 232, 232; aneurysm and, 351 anisocoria and, 267. 269 divisional, 231 pupil-sparing, 230-231 pupillary involvement in. 228-230, 229; in younger patients, 231 Third-order neuron lesions. Horner syndrome caused by. 263, 264 Three-step test. Parks- Bielschowsky. for fourth nerve palsy. 232-233 Threshold sensitivity, in perimetry. 91, 92 Thrombosis, cerebral and dural sinus. 357-358 Thyroid-associated orbitopathy (TAG). 145. 146;. 329-332 compressive optic neuropathy in. 330. 330;

diagnosis of, 330-331 extraocular myopathy in, 329;, 330 eyelid retraction in, 274-275. 276;, 279 eyelid signs in, 329, 329; proptosis and, 329 strabismus and. 217-218 treatment of, 331-332 Thyroid function tests, in diagnosis of thyroidassociated orbitopathy, 330 TIAs. See Transient ischemic attacks (TIAs) Tic, facial (habit spasm), 290 Tic douloureux (trigeminal neuralgia). 299 Tillaux spiral, 41 Tilted disc syndrome, congenital. 139-140, 140; Time course, of visual loss. 83 Time to echo (TE). definition of. 81 Time to repetition (TR), definition of. 81 Tinnitus. in peripheral vestibular nystagmus, 246 Titmus stereoacuity test. Polaroid glasses with. in evaluation of functional visual disorders, 307, 308; Tobacco use, optic neuropathy and, 152 Todd's paralysis, 289 Tolosa-Hunt syndrome, 236, 298 Tonic eye deviation. 211-212 Tonic fibers, 41 Tonic pupils, Adie's, 266-267, 267;, 268; Torcular Herophili, 22 Torsional nystagmus, 249-250 Tourette syndrome. 290 Toxemia of pregnancy (preeclampsia). 343. 344; Toxic optic neuropathy, 152 Toxin. botulinum for blepharospasm, 288 for hemifacial spasm. 289 for ptosis, 286 Toxoplasmosis. in HIV infection/AIDS. 362 TR (time to repetition), definition of, 81 Transient ischemic attacks (TIAs) carotid disease causing, 177 stroke following, 180-18 I, 1801 transient visual loss and. 177 vertebrobasilar, 348;, 349 causes of. 349 nonophthalmic symptoms of. 347-348 treatment of. 349 Transient visual loss, 171-186. See also Amaurosis fugax age of patient and, 171 binocular, 185-186 versus monocular, 171 cerebrovascular causes of. 345-346. 345-349 duration of, 171-172 examination of, 173, 173; hypercoagulability causing, 185 hyperviscosity causing. 185 monocular, 173-184. See also Monocular transient visual loss versus binocular, 171 pattern of, 172 in pregnancy. 343-344. 344;, 345; recovery in, 172 signs and symptoms associated with, 172 vasospasm causing. 184-185 Transverse sinus, 22

Index. Trauma head, seventh nerve palsy in, 285 optic neuropathy caused by, 153-155, 154i ptosis caused by, 278 pupillary irregularity caused by, 259 Trigeminal ganglion, 52 Trigeminal nerve. See Cranial nerve V (trigeminal nerve) Trigeminal neuralgia (tic douloureux), 299 Trigeminal nucleus, 50 Tritanopia in dominant optic atrophy, 136 testing for, in low vision evaluation, 96 Trochlear nerve. See Cranial nerve IV (trochlear nerve) Tuberculosis, Mycobacterium, in HIV infection/AIDS, 361 Tuberin, Tuberous

338 sclerosis

338-340, Tumors.

(Bourneville

syndrome),

336t,

339i

See also specific

cerebellopontine

angle,

till/lOr 234, 283, 284, 285i

orbital MR imaging of, 64i pain caused by, 298-299 parasellar, drugs for, 163 Turbinate, inferior, 10 Twitch fibers, 41 Tympanic bone, 54 UGH (uveitis-glaucoma-hyphema) syndrome, 174 Uhthoff symptom, 172 Ultrasonography, 69 B-scan, in differentiating drusen from papilledema, l31,132i of carotid stenosis, 179 duplex, in carotid evaluation, 179 Underactivity disorders, of cranial nerve VII, 281-286, 283t Unilateral visual loss, versus bilateral visual loss, 83 Upbeat nystagmus, 249 Upgaze conjugate paresis of, 211 disorders of, conjugate limitation, 207 limited, in Brown syndrome, 219, 220i Urinary sphincter disturbances, in multiple sclerosis, 320 Uveitis, 299 ischemic, 183-184 Uveitis-glaucoma-hyphema (UGH) syndrome, 174 Uvula, ventral, 33 VI (Brodmann area 17/striate cortex), 29, 30i V2 (Brodmann area 18/parastriate cortex), 29, 31 V3 (area of brain), 29 V4 (area of brain), 29, 31 V5 (area of brain), 31 V6 (area of brain), 31 Vascular system, anatomy of, 10-23 arterial, 11-20 venous, 20-23 Vasculitis optic disc, 128, 128i transient visual loss caused by, 183 Vasospasm cerebral aneurysm and, 352

retinal (migraine), 190,294 transient visual loss and, 184-185 Vein of Galen, 23 Vein of Labbe, 22 Velocity in saccades testing, 202 zero, in pursuit testing, 203 Venous plexus, pterygoid, 20, 22i Venous stasis retinopathy, 184 Venous system. See also named vein anatomy of, 20-23 Venous thrombosis, cerebral, 357-358 Ventral uvula, 33 VEP (visual evoked potential) testing, in low vision evaluation, 100-10 1 Vergence system assessment of, 203-204 disorders of, 210-211 Vermis, dorsal, 41 Vertebral artery, 178i dissection of, 355 leftlright, 17 Vertebrobasilar system arterial, 17-18, 19i disorders of blurred vision with, 186 neuro-ophthalmic signs in, 347-349, 348i Vertical gaze, 37i, 39, 40i Vertical gaze palsy, 208-209, 210i Vertical prism dissociation test, in evaluation of functional visual disorders, 307 Vertigo, benign paroxysmal positional, 247 Vestibular artery, anterior/posterior, 18 Vestibular nerve, inferior/superior, 32, 54 Vestibular nuclei, 32 Vestibular nystagmus, 245-250 central, 246t, 247-250, 247t peripheral, 245-247, 246t Vestibular system anatomy of, 32, 32i dynamic function of, 200 imbalance of, brain stem lesions and, 205 Vestibulocerebellum, anatomy of, 39-40 Vestibulo-ocular reflex (VOR), 32-33, 33i. 198 assessment of, 200-201 disorders of, 205 gain of, 201 imbalance of, tests for, 200 Vidian nerve, 57 Villus(i), arachnoid, 20 Vision awareness of, problems with, 195-196 blurred, 213 vertebrobasilar insufficiency and, 186 color, defects in. See Color vision, defects in double. See Diplopia low. See Low vision reduced binocular, 308-309 monocular, 308, 309t Visual acuity best-corrected, in low vision evaluation, 84 bottom-up, in evaluation of functional visual disorders, 308-309

411

412

. Index

relationship of. to stereopsis. 3091 Visual aids, in evaluation of functional visual disorders. 309 Visual allesthesia. 195 Visual aura migraine (classic) headache with. 185.293-294. 293i migraine (common) headache without. 294 Visual (calcarine/occipital/striate) cortex. 28-29. 30i, 31,31i disorders of, 191-196, 1931 hallucinations and. 170 problems of object recognition in, 192, 193i, 194 vision or vision deficit awareness in. 195-196 visual-spatial relationships in, 194-195, 195i Visual deficit. problems with, 195-196 Visual evoked potential (VEP) testing, in low vision evaluation, 100-10 I Visual field defects bilateral. 1131 characteristics of, 1131 congruous, 29 evaluation of as functional disorder, 309-311. 311i, 312i, 313i neuroimaging in, 73, 73i incongruous. 29 terms describing, 1131 Visual field patterns in chiasmallesions, 158, 159i. 160i, 161i in optic neuropathy. III, 112i, 1131, 114i in retrochiasmallesions. 164 Visual field testing, 89-96 Amsler grid in. 90 confrontation test in. 89-90 Goldmann perimetry in. 91-92 perimetry in. 90-96 automated static. 92-93, 93i, 94i, 95i, 96 tangent screen for, 91 silent, in evaluation of functional disorders, 310 Visual loss/impairment. See also Blindness assessment of, 83-102 adjunctive testing in, 96-102 best-corrected visual acuity in, 84 color vision testing in, 96 electrophysiologic testing in, 99-102 electroretinography in, 10 I-I 02. 102i examination in. 84-102 fluorescein angiography in, 98, 99i fundus examination in, 87-89, 88i, 89i, 891 history in, 83-84 photostress recovery test in, 97 potential acuity meter testing in, 97-98 pupillary testing in, 84-87, 86i spatial contrast sensitivity testing in, 97 visual evoked potential testing in, 100-10 I visual field testing in. 89-96. See also Visual field testing associated with carotid dissection, 354 bilateral versus unilateral involvement in, 83 delayed, following parasellar tumor therapy, 163 functional, 303-315 categories of, 303 diagnosis of, 304 examination techniques in, 305-315 identification of patient with, 303-304

management of, 315 symptoms associated with, 83-84 time course in, 83 transient, 171-186. See also Transient visual loss monocular. 173-184. See also Monocular transient visual loss Visual pathways afferent, 23-31, 269. See also Afferent visual pathways in evaluation of functional visual disorders, 305-311 anatomy of, 5-60 bony head in, 5-10 facial motor and sensory fibers in, 49-56 ocular autonomic pathways in, 56-60 vascular, 10-23 efferent (ocular motor), 32-49. See also Ocular motor pathways Visual processing stream, dorsal, in pursuit system, 203 Visual-spatial relationships, disorders of. 194-195, 195i deficiency, optic neuropathy caused by, 152 Vitamin B'2 Vitreous abnormalities of, decreased vision with, 104 detachment of, hallucinations and, 189 Voluntary nystagmus, 253-254, 312 Von Hippel-Lindau disease (retinal angiomatosis), 3361, 340, 342i von Recklinghausen neurofibromatosis. See Neurofibromatosis, von Recklinghausen (type 1) VOR. See Vestibulo-ocular reflex (VOR) Vortex vein, 20 Voxel, definition of. 81 Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO). 224, 225i Wallenberg syndrome, 207. 263 lateropulsion in, 205 Weber syndrome, 227 WEBINO (wall-eyed bilateral internuclear ophthalmoplegia), 224, 225i Weight loss, for idiopathic intracranial hypertension. 119 Whipple disease. 255 White dot syndrome. multiple evanescent, 107. 108i White matter lesions. associated with multiple sclerosis, 143 treatment of, 143-144 White pupil (leukocoria), 259 Willebrand's knee. 27.158 Willis, circle of, 16 Wyburn-Mason syndrome (racemose angioma), 3361, 342-343, 343i Yeasts, 365 Zero velocity. Zinn, annulus

in pursuit testing, of, 26, 41

203

Zinn- Haller, circle of, 15 Zoster sine herpete, 300 Zygomatic bone, 5, 6-7i. 7i, 10 Zygomatic

nerve,

Zygomaticofacial

52. 53i, 56 nerve,

52, 53i

Zygomaticomaxillary

suture.

Zygomaticotemporal Zygomaticotemporal

artery, nerve,

10 13 52. 53i